Seules les publications les plus récentes sont présentées – Pour voir plus de publications aller à la page de recherche : toutes les publications
Only the most recent publications are displayed – to see more, go to the search page : all publications
1368488
tuberculosis
1
heidelberg-university-faculty-of-medicine
50
date
desc
1
245
https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A250%2C%22request_next%22%3A50%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22J8DRRQV9%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kherabi%20et%20al.%22%2C%22parsedDate%22%3A%222025-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKherabi%2C%20Y.%2C%20Skouvig%20Pedersen%2C%20O.%2C%20Lange%2C%20C.%2C%20B%26%23xE9%3Bn%26%23xE9%3Bzit%2C%20F.%2C%20Chesov%2C%20D.%2C%20Codecasa%2C%20L.%20R.%2C%20Dudnyk%2C%20A.%2C%20Kiria%2C%20N.%2C%20Konstantynovska%2C%20O.%2C%20Marigot-Outtandy%2C%20D.%2C%20Panciu%2C%20T.-C.%2C%20Poignon%2C%20C.%2C%20Sasi%2C%20S.%2C%20Schaub%2C%20D.%2C%20Solodovnikova%2C%20V.%2C%20Vasiliauskait%26%23xE8%3B%2C%20L.%2C%20Yeghiazaryan%2C%20L.%2C%20G%26%23xFC%3Bnther%2C%20G.%2C%20Guglielmetti%2C%20L.%20and%20TBnet%5C%2FESGMYC%20XDR-TB%20Study%20Group%20%282025%29.%20%26lt%3Bb%26gt%3BTreatment%20outcomes%20of%20extensively%20drug-resistant%20tuberculosis%20in%20Europe%3A%20a%20retrospective%20cohort%20study%26lt%3B%5C%2Fb%26gt%3B.%20Lancet%20Reg%20Health%20Eur%20%26lt%3Bi%26gt%3B56%26lt%3B%5C%2Fi%26gt%3B%2C%20101380%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lanepe.2025.101380%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lanepe.2025.101380%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Treatment%20outcomes%20of%20extensively%20drug-resistant%20tuberculosis%20in%20Europe%3A%20a%20retrospective%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yousra%22%2C%22lastName%22%3A%22Kherabi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ole%22%2C%22lastName%22%3A%22Skouvig%20Pedersen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22B%5Cu00e9n%5Cu00e9zit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dumitru%22%2C%22lastName%22%3A%22Chesov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luigi%20Ruffo%22%2C%22lastName%22%3A%22Codecasa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrii%22%2C%22lastName%22%3A%22Dudnyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nana%22%2C%22lastName%22%3A%22Kiria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olha%22%2C%22lastName%22%3A%22Konstantynovska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiba%22%2C%22lastName%22%3A%22Marigot-Outtandy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Traian-Constantin%22%2C%22lastName%22%3A%22Panciu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corentin%22%2C%22lastName%22%3A%22Poignon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sirje%22%2C%22lastName%22%3A%22Sasi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dagmar%22%2C%22lastName%22%3A%22Schaub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Varvara%22%2C%22lastName%22%3A%22Solodovnikova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laima%22%2C%22lastName%22%3A%22Vasiliauskait%5Cu00e8%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lusine%22%2C%22lastName%22%3A%22Yeghiazaryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunar%22%2C%22lastName%22%3A%22G%5Cu00fcnther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22TBnet%5C%2FESGMYC%20XDR-TB%20Study%20Group%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20In%202021%2C%20World%20Health%20Organization%20revised%20of%20definition%20of%20extensive%20drug-resistant%20tuberculosis.%20We%20aimed%20to%20determine%20treatment%20outcomes%20of%20individuals%20affected%20by%20extensively%20drug-resistant%20tuberculosis%20in%20Europe.%5CnMETHODS%3A%20This%20observational%2C%20retrospective%20cohort%20study%20included%20patients%20diagnosed%20with%20extensively%20drug-resistant%20tuberculosis%20in%20the%20World%20Health%20Organization%20European%20Region%20from%202017%20to%202023.%20Participating%20centres%20collected%20consecutive%2C%20detailed%20individual%20data%20for%20extensively%20drug-resistant%20tuberculosis%20patients.%20Data%20were%20analysed%20with%20meta-%20and%20regression%20methods%2C%20accounting%20for%20between-country%20heterogeneity.%5CnFINDINGS%3A%20Among%2011%2C003%20patients%20with%20multidrug-resistant%5C%2Frifampicin-resistant%20tuberculosis%2C%20188%20%281%5Cu00b77%25%29%20from%2016%20countries%20had%20extensively%20drug-resistant%20tuberculosis.%20Of%20these%2C%2048%5Cu00b74%25%20harboured%20strains%20with%20resistance%20to%20bedaquiline%20%28n%20%3D%2091%5C%2F188%29%2C%2034%5Cu00b70%25%20to%20linezolid%20%28n%20%3D%2064%5C%2F188%29%2C%20and%2017%5Cu00b76%25%20to%20both%20%28n%20%3D%2033%5C%2F188%29.%20The%20individual%20composition%20of%20anti-tuberculosis%20regimens%20was%20highly%20variable%2C%20with%20151%20different%20drug%20combinations.%20Among%20the%20156%5C%2F188%20%2883%5Cu00b70%25%29%20patients%20with%20available%20treatment%20outcomes%2C%20the%20pooled%20percentage%20of%20successful%20outcomes%20was%2040%5Cu00b72%25%20%2895%25%20confidence%20interval%20%5B95%25%20CI%5D%2028%5Cu00b74%25-53%5Cu00b72%25%29.%20In%20patients%20with%20unsuccessful%20treatment%20outcomes%20%28101%5C%2F156%29%2C%20most%20experienced%20treatment%20failure%20%28n%20%3D%2057%5C%2F156%20%5Bpooled%20proportion%2037%5Cu00b71%25%5D%2C%2095%25%20CI%3A%2026%5Cu00b71%25-49%5Cu00b77%25%29%20or%20death%20%28n%20%3D%2030%5C%2F156%20%5Bpooled%20proportion%2021%5Cu00b73%25%5D%2C%2095%25%20CI%3A%2015%5Cu00b77%25-28%5Cu00b72%25%29.%20After%20adjustment%20for%20disease%20severity%2C%20each%20additional%20likely%20effective%20drug%20decreased%20the%20odds%20of%20unsuccessful%20outcomes%20%28adjusted%20odds%20ratio%3A%200%5Cu00b765%2C%2095%25%20CI%3A%200%5Cu00b745-0%5Cu00b796%29%20%28p%20%3D%200%5Cu00b7026%29%2C%20whereas%20being%20treated%20in%20an%20upper-middle-income%20country%20increased%20the%20odds%20of%20unsuccessful%20outcomes%20compared%20with%20being%20treated%20in%20a%20high-income%20country%20%28adjusted%20odds%20ratio%3A%2013%5Cu00b77%2C%2095%25%20CI%3A%203%5Cu00b77-50%5Cu00b72%29%20%28p%20%26lt%3B%200%5Cu00b7001%29.%20Compared%20with%20other%20levels%20of%20drug%20resistance%2C%20treatment%20outcomes%20were%20significantly%20worse%20for%20extensively%20drug-resistant%20tuberculosis.%5CnINTERPRETATION%3A%20Only%20four%20out%20of%20ten%20patients%20affected%20by%20extensively%20drug-resistant%20tuberculosis%20achieved%20successful%20treatment%20outcomes.%20These%20findings%20highlight%20the%20need%20for%20adequate%2C%20individualised%20treatment%20regimens%20and%20optimised%20drug%20susceptibility%20testing.%5CnFUNDING%3A%20None.%22%2C%22date%22%3A%222025-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lanepe.2025.101380%22%2C%22ISSN%22%3A%222666-7762%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-08-21T13%3A36%3A00Z%22%7D%7D%2C%7B%22key%22%3A%227N5LTZQU%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Benhard%20et%20al.%22%2C%22parsedDate%22%3A%222025-07-31%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBenhard%2C%20J.%2C%20Monsel%2C%20G.%2C%20Dub%26%23xE9%3Be%2C%20V.%2C%20Pavese%2C%20P.%2C%20Rasoldier%2C%20V.%2C%20Garrait%2C%20V.%2C%20Talleux%2C%20M.%2C%20Vuotto%2C%20F.%2C%20Gueneau%2C%20R.%2C%20Pouget-Abadie%2C%20X.%2C%20Thy%2C%20M.%2C%20Palacios%2C%20C.%2C%20Bachir%2C%20M.%2C%20Djossou%2C%20F.%2C%20Tunesi%2C%20S.%2C%20Jachym%2C%20M.%20F.%2C%20Pourcher%2C%20V.%2C%20Veziris%2C%20N.%20and%20Bourgarit%2C%20A.%20%282025%29.%20%26lt%3Bb%26gt%3BStandardized%20Infliximab%20Regimen%20to%20Treat%20Severe%20Central%20Nervous%20System%20Tuberculosis%3A%20A%20Case%20Series%20of%2018%20Patients%26lt%3B%5C%2Fb%26gt%3B.%20Open%20Forum%20Infectious%20Diseases%20%26lt%3Bi%26gt%3B12%26lt%3B%5C%2Fi%26gt%3B%2C%20ofaf450%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fofid%5C%2Fofaf450%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fofid%5C%2Fofaf450%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Standardized%20Infliximab%20Regimen%20to%20Treat%20Severe%20Central%20Nervous%20System%20Tuberculosis%3A%20A%20Case%20Series%20of%2018%20Patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johan%22%2C%22lastName%22%3A%22Benhard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gentiane%22%2C%22lastName%22%3A%22Monsel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Dub%5Cu00e9e%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Pavese%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vero%22%2C%22lastName%22%3A%22Rasoldier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9rie%22%2C%22lastName%22%3A%22Garrait%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Talleux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fanny%22%2C%22lastName%22%3A%22Vuotto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romain%22%2C%22lastName%22%3A%22Gueneau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xavier%22%2C%22lastName%22%3A%22Pouget-Abadie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Thy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christia%22%2C%22lastName%22%3A%22Palacios%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marwa%22%2C%22lastName%22%3A%22Bachir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felix%22%2C%22lastName%22%3A%22Djossou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simone%22%2C%22lastName%22%3A%22Tunesi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%20Fr%5Cu00e9chet%22%2C%22lastName%22%3A%22Jachym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9rie%22%2C%22lastName%22%3A%22Pourcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Bourgarit%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Background%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Morbidity%20associated%20with%20central%20nervous%20system%20tuberculosis%20%28CNS%20TB%29%20remains%20high%20due%20to%20persistent%20inflammation%20despite%20standard-of-care%20%28SOC%29%20treatment%2C%20including%20antituberculosis%20therapy%20and%20corticosteroids.%20Tumor%20necrosis%20factor%20alpha%20%28TNF-%5Cu03b1%29%20is%20a%20key%20cytokine%20driving%20this%20inflammatory%20response%2C%20and%20a%20limited%20number%20of%20case%20reports%20suggest%20that%20TNF-%5Cu03b1%20inhibitors%20may%20improve%20outcomes.%20We%20report%20the%201-year%20outcome%20of%20a%20cohort%20of%20consecutive%20patients%20treated%20with%20infliximab%20for%20severe%20CNS%20TB.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Methods%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Following%20the%20guidance%20provided%20by%20the%20French%20Tuberculosis%20Consilium%2C%20a%20standardized%20regimen%20of%20intravenous%20infliximab%20at%205%5Cu2005mg%5C%2Fkg%20per%20dose%20was%20used%20to%20treat%20CNS%20TB%20unresponsive%20to%20SOC.%20We%20retrospectively%20included%20consecutive%20patients%20who%20received%20at%20least%201%20infliximab%20injection%20for%20CNS%20TB%20from%202017%20to%20September%202021.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Results%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Eighteen%20patients%20with%20CNS%20TB%2C%2094%25%20with%20tuberculous%20meningitis%2C%20were%20included.%20Most%20had%20severe%20disease%3A%2082%25%20were%20classified%20as%20British%20Medical%20Research%20Council%20grade%20II%20or%20III%2C%20and%2044%25%20required%20intensive%20care%20unit%20admission.%20All%20demonstrated%20clinical%20and%20radiological%20worsening%20despite%20SOC%3B%20in%2089%25%20due%20to%20paradoxical%20reaction.%20At%20infliximab%20initiation%2C%20symptoms%20remained%20disabling%2C%20with%20a%20median%20modified%20Rankin%20scale%20%28mRS%29%20score%20of%203.5%20%28interquartile%20range%2C%203%5Cu20134%29.%20One%20month%20after%20the%20first%20infusion%2C%2038%25%20showed%20improved%20mRS%20scores%2C%20increasing%20to%2078%25%20at%201%5Cu2005year.%20One-year%20survival%20was%2094%25%3B%201%20death%20occurred%2012%5Cu2005months%20after%20a%20single%20infliximab%20dose%20and%20was%20unrelated%20to%20TB%20treatment.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Conclusions%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Infliximab%20may%20represent%20a%20promising%20adjunctive%20treatment%20for%20CNS%20TB%20unresponsive%20to%20SOC%2C%20including%20paradoxical%20reaction.%20Prospective%20studies%20are%20needed%20to%20confirm%20these%20findings.%22%2C%22date%22%3A%222025-07-31%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1093%5C%2Fofid%5C%2Fofaf450%22%2C%22ISSN%22%3A%222328-8957%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Facademic.oup.com%5C%2Fofid%5C%2Farticle%5C%2Fdoi%5C%2F10.1093%5C%2Fofid%5C%2Fofaf450%5C%2F8232409%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-09-30T15%3A04%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22G5G79UG2%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222025-07-16%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuglielmetti%2C%20L.%2C%20Khan%2C%20U.%2C%20Vel%26%23xE1%3Bsquez%2C%20G.%20E.%2C%20Gouillou%2C%20M.%2C%20Ali%2C%20M.%20H.%2C%20Amjad%2C%20S.%2C%20Kamal%2C%20F.%2C%20Abubakirov%2C%20A.%2C%20Ardizzoni%2C%20E.%2C%20Baudin%2C%20E.%2C%20Bektassov%2C%20S.%2C%20Berry%2C%20C.%2C%20Bonnet%2C%20M.%2C%20Chavan%2C%20V.%2C%20Coutisson%2C%20S.%2C%20Dakenova%2C%20Z.%2C%20de%20Jong%2C%20B.%20C.%2C%20Dinh%2C%20L.%20V.%2C%20Ferlazzo%2C%20G.%2C%20Kirakosyan%2C%20O.%2C%20Lachenal%2C%20N.%2C%20Lecca%2C%20L.%2C%20McIlleron%2C%20H.%2C%20Mikanda%2C%20K.%20K.%2C%20Mucching-Toscano%2C%20S.%2C%20Mulders%2C%20W.%2C%20Mushtaque%2C%20H.%2C%20Nahid%2C%20P.%2C%20Nguyen%2C%20D.%20V.%2C%20Nguyen%2C%20N.%20V.%2C%20Oyewusi%2C%20L.%2C%20Motta%2C%20I.%2C%20Panda%2C%20S.%2C%20Patil%2C%20Sandip%2C%20Pham%2C%20T.%20H.%2C%20Phan%2C%20D.%20T.%2C%20Phan%2C%20H.%20T.%20T.%2C%20Phillips%2C%20P.%20P.%20J.%2C%20Ruiz%2C%20J.%2C%20Rupasinghe%2C%20Praharshinie%2C%20Salahuddin%2C%20N.%2C%20Sanchez-Garavito%2C%20E.%2C%20Seung%2C%20K.%20J.%2C%20Asfaw%2C%20M.%20T.%2C%20Vargas%20Vasquez%2C%20D.%2C%20Rich%2C%20M.%20L.%2C%20Varaine%2C%20F.%2C%20Mitnick%2C%20C.%20D.%2C%20Arora%2C%20G.%2C%20Ashara%2C%20V.%2C%20Bhattacharjee%2C%20S.%2C%20Borkar%2C%20R.%2C%20Chincholikar%2C%20N.%2C%20Choudhary%2C%20N.%2C%20Davuluri%2C%20P.%2C%20Desai%2C%20N.%2C%20Dipika%2C%20Dhongade%2C%20S.%2C%20Dulani%2C%20D.%2C%20Ghule%2C%20S.%2C%20Hirani%2C%20N.%2C%20Hurali%2C%20P.%2C%20Irani%2C%20R.%2C%20Jadhav%2C%20K.%2C%20Jadhav%2C%20P.%2C%20Jadhav%2C%20R.%2C%20Joseph%2C%20N.%2C%20Joshi%2C%20A.%2C%20Joshi%2C%20P.%2C%20K%2C%20A.%2C%20K%2C%20S.%2C%20Kamble%2C%20M.%2C%20Kate%2C%20R.%2C%20Keer%2C%20T.%2C%20S%20Kenche%2C%20M.%2C%20Khandare%2C%20H.%2C%20Koli%2C%20P.%2C%20Kulkarni%2C%20A.%2C%20Patra%2C%20S.%20K.%2C%20Kuwar%2C%20A.%2C%20Lande%2C%20P.%2C%20Mane%2C%20N.%2C%20Masalge%2C%20P.%2C%20Mishra%2C%20P.%2C%20Mitkari%2C%20R.%2C%20More%2C%20A.%2C%20Munot%2C%20P.%2C%20Murgesh%2C%20R.%2C%20Muthe%2C%20S.%2C%20Nakashe%2C%20N.%2C%20Natarajan%2C%20D.%2C%20Paril%2C%20S.%2C%20Patil%2C%20Supriya%2C%20Patil%2C%20V.%2C%20Patwardhan%2C%20V.%2C%20Posture%2C%20V.%2C%20Pradeshi%2C%20A.%2C%20Prasad%2C%20V.%2C%20Pundir%2C%20B.%2C%20Rajendran%2C%20S.%2C%20Randhit%2C%20Y.%2C%20Rekart%2C%20M.%2C%20Samant%2C%20P.%2C%20Shaikh%2C%20H.%2C%20Sharma%2C%20A.%2C%20Sharma%2C%20N.%2C%20Sharma%2C%20S.%2C%20Shinde%2C%20N.%2C%20Shinde%2C%20S.%2C%20Shingare%2C%20G.%2C%20Shulka%2C%20A.%2C%20Shriwas%2C%20A.%2C%20Sonawane%2C%20L.%2C%20Sudhindra%2C%20U.%2C%20Suryavanshi%2C%20D.%2C%20Thakare%2C%20A.%2C%20Udare%2C%20D.%2C%20Vaidya%2C%20G.%2C%20Wagh%2C%20R.%2C%20Isenova%2C%20L.%2C%20Konigratbayeva%2C%20G.%2C%20Nurtayeva%2C%20G.%2C%20Zekeshov%2C%20N.%2C%20Chenu%2C%20R.%2C%20Garba%2C%20S.%2C%20Tozzi%2C%20D.%2C%20Yuya-Septoh%2C%20F.-J.%2C%20Thi%20Tuyet%20Mai%2C%20B.%2C%20Thi%20Hai%2C%20D.%2C%20Thi%20Thuy%2C%20D.%2C%20Thi%20Oanh%2C%20L.%2C%20Do%2C%20B.%20T.%2C%20Nguyen%2C%20D.%20T.%2C%20Nguyen%2C%20P.%20H.%2C%20Nguyen%2C%20T.%20M.%20A.%2C%20Nguyen%2C%20Thi%20Thuy%20Hanh%2C%20Nguyen%2C%20T.%20K.%20N.%2C%20Nguyen%2C%20T.%20N.%2C%20Nguyen%2C%20V.%20K.%2C%20Nog%2C%20N.%2C%20Pham%2C%20T.%20N.%2C%20Pham%2C%20T.%20L.%2C%20Pham%2C%20T.%20A.%2C%20Phung%2C%20T.%20B.%2C%20Tran%2C%20B.%20T.%2C%20Trinh%2C%20M.%20T.%2C%20Chang%2C%20E.%2C%20Coit%2C%20J.%2C%20Do%2C%20J.-M.%2C%20LaHood%2C%20A.%2C%20O%26%23x2019%3BBrien%2C%20K.%2C%20Okunbor%2C%20E.%2C%20Osso%2C%20E.%2C%20Ch%26%23xE1%3Bvez%2C%20V.%2C%20Larco%2C%20P.%2C%20Mendoza%2C%20D.%2C%20Robles%2C%20C.%2C%20Rojas%2C%20A.%2C%20Salazar%2C%20J.%2C%20Santos%2C%20G.%2C%20Sosa%2C%20J.%2C%20Ticona%2C%20C.%2C%20Carranza%2C%20S.%2C%20Delgado%2C%20D.%2C%20Galarza%2C%20C.%2C%20Murga%2C%20G.%2C%20Ramos%2C%20E.%2C%20Cantaro%2C%20K.%2C%20Huerta%2C%20A.%2C%20Maldonado%2C%20J.%2C%20Nu%26%23xF1%3Bez%2C%20R.%2C%20Panduro%2C%20K.%2C%20Rafael%2C%20R.%2C%20Abdul%2C%20A.%2C%20Abedin%2C%20S.%2C%20Afreen%2C%20E.%2C%20Ahmed%2C%20Sohail%2C%20Ahmed%2C%20U.%2C%20Ali%20Shah%2C%20J.%2C%20Ashraf%2C%20A.%2C%20Aslam%2C%20F.%2C%20Bashir%2C%20Z.%2C%20Fayyaz%2C%20S.%2C%20Hafeez%2C%20K.%2C%20Hamid%2C%20M.%2C%20Hassan%2C%20B.%2C%20Hussain%2C%20M.%2C%20Irfan%2C%20M.%2C%20Omar%2C%20M.%2C%20Parveen%2C%20S.%2C%20Sunail%2C%20S.%2C%20Farooq%2C%20M.%2C%20Mazhar%2C%20B.%2C%20Munir%2C%20S.%2C%20Sonia%2C%20N.%2C%20Yaseen%2C%20M.%2C%20Zubair%2C%20M.%2C%20Zehra%2C%20F.%2C%20Zulfiqar%2C%20I.%2C%20Abbasi%2C%20T.%2C%20Akbar%20Abro%2C%20G.%2C%20Ahmed%2C%20M.%2C%20Ahmed%2C%20N.%2C%20Hammad%20Ali%2C%20M.%2C%20Ali%2C%20N.%2C%20Danish%2C%20R.%2C%20Farhat%2C%20A.%2C%20Gill%2C%20S.%2C%20Hafeez%2C%20M.%2C%20Hussain%2C%20G.%2C%20Inayat%2C%20H.%2C%20Johnson%2C%20S.%2C%20Kamal%2C%20F.%2C%20Kamran%2C%20A.%2C%20Kumar%2C%20Sanjeet%2C%20Maheshwari%2C%20M.%2C%20Mamsa%2C%20S.%2C%20Massey%2C%20S.%2C%20Mehmood%2C%20A.%2C%20Memon%2C%20A.%2C%20Ali%20Mirani%2C%20A.%2C%20Naz%2C%20S.%2C%20Rafique%20Qureshi%2C%20T.%2C%20Roop%20Moazzam%20Sheikh%2C%20Y.%2C%20Rafi%20Siddiqui%2C%20M.%2C%20Singh%2C%20B.%2C%20Soomro%2C%20M.%2C%20Ardizzoni%2C%20E.%2C%20Rigouts%2C%20L.%2C%20Rupasinghe%2C%20Praha%2C%20Aftab%2C%20A.%2C%20Ahmed%2C%20Saman%2C%20Adnan%20Alamgir%2C%20M.%2C%20Ali%2C%20Ayaz%2C%20Ali%2C%20Azhar%2C%20Ahmed%20Ali%2C%20S.%2C%20Ali%2C%20S.%2C%20Altaf%2C%20S.%2C%20Amjad%2C%20S.%2C%20Sahiba%20Arshad%2C%20M.%2C%20Ausim%2C%20S.%2C%20Basit%2C%20A.%2C%20Ezik%2C%20H.%2C%20Hussain%2C%20H.%2C%20Hyder%2C%20S.%2C%20Inayat%2C%20S.%2C%20Janmohammed%2C%20A.%2C%20Jaseem%2C%20K.%2C%20Jawed%2C%20A.%2C%20Maniar%2C%20L.%2C%20Kumar%2C%20P.%2C%20Kumar%2C%20Susheel%2C%20Latif%2C%20R.%2C%20Liaqat%2C%20S.%2C%20Ammar%20Nasser%2C%20M.%2C%20Shakeel%2C%20M.%2C%20Shaikh%2C%20S.%2C%20Siddiqui%2C%20A.%2C%20Singh%2C%20J.%2C%20Sivan%2C%20K.%2C%20Taimoor%2C%20M.%2C%20Zia%2C%20N.%2C%20Li%2C%20I.%2C%20Otepbergenova%2C%20M.%2C%20Dinh%2C%20T.%20H.%2C%20Do%2C%20Thi%20Thu%2C%20Do%2C%20Thu%20Thuong%2C%20Le%2C%20T.%20N.%2C%20Nguyen%2C%20K.%20C.%2C%20Nguyen%2C%20T.%20T.%2C%20Nguyen%2C%20V.%20H.%2C%20Abildayeva%2C%20G.%2C%20Maryash%2C%20O.%2C%20Telegina%2C%20E.%2C%20Tursynbekova%2C%20L.%2C%20Amanzholova%2C%20Z.%2C%20Bektassova%2C%20P.%2C%20Belgozhanova%2C%20A.%2C%20Birimkulova%2C%20N.%2C%20Dyusebayeva%2C%20N.%2C%20Erkut%2C%20N.%2C%20Gusmanov%2C%20A.%2C%20Kassenova%2C%20B.%2C%20Kassym%2C%20A.%2C%20Khazhidinov%2C%20K.%2C%20Lee%2C%20T.%2C%20Magzumova%2C%20A.%2C%20Mussabayeva%2C%20M.%2C%20Omarova%2C%20G.%2C%20Ryapolova%2C%20N.%2C%20Sagyndykova%2C%20L.%2C%20Serekbay%2C%20A.%2C%20Stambekova%2C%20A.%2C%20Tanatarova%2C%20G.%2C%20Uaisov%2C%20Z.%2C%20Zhantuarova%2C%20Z.%2C%20Zhumakairova%2C%20G.%2C%20Arlyapova%2C%20N.%2C%20Bogus%2C%20J.%2C%20Cain%2C%20M.%2C%20Carmona%2C%20M.%2C%20Flanagan%2C%20C.%2C%20McAnaw%2C%20S.%2C%20Scharff%2C%20A.%2C%20Soni%2C%20S.%2C%20Striplin%2C%20M.%2C%20Abebe%2C%20S.%2C%20Alakaye%2C%20J.%2C%20Bulane%2C%20A.%2C%20Custodio%2C%20M.%2C%20Hajison%2C%20P.%2C%20Hetsa%2C%20M.%2C%20Holtzman%2C%20D.%2C%20Khesa%2C%20M.%2C%20Lethola%2C%20M.%2C%20Lebitsa%2C%20T.%2C%20Mahamo%2C%20M.%2C%20Makaka%2C%20J.%2C%20Matoko%2C%20M.%2C%20Mpinda%2C%20S.%2C%20Mohoang%2C%20P.%2C%20Monyaesa%2C%20D.%2C%20Nkundayirazo%2C%20P.%2C%20Ntsane%20Sesomo%20Mohale%2C%20M.%2C%20Ntsibane%2C%20S.%2C%20Phate%2C%20S.%2C%20Radebe%20%28Retsepile%20Tlali%29%2C%20M.%2C%20Rakhetsi%2C%20M.%2C%20Ranoosi%2C%20T.%2C%20Tamirat%2C%20M.%2C%20Thokoana%2C%20M.%2C%20Alegre%2C%20E.%2C%20Aguilar%2C%20C.%2C%20Armuto%2C%20L.%2C%20Barreda%2C%20N.%2C%20Barreto%2C%20M.%2C%20Cabrera%2C%20S.%2C%20Calderon%2C%20R.%2C%20Castro%2C%20M.%2C%20Chavez%2C%20J.%2C%20Chavez%2C%20L.%2C%20Cheje%2C%20H.%2C%20Cori%2C%20L.%2C%20D%26%23xE1%3Bvalos%2C%20D.%2C%20de%20la%20Gala%2C%20S.%2C%20Delgadillo%2C%20K.%2C%20Diaz%2C%20H.%2C%20Flores%2C%20X.%2C%20Galarza%2C%20J.%2C%20Garc%26%23xED%3Ba%2C%20D.%2C%20Garcia%2C%20F.%2C%20Gaspar%2C%20M.%2C%20Godos%2C%20R.%2C%20Gomez%2C%20P.%2C%20Gonzales%2C%20L.%2C%20Guerrero%2C%20L.%2C%20Inga%2C%20S.%2C%20Jasaycucho%2C%20J.%2C%20Martel%2C%20B.%2C%20Pro%20Martinez%2C%20A.%2C%20Molina%2C%20R.%2C%20Mugruza%2C%20R.%2C%20Mundaca%2C%20H.%2C%20Nuahan%2C%20M.%2C%20Ore%2C%20K.%2C%20Panduro%2C%20L.%2C%20Pe%26%23xF1%3Ba%2C%20O.%2C%20Perea%2C%20S.%2C%20Pinedo%2C%20C.%2C%20Ponce%2C%20Y.%2C%20Quinte%2C%20C.%2C%20Qui%26%23xF1%3Bones%2C%20M.%2C%20Ramos%2C%20A.%2C%20Ramirez%2C%20E.%2C%20Reynoso%2C%20R.%2C%20Reyes%2C%20C.%2C%20Reyes%2C%20J.%2C%20Riccio%2C%20V.%2C%20Robles%2C%20B.%2C%20Rojas%2C%20K.%2C%20Sanabria%2C%20O.%2C%20Saravia%2C%20M.%2C%20Saravia%2C%20S.%2C%20Senador%2C%20L.%2C%20Soberon%2C%20J.%2C%20Soncco%2C%20E.%2C%20Soto%2C%20M.%2C%20Suarez%2C%20C.%2C%20Suarez%2C%20M.%2C%20Suarez%2C%20V.%2C%20Torpoco%2C%20E.%2C%20Torres%2C%20O.%2C%20Torrez%2C%20C.%2C%20Tunque%2C%20G.%2C%20Ugarte%2C%20A.%2C%20Vaderrama%2C%20G.%2C%20Valdivia%2C%20W.%2C%20Valdivia%2C%20Y.%2C%20Valverde%2C%20I.%2C%20Vargas%2C%20C.%2C%20Vargas%2C%20J.%2C%20Vasquez%2C%20E.%2C%20Veliz%2C%20J.%2C%20Villa%2C%20D.%2C%20Villafuerte%2C%20S.%2C%20Villar%2C%20G.%2C%20Villegas%2C%20S.%2C%20Wong%2C%20M.%2C%20Yataco%2C%20R.%2C%20Pham%2C%20H.%2C%20Truong%2C%20H.%2C%20Nguyen%2C%20H.%2C%20Huy%2C%20V.%2C%20Nguyen%2C%20V.%20S.%2C%20Nguyen%2C%20T.%20M.%20K.%2C%20Minh%2C%20T.%2C%20Bui%2C%20D.%20T.%20T.%2C%20Truong%2C%20V.%20V.%2C%20Nguyen%2C%20Thi%20Thu%20Ha%2C%20Coutisson%2C%20S.%2C%20Atger%2C%20M.%2C%20Nadia%20Baya%2C%20S.%2C%20Bekhiet%2C%20M.%2C%20Boissi%26%23xE8%3Bre%2C%20V.%2C%20Caboclo%2C%20R.%2C%20Chaudhry%2C%20M.%2C%20Cloez%2C%20S.%2C%20Collin%2C%20S.%2C%20Delifer%2C%20C.%2C%20Demaisons%2C%20S.%2C%20Ducher%2C%20V.%2C%20Hewison%2C%20C.%2C%20Ibrahim%2C%20M.%2C%20Lebeau%2C%20K.%2C%20Mazmanian%2C%20M.%2C%20Mirzayeva%2C%20R.%2C%20Moreau%2C%20M.%2C%20Moschioni%2C%20M.%2C%20P%26%23xE2%3Bquet%2C%20A.%2C%20Perrin%2C%20C.%2C%20Pichon%2C%20L.%2C%20Roussel%2C%20J.%2C%20Scotton%2C%20M.%2C%20Austin%2C%20A.%20and%20Sun%2C%20P.%20%282025%29.%20%26lt%3Bb%26gt%3BBedaquiline%2C%20delamanid%2C%20linezolid%2C%20and%20clofazimine%20for%20rifampicin-resistant%20and%20fluoroquinolone-resistant%20tuberculosis%20%28endTB-Q%29%3A%20an%20open-label%2C%20multicentre%2C%20stratified%2C%20non-inferiority%2C%20randomised%2C%20controlled%2C%20phase%203%20trial%26lt%3B%5C%2Fb%26gt%3B.%20The%20Lancet%20Respiratory%20Medicine%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2213-2600%2825%2900194-8%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2213-2600%2825%2900194-8%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Bedaquiline%2C%20delamanid%2C%20linezolid%2C%20and%20clofazimine%20for%20rifampicin-resistant%20and%20fluoroquinolone-resistant%20tuberculosis%20%28endTB-Q%29%3A%20an%20open-label%2C%20multicentre%2C%20stratified%2C%20non-inferiority%2C%20randomised%2C%20controlled%2C%20phase%203%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Uzma%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%20E%22%2C%22lastName%22%3A%22Vel%5Cu00e1squez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maelenn%22%2C%22lastName%22%3A%22Gouillou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%20Hammad%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samreen%22%2C%22lastName%22%3A%22Amjad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farees%22%2C%22lastName%22%3A%22Kamal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanzhan%22%2C%22lastName%22%3A%22Abubakirov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisa%22%2C%22lastName%22%3A%22Ardizzoni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Baudin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sagit%22%2C%22lastName%22%3A%22Bektassov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Berry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maryline%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%22%2C%22lastName%22%3A%22Chavan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvine%22%2C%22lastName%22%3A%22Coutisson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhanna%22%2C%22lastName%22%3A%22Dakenova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bouke%20Catherine%22%2C%22lastName%22%3A%22de%20Jong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luong%20Van%22%2C%22lastName%22%3A%22Dinh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriella%22%2C%22lastName%22%3A%22Ferlazzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ohanna%22%2C%22lastName%22%3A%22Kirakosyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Lachenal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonid%22%2C%22lastName%22%3A%22Lecca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22McIlleron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kwabisha%20Kunda%22%2C%22lastName%22%3A%22Mikanda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergio%22%2C%22lastName%22%3A%22Mucching-Toscano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wim%22%2C%22lastName%22%3A%22Mulders%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hebah%22%2C%22lastName%22%3A%22Mushtaque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Payam%22%2C%22lastName%22%3A%22Nahid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dong%20Van%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nhung%20Viet%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lawrence%22%2C%22lastName%22%3A%22Oyewusi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilaria%22%2C%22lastName%22%3A%22Motta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samiran%22%2C%22lastName%22%3A%22Panda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandip%22%2C%22lastName%22%3A%22Patil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thuong%20Huu%22%2C%22lastName%22%3A%22Pham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dat%20Thuong%22%2C%22lastName%22%3A%22Phan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ha%20Thi%20Thu%22%2C%22lastName%22%3A%22Phan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20P%20J%22%2C%22lastName%22%3A%22Phillips%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jimena%22%2C%22lastName%22%3A%22Ruiz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Praharshinie%22%2C%22lastName%22%3A%22Rupasinghe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naseem%22%2C%22lastName%22%3A%22Salahuddin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Epifanio%22%2C%22lastName%22%3A%22Sanchez-Garavito%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kwonjune%20J%22%2C%22lastName%22%3A%22Seung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meseret%20Tamirat%22%2C%22lastName%22%3A%22Asfaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dante%22%2C%22lastName%22%3A%22Vargas%20Vasquez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20L%22%2C%22lastName%22%3A%22Rich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francis%22%2C%22lastName%22%3A%22Varaine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carole%20D%22%2C%22lastName%22%3A%22Mitnick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gurpreet%22%2C%22lastName%22%3A%22Arora%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valay%22%2C%22lastName%22%3A%22Ashara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonali%22%2C%22lastName%22%3A%22Bhattacharjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rakshanda%22%2C%22lastName%22%3A%22Borkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Namita%22%2C%22lastName%22%3A%22Chincholikar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikita%22%2C%22lastName%22%3A%22Choudhary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Praveen%22%2C%22lastName%22%3A%22Davuluri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neha%22%2C%22lastName%22%3A%22Desai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Dipika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunil%22%2C%22lastName%22%3A%22Dhongade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Drishti%22%2C%22lastName%22%3A%22Dulani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheetal%22%2C%22lastName%22%3A%22Ghule%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nilma%22%2C%22lastName%22%3A%22Hirani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prakash%22%2C%22lastName%22%3A%22Hurali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reeana%22%2C%22lastName%22%3A%22Irani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiran%22%2C%22lastName%22%3A%22Jadhav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pritesh%22%2C%22lastName%22%3A%22Jadhav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Radhika%22%2C%22lastName%22%3A%22Jadhav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nidhin%22%2C%22lastName%22%3A%22Joseph%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akshay%22%2C%22lastName%22%3A%22Joshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pranav%22%2C%22lastName%22%3A%22Joshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akhilraj%22%2C%22lastName%22%3A%22K%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sagar%22%2C%22lastName%22%3A%22K%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madhavi%22%2C%22lastName%22%3A%22Kamble%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rashmi%22%2C%22lastName%22%3A%22Kate%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanvi%22%2C%22lastName%22%3A%22Keer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madhuri%22%2C%22lastName%22%3A%22S%20Kenche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harsha%22%2C%22lastName%22%3A%22Khandare%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pranesha%22%2C%22lastName%22%3A%22Koli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Apurva%22%2C%22lastName%22%3A%22Kulkarni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sagar%20Kumar%22%2C%22lastName%22%3A%22Patra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abhishek%22%2C%22lastName%22%3A%22Kuwar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prakash%22%2C%22lastName%22%3A%22Lande%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nana%22%2C%22lastName%22%3A%22Mane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priya%22%2C%22lastName%22%3A%22Masalge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priya%22%2C%22lastName%22%3A%22Mishra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rishabh%22%2C%22lastName%22%3A%22Mitkari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%22%2C%22lastName%22%3A%22More%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pracheta%22%2C%22lastName%22%3A%22Munot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ramya%22%2C%22lastName%22%3A%22Murgesh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sagar%22%2C%22lastName%22%3A%22Muthe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nupur%22%2C%22lastName%22%3A%22Nakashe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dwaragesh%22%2C%22lastName%22%3A%22Natarajan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharad%22%2C%22lastName%22%3A%22Paril%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Supriya%22%2C%22lastName%22%3A%22Patil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vaishali%22%2C%22lastName%22%3A%22Patil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vaijayanti%22%2C%22lastName%22%3A%22Patwardhan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivek%22%2C%22lastName%22%3A%22Posture%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anil%22%2C%22lastName%22%3A%22Pradeshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanya%22%2C%22lastName%22%3A%22Prasad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bhavya%22%2C%22lastName%22%3A%22Pundir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarathi%22%2C%22lastName%22%3A%22Rajendran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yogesh%22%2C%22lastName%22%3A%22Randhit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Rekart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pradnya%22%2C%22lastName%22%3A%22Samant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanif%22%2C%22lastName%22%3A%22Shaikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashutosh%22%2C%22lastName%22%3A%22Sharma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neela%22%2C%22lastName%22%3A%22Sharma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharda%22%2C%22lastName%22%3A%22Sharma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nilesh%22%2C%22lastName%22%3A%22Shinde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suvarna%22%2C%22lastName%22%3A%22Shinde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gauri%22%2C%22lastName%22%3A%22Shingare%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abhay%22%2C%22lastName%22%3A%22Shulka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aniket%22%2C%22lastName%22%3A%22Shriwas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lokesh%22%2C%22lastName%22%3A%22Sonawane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Urmila%22%2C%22lastName%22%3A%22Sudhindra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dipali%22%2C%22lastName%22%3A%22Suryavanshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akshay%22%2C%22lastName%22%3A%22Thakare%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danashree%22%2C%22lastName%22%3A%22Udare%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gayatri%22%2C%22lastName%22%3A%22Vaidya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rani%22%2C%22lastName%22%3A%22Wagh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lyazzat%22%2C%22lastName%22%3A%22Isenova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gulbakhar%22%2C%22lastName%22%3A%22Konigratbayeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gulnar%22%2C%22lastName%22%3A%22Nurtayeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nurlan%22%2C%22lastName%22%3A%22Zekeshov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romain%22%2C%22lastName%22%3A%22Chenu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Souna%22%2C%22lastName%22%3A%22Garba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daiane%22%2C%22lastName%22%3A%22Tozzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francis-Jaudel%22%2C%22lastName%22%3A%22Yuya-Septoh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bui%22%2C%22lastName%22%3A%22Thi%20Tuyet%20Mai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dang%22%2C%22lastName%22%3A%22Thi%20Hai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dinh%22%2C%22lastName%22%3A%22Thi%20Thuy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lai%22%2C%22lastName%22%3A%22Thi%20Oanh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bang%20Tam%22%2C%22lastName%22%3A%22Do%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dinh%20Tuyen%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Phuong%20Hoang%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Mai%20Anh%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Thuy%20Hanh%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Kieu%20Ninh%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Nhien%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Van%20Khiem%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nog%22%2C%22lastName%22%3A%22Nog%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thanh%20Nam%22%2C%22lastName%22%3A%22Pham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Lan%22%2C%22lastName%22%3A%22Pham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thu%20Anh%22%2C%22lastName%22%3A%22Pham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Bich%22%2C%22lastName%22%3A%22Phung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bao%20Trung%22%2C%22lastName%22%3A%22Tran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minh%20Trang%22%2C%22lastName%22%3A%22Trinh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eva%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Coit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacquelyn-My%22%2C%22lastName%22%3A%22Do%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allison%22%2C%22lastName%22%3A%22LaHood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelsey%22%2C%22lastName%22%3A%22O%27Brien%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Enoma%22%2C%22lastName%22%3A%22Okunbor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elna%22%2C%22lastName%22%3A%22Osso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victor%22%2C%22lastName%22%3A%22Ch%5Cu00e1vez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Piero%22%2C%22lastName%22%3A%22Larco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Mendoza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Robles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angelo%22%2C%22lastName%22%3A%22Rojas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janet%22%2C%22lastName%22%3A%22Salazar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Sosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cesar%22%2C%22lastName%22%3A%22Ticona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shirley%22%2C%22lastName%22%3A%22Carranza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diego%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cemir%22%2C%22lastName%22%3A%22Galarza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gladys%22%2C%22lastName%22%3A%22Murga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Ramos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelly%22%2C%22lastName%22%3A%22Cantaro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrely%22%2C%22lastName%22%3A%22Huerta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Maldonado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roberto%22%2C%22lastName%22%3A%22Nu%5Cu00f1ez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%22%2C%22lastName%22%3A%22Panduro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruth%22%2C%22lastName%22%3A%22Rafael%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amaan%22%2C%22lastName%22%3A%22Abdul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Abedin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eraj%22%2C%22lastName%22%3A%22Afreen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sohail%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ubaid%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinsar%22%2C%22lastName%22%3A%22Ali%20Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azka%22%2C%22lastName%22%3A%22Ashraf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faisal%22%2C%22lastName%22%3A%22Aslam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zahida%22%2C%22lastName%22%3A%22Bashir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saba%22%2C%22lastName%22%3A%22Fayyaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiren%22%2C%22lastName%22%3A%22Hafeez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meherunissa%22%2C%22lastName%22%3A%22Hamid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Basmah%22%2C%22lastName%22%3A%22Hassan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muzamil%22%2C%22lastName%22%3A%22Hussain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Irfan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Omar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shafiqua%22%2C%22lastName%22%3A%22Parveen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharoon%22%2C%22lastName%22%3A%22Sunail%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Farooq%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Batool%22%2C%22lastName%22%3A%22Mazhar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sana%22%2C%22lastName%22%3A%22Munir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neelofer%22%2C%22lastName%22%3A%22Sonia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Yaseen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Zubair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fatima%22%2C%22lastName%22%3A%22Zehra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iqra%22%2C%22lastName%22%3A%22Zulfiqar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tazeen%22%2C%22lastName%22%3A%22Abbasi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ghulam%22%2C%22lastName%22%3A%22Akbar%20Abro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mushtaque%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nazir%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Hammad%20Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nazakat%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rao%22%2C%22lastName%22%3A%22Danish%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayesha%22%2C%22lastName%22%3A%22Farhat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunaina%22%2C%22lastName%22%3A%22Gill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Hafeez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ghulam%22%2C%22lastName%22%3A%22Hussain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Habib%22%2C%22lastName%22%3A%22Inayat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvia%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farees%22%2C%22lastName%22%3A%22Kamal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adil%22%2C%22lastName%22%3A%22Kamran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjeet%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahveer%22%2C%22lastName%22%3A%22Maheshwari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shahid%22%2C%22lastName%22%3A%22Mamsa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sumera%22%2C%22lastName%22%3A%22Massey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asif%22%2C%22lastName%22%3A%22Mehmood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaisha%22%2C%22lastName%22%3A%22Memon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayaz%22%2C%22lastName%22%3A%22Ali%20Mirani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shafaque%22%2C%22lastName%22%3A%22Naz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanzeel%22%2C%22lastName%22%3A%22Rafique%20Qureshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yash%22%2C%22lastName%22%3A%22Roop%20Moazzam%20Sheikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Rafi%20Siddiqui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bhom%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mustajab%22%2C%22lastName%22%3A%22Soomro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisa%22%2C%22lastName%22%3A%22Ardizzoni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leen%22%2C%22lastName%22%3A%22Rigouts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Praha%22%2C%22lastName%22%3A%22Rupasinghe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annum%22%2C%22lastName%22%3A%22Aftab%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saman%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Adnan%20Alamgir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayaz%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azhar%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shahzaib%22%2C%22lastName%22%3A%22Ahmed%20Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sakhawat%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanam%22%2C%22lastName%22%3A%22Altaf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samreen%22%2C%22lastName%22%3A%22Amjad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahnoor%22%2C%22lastName%22%3A%22Sahiba%20Arshad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sadia%22%2C%22lastName%22%3A%22Ausim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdul%22%2C%22lastName%22%3A%22Basit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haroon%22%2C%22lastName%22%3A%22Ezik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hira%22%2C%22lastName%22%3A%22Hussain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sibtain%22%2C%22lastName%22%3A%22Hyder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shahzad%22%2C%22lastName%22%3A%22Inayat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aleeza%22%2C%22lastName%22%3A%22Janmohammed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Komal%22%2C%22lastName%22%3A%22Jaseem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aqsa%22%2C%22lastName%22%3A%22Jawed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lamis%22%2C%22lastName%22%3A%22Maniar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pardeep%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susheel%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reema%22%2C%22lastName%22%3A%22Latif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Liaqat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Ammar%20Nasser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Shakeel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shahzaib%22%2C%22lastName%22%3A%22Shaikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anique%22%2C%22lastName%22%3A%22Siddiqui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jetmal%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Koushalia%22%2C%22lastName%22%3A%22Sivan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Momal%22%2C%22lastName%22%3A%22Taimoor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nabeel%22%2C%22lastName%22%3A%22Zia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inessa%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Merei%22%2C%22lastName%22%3A%22Otepbergenova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thu%20Huong%22%2C%22lastName%22%3A%22Dinh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Thu%22%2C%22lastName%22%3A%22Do%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thu%20Thuong%22%2C%22lastName%22%3A%22Do%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Nguyet%22%2C%22lastName%22%3A%22Le%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%20Cuong%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Thuy%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Van%20Hung%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaukhar%22%2C%22lastName%22%3A%22Abildayeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orazbayeva%22%2C%22lastName%22%3A%22Maryash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elena%22%2C%22lastName%22%3A%22Telegina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lyailya%22%2C%22lastName%22%3A%22Tursynbekova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhanelya%22%2C%22lastName%22%3A%22Amanzholova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Perizat%22%2C%22lastName%22%3A%22Bektassova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anel%22%2C%22lastName%22%3A%22Belgozhanova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nazerke%22%2C%22lastName%22%3A%22Birimkulova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nurgul%22%2C%22lastName%22%3A%22Dyusebayeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nilay%22%2C%22lastName%22%3A%22Erkut%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnur%22%2C%22lastName%22%3A%22Gusmanov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Banu%22%2C%22lastName%22%3A%22Kassenova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aigerim%22%2C%22lastName%22%3A%22Kassym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kanat%22%2C%22lastName%22%3A%22Khazhidinov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tatyana%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azhar%22%2C%22lastName%22%3A%22Magzumova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moldir%22%2C%22lastName%22%3A%22Mussabayeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gulnar%22%2C%22lastName%22%3A%22Omarova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadezhda%22%2C%22lastName%22%3A%22Ryapolova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lyazzat%22%2C%22lastName%22%3A%22Sagyndykova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asel%22%2C%22lastName%22%3A%22Serekbay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Assel%22%2C%22lastName%22%3A%22Stambekova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gulmira%22%2C%22lastName%22%3A%22Tanatarova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zinatdin%22%2C%22lastName%22%3A%22Uaisov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhanel%22%2C%22lastName%22%3A%22Zhantuarova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gulnara%22%2C%22lastName%22%3A%22Zhumakairova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nataliya%22%2C%22lastName%22%3A%22Arlyapova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%22%2C%22lastName%22%3A%22Bogus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meredith%22%2C%22lastName%22%3A%22Cain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Merida%22%2C%22lastName%22%3A%22Carmona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clare%22%2C%22lastName%22%3A%22Flanagan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22McAnaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alyssa%22%2C%22lastName%22%3A%22Scharff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonya%22%2C%22lastName%22%3A%22Soni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%22%2C%22lastName%22%3A%22Striplin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seyfu%22%2C%22lastName%22%3A%22Abebe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johnson%22%2C%22lastName%22%3A%22Alakaye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atang%22%2C%22lastName%22%3A%22Bulane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Custodio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Precious%22%2C%22lastName%22%3A%22Hajison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malefetsane%22%2C%22lastName%22%3A%22Hetsa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Holtzman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matlotliso%22%2C%22lastName%22%3A%22Khesa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Makatleho%22%2C%22lastName%22%3A%22Lethola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Talime%22%2C%22lastName%22%3A%22Lebitsa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mpho%22%2C%22lastName%22%3A%22Mahamo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joalane%22%2C%22lastName%22%3A%22Makaka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mokenyakenya%22%2C%22lastName%22%3A%22Matoko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephane%22%2C%22lastName%22%3A%22Mpinda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Polo%22%2C%22lastName%22%3A%22Mohoang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Monyaesa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Nkundayirazo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mabohlokoa%22%2C%22lastName%22%3A%22Ntsane%20Sesomo%20Mohale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seabata%22%2C%22lastName%22%3A%22Ntsibane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebakeng%22%2C%22lastName%22%3A%22Phate%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathemba%22%2C%22lastName%22%3A%22Radebe%20%28Retsepile%20Tlali%29%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moliehi%22%2C%22lastName%22%3A%22Rakhetsi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tello%22%2C%22lastName%22%3A%22Ranoosi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meseret%22%2C%22lastName%22%3A%22Tamirat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahooe%22%2C%22lastName%22%3A%22Thokoana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ericka%22%2C%22lastName%22%3A%22Alegre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lourdes%22%2C%22lastName%22%3A%22Armuto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadia%22%2C%22lastName%22%3A%22Barreda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Barreto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%22%2C%22lastName%22%3A%22Cabrera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roger%22%2C%22lastName%22%3A%22Calderon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milagros%22%2C%22lastName%22%3A%22Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jelina%22%2C%22lastName%22%3A%22Chavez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Chavez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haydee%22%2C%22lastName%22%3A%22Cheje%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lesli%22%2C%22lastName%22%3A%22Cori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22D%5Cu00e1valos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Silvana%22%2C%22lastName%22%3A%22de%20la%20Gala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Delgadillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannely%22%2C%22lastName%22%3A%22Diaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ximena%22%2C%22lastName%22%3A%22Flores%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jimmy%22%2C%22lastName%22%3A%22Galarza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dalicxa%22%2C%22lastName%22%3A%22Garc%5Cu00eda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fanny%22%2C%22lastName%22%3A%22Garcia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%22%2C%22lastName%22%3A%22Gaspar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roselena%22%2C%22lastName%22%3A%22Godos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luz%22%2C%22lastName%22%3A%22Gonzales%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lizsery%22%2C%22lastName%22%3A%22Guerrero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sadith%22%2C%22lastName%22%3A%22Inga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22Jasaycucho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%22%2C%22lastName%22%3A%22Martel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%22%2C%22lastName%22%3A%22Pro%20Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%22%2C%22lastName%22%3A%22Molina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%22%2C%22lastName%22%3A%22Mugruza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hansel%22%2C%22lastName%22%3A%22Mundaca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Merilyn%22%2C%22lastName%22%3A%22Nuahan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Ore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liliana%22%2C%22lastName%22%3A%22Panduro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Pe%5Cu00f1a%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Perea%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%22%2C%22lastName%22%3A%22Pinedo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yhomay%22%2C%22lastName%22%3A%22Ponce%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Quinte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maritza%22%2C%22lastName%22%3A%22Qui%5Cu00f1ones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alicia%22%2C%22lastName%22%3A%22Ramos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elmer%22%2C%22lastName%22%3A%22Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosina%22%2C%22lastName%22%3A%22Reynoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%22%2C%22lastName%22%3A%22Reyes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%22%2C%22lastName%22%3A%22Reyes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Riccio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%22%2C%22lastName%22%3A%22Robles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Rojas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oswaldo%22%2C%22lastName%22%3A%22Sanabria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Saravia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susana%22%2C%22lastName%22%3A%22Saravia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liz%22%2C%22lastName%22%3A%22Senador%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%22%2C%22lastName%22%3A%22Soberon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%22%2C%22lastName%22%3A%22Soncco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maribel%22%2C%22lastName%22%3A%22Soto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Suarez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milagros%22%2C%22lastName%22%3A%22Suarez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronica%22%2C%22lastName%22%3A%22Suarez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erika%22%2C%22lastName%22%3A%22Torpoco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oscar%22%2C%22lastName%22%3A%22Torres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Torrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Tunque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aida%22%2C%22lastName%22%3A%22Ugarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gissela%22%2C%22lastName%22%3A%22Vaderrama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Valdivia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yesica%22%2C%22lastName%22%3A%22Valdivia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabel%22%2C%22lastName%22%3A%22Valverde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%22%2C%22lastName%22%3A%22Vargas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janet%22%2C%22lastName%22%3A%22Vargas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elvia%22%2C%22lastName%22%3A%22Vasquez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Veliz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dioselinda%22%2C%22lastName%22%3A%22Villa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheyla%22%2C%22lastName%22%3A%22Villafuerte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geraldine%22%2C%22lastName%22%3A%22Villar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22Villegas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milagros%22%2C%22lastName%22%3A%22Wong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosa%22%2C%22lastName%22%3A%22Yataco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hang%22%2C%22lastName%22%3A%22Pham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hieu%22%2C%22lastName%22%3A%22Truong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hai%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vo%22%2C%22lastName%22%3A%22Huy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Van%20Song%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Minh%20Khai%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Trung%22%2C%22lastName%22%3A%22Minh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Duyen%20Thanh%20Thao%22%2C%22lastName%22%3A%22Bui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Van%20Vinh%22%2C%22lastName%22%3A%22Truong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Thu%20Ha%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvine%22%2C%22lastName%22%3A%22Coutisson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melchior%22%2C%22lastName%22%3A%22Atger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%22%2C%22lastName%22%3A%22Nadia%20Baya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marwa%22%2C%22lastName%22%3A%22Bekhiet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronique%22%2C%22lastName%22%3A%22Boissi%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roberta%22%2C%22lastName%22%3A%22Caboclo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marhaba%22%2C%22lastName%22%3A%22Chaudhry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandrine%22%2C%22lastName%22%3A%22Cloez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%22%2C%22lastName%22%3A%22Collin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9line%22%2C%22lastName%22%3A%22Delifer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shana%22%2C%22lastName%22%3A%22Demaisons%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Ducher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathy%22%2C%22lastName%22%3A%22Hewison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohamed%22%2C%22lastName%22%3A%22Ibrahim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristen%22%2C%22lastName%22%3A%22Lebeau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Merry%22%2C%22lastName%22%3A%22Mazmanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rada%22%2C%22lastName%22%3A%22Mirzayeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Moreau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monica%22%2C%22lastName%22%3A%22Moschioni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Audrey%22%2C%22lastName%22%3A%22P%5Cu00e2quet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Perrin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Pichon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeanne%22%2C%22lastName%22%3A%22Roussel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Scotton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ariana%22%2C%22lastName%22%3A%22Austin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pearl%22%2C%22lastName%22%3A%22Sun%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnPre-extensively%20drug-resistant%20%28pre-XDR%29%20tuberculosis%20%28ie%2C%20multidrug-resistant%20or%20rifampicin-resistant%20with%20additional%20resistance%20to%20any%20fluoroquinolone%29%20is%20difficult%20to%20treat.%20endTB-Q%20aimed%20to%20evaluate%20the%20efficacy%20and%20safety%20of%20bedaquiline%2C%20delamanid%2C%20linezolid%2C%20and%20clofazimine%20%28BDLC%29%20compared%20with%20the%20standard%20of%20care%20for%20patients%20with%20pre-XDR%20tuberculosis.%5CnMethods%5CnThis%20open-label%2C%20multicentre%2C%20stratified%2C%20non-inferiority%2C%20randomised%2C%20controlled%2C%20phase%203%20trial%20was%20conducted%20in%20ten%20hospitals%20in%20India%2C%20Kazakhstan%2C%20Lesotho%2C%20Pakistan%2C%20Peru%2C%20and%20Viet%20Nam.%20Participants%20aged%2015%20years%20or%20older%20who%20had%20pulmonary%20tuberculosis%20with%20resistance%20to%20rifampicin%20and%20fluoroquinolones%20were%20included.%20Participants%20were%20randomly%20assigned%20%282%3A1%29%20to%20the%20BDLC%20group%20%28all-oral%20bedaquiline%20400%20mg%20once%20per%20day%20for%202%20weeks%20followed%20by%20200%20mg%20three%20times%20per%20week%2C%20delamanid%20100%20mg%20twice%20per%20day%2C%20linezolid%20600%20mg%20once%20per%20day%20for%2016%20weeks%20and%20then%20either%20300%20mg%20once%20per%20day%20or%20600%20mg%20three%20times%20per%20week%2C%20and%20clofazimine%20100%20mg%20once%20per%20day%29%20or%20the%20control%20group%20%28individualised%20WHO-recommended%20longer%20standard%20of%20care%29.%20Randomisation%20was%20stratified%20by%20country%20and%20baseline%20disease%20extent.%20BDLC%20was%20administered%20for%2039%20weeks%20%289-month%20regimen%29%20for%20extensive%20disease%20and%2024%20weeks%20%286-month%20regimen%29%20for%20limited%20disease%20and%20extended%20to%209%20months%20for%20those%20with%20a%20positive%20culture%20at%208%20weeks%20or%20later%20or%20a%20missing%208-week%20culture%20result.%20Site%20staff%20and%20participants%20were%20not%20masked%2C%20whereas%20investigators%20and%20laboratory%20staff%20were%20masked%20to%20treatment%20assignment.%20The%20primary%20endpoint%20was%20favourable%20outcome%20%28two%20consecutive%2C%20negative%20cultures%20including%20one%20between%20weeks%2065%20and%2073%3B%20or%20favourable%20bacteriological%2C%20radiological%2C%20and%20clinical%20evolution%29%20at%20week%2073%20after%20randomisation%20in%20the%20modified%20intention-to-treat%20%28mITT%29%20and%20per-protocol%20populations.%20We%20report%20the%20risk%20differences%20adjusted%20for%20stratification%20variables%2C%20with%20a%20non-inferiority%20margin%20of%20%5Cu201312%25.%20This%20trial%20is%20registered%20with%20ClinicalTrials.gov%2C%20NCT03896685.%5CnFindings%5CnBetween%20April%204%2C%202020%2C%20and%20March%2028%2C%202023%2C%201030%20individuals%20were%20screened%20and%20324%20%2831%25%29%20were%20randomly%20assigned%20%28219%20to%20the%20BDLC%20group%20and%20105%20to%20the%20control%20group%29.%20114%20%2846%25%29%20participants%20were%20female%20and%20133%20%2854%25%29%20were%20male.%20Median%20age%20was%2030%5Cu00b75%20years%20%28IQR%2021%5Cu00b76%5Cu201343%5Cu00b70%29.%20157%20%2864%25%29%20participants%20had%20extensive%20disease%20at%20baseline.%20In%20the%20BDLC%20group%2C%2047%20%2829%25%29%20of%20163%20were%20assigned%20to%20receive%20the%206-month%20regimen%20and%20116%20%2871%25%29%20the%209-month%20regimen.%20The%20core%20regimen%20of%20BDLC%20plus%20one%20or%20more%20other%20drugs%20was%20used%20for%2076%20%2891%25%29%20of%2084%20participants%20in%20the%20control%20group.%20At%20week%2073%2C%20favourable%20outcome%20was%20reached%20by%20141%20%2887%25%29%20participants%20in%20the%20BDLC%20group%20versus%2075%20%2889%25%29%20in%20the%20control%20group%20in%20the%20mITT%20population%20%28adjusted%20risk%20difference%200%5Cu00b72%25%20%5B95%25%20CI%20%5Cu20139%5Cu00b71%20to%209%5Cu00b75%5D%3B%20pnon-inferiority%3D0%5Cu00b70051%29%20and%20by%20138%20%2888%25%29%20of%20157%20versus%2071%20%2893%25%29%20of%2076%20in%20the%20per-protocol%20population%20%28adjusted%20risk%20difference%20%5Cu20133%5Cu00b75%25%20%5B%5Cu201312%5Cu00b78%20to%205%5Cu00b79%5D%3B%20pnon-inferiority%3D0%5Cu00b7037%29.%20Overall%20non-inferiority%20was%20not%20shown.%20145%20%2868%25%29%20of%20213%20participants%20in%20the%20BDLC%20group%20and%2077%20%2873%25%29%20of%20105%20in%20the%20control%20group%20had%20at%20least%20one%20grade%203%20or%20higher%20adverse%20event%2C%20with%20eight%20%284%25%29%20and%20two%20%282%25%29%20all-cause%20deaths%20by%20week%2073%2C%20respectively.%5CnInterpretation%5CnThe%20shortened%20BDLC%20strategy%20was%20not%20non-inferior%20to%20the%20control.%20Accumulating%20evidence%20suggests%20that%20this%20patient%20population%20might%20require%20longer%2C%20reinforced%20regimens.%5CnFunding%5CnUnitaid%2C%20M%5Cu00e9decins%20Sans%20Fronti%5Cu00e8res%2C%20Partners%20In%20Health%2C%20Interactive%20Research%20and%20Development%2C%20Ram%5Cu00f3n%20Areces%20Foundation%2C%20the%20Jung%20Foundation%20for%20Science%20and%20Research%2C%20Research%20Foundation-Flanders.%5CnTranslations%5CnFor%20the%20Hindi%2C%20Marathi%2C%20Spanish%2C%20Vietnamese%2C%20Russian%2C%20Urdu%20and%20French%20translations%20of%20the%20abstract%20see%20Supplementary%20Materials%20section.%22%2C%22date%22%3A%222025-07-16%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2FS2213-2600%2825%2900194-8%22%2C%22ISSN%22%3A%222213-2600%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS2213260025001948%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-08-21T13%3A27%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22348MPEYW%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Serge%20Diagbouga%20et%20al.%22%2C%22parsedDate%22%3A%222025-06-11%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSerge%20Diagbouga%2C%20P.%2C%20Djibougou%2C%20A.%20D.%2C%20Pease%2C%20C.%2C%20Alcaide%2C%20A.%2C%20Berthoux%2C%20A.%2C%20Bruiners%2C%20N.%2C%20Cirillo%2C%20D.%20M.%2C%20Combary%2C%20A.%2C%20Falchero%2C%20N.%2C%20Handler%2C%20D.%2C%20Kabor%26%23xE9%3B%2C%20A.%2C%20Lardizabal%2C%20A.%2C%20Lopes%2C%20A.%2C%20Loubet%2C%20M.%2C%20Manivet%2C%20P.%2C%20Margain%2C%20C.%2C%20Meunier%2C%20V.%2C%20Mougari%2C%20F.%2C%20Onyuka%2C%20A.%2C%20Rivoiron%2C%20S.%2C%20Sagna%2C%20T.%2C%20Sanvert%2C%20M.%2C%20Sawadogo%2C%20L.%2C%20Simpor%26%23xE9%3B%2C%20J.%2C%20Cambau%2C%20E.%20and%20Gennaro%2C%20M.%20L.%20%282025%29.%20%26lt%3Bb%26gt%3BPreliminary%20performance%20of%20the%20VIDAS%20TB-IGRA%20as%20an%20aid%20in%20the%20diagnosis%20of%20individuals%20infected%20with%20%26lt%3Bi%26gt%3BMycobacterium%20tuberculosis%26lt%3B%5C%2Fi%26gt%3B%26lt%3B%5C%2Fb%26gt%3B%20Ed.%20Miller%2C%20M.%20B.%20J%20Clin%20Microbiol%20%26lt%3Bi%26gt%3B63%26lt%3B%5C%2Fi%26gt%3B%2C%20e01641-24%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Fjcm.01641-24%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Fjcm.01641-24%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Preliminary%20performance%20of%20the%20VIDAS%20TB-IGRA%20as%20an%20aid%20in%20the%20diagnosis%20of%20individuals%20infected%20with%20%3Ci%3EMycobacterium%20tuberculosis%3C%5C%2Fi%3E%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Potiandi%22%2C%22lastName%22%3A%22Serge%20Diagbouga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arthur%20Diakourga%22%2C%22lastName%22%3A%22Djibougou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Pease%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ariana%22%2C%22lastName%22%3A%22Alcaide%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Audrey%22%2C%22lastName%22%3A%22Berthoux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%22%2C%22lastName%22%3A%22Bruiners%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%20Maria%22%2C%22lastName%22%3A%22Cirillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ardjouma%22%2C%22lastName%22%3A%22Combary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadine%22%2C%22lastName%22%3A%22Falchero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Handler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoinette%22%2C%22lastName%22%3A%22Kabor%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alfred%22%2C%22lastName%22%3A%22Lardizabal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%22%2C%22lastName%22%3A%22Lopes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marissa%22%2C%22lastName%22%3A%22Loubet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Manivet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemence%22%2C%22lastName%22%3A%22Margain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valerie%22%2C%22lastName%22%3A%22Meunier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alberta%22%2C%22lastName%22%3A%22Onyuka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Rivoiron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tani%22%2C%22lastName%22%3A%22Sagna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Sanvert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L%5Cu00e9on%22%2C%22lastName%22%3A%22Sawadogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacques%22%2C%22lastName%22%3A%22Simpor%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Laura%22%2C%22lastName%22%3A%22Gennaro%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Melissa%20B.%22%2C%22lastName%22%3A%22Miller%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20This%20preliminary%20study%20compares%20VIDAS%20TB-IGRA%20%28bioM%5Cu00e9rieux%2C%20Marcy-l%26%23039%3BEtoile%2C%20France%29%20with%20the%20established%20QuantiFERON-TB%20Gold%20Plus%20%28QFT-Plus%29%20%28Qiagen%2C%20Hilden%2C%20Germany%29%20to%20evaluate%20diagnostic%20performance%20for%20the%20diagnosis%20of%20individuals%20infected%20with%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mycobacterium%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20complex%20%28latent%20infection%20and%20disease%29.%20The%20study%20was%20multi-center%20and%20performed%20between%202%20October%202019%20and%204%20February%202020.%20Participants%20were%20divided%20into%20tuberculosis%20%28TB%29%20disease%2C%20high-risk%2C%20and%20low-risk%20populations.%20The%20confirmed%20TB%20disease%20population%20included%20104%20patients.%20The%20high-risk%20population%20included%20162%20individuals%20with%20flagged%20risk%20factors%20on%20a%20questionnaire%20but%20without%20objective%20clinical%20confirmation%20of%20TB.%20The%20low-risk%20population%20included%20117%20healthy%20blood%20donors%20from%20the%20French%20National%20Blood%20Bank.%20Positive%20and%20negative%20percent%20agreement%20%28PPA%20and%20NPA%29%20were%20determined%20between%20the%20VIDAS%20TB-IGRA%20and%20QFT-Plus.%20In%20the%20TB%20disease%20population%2C%20sensitivity%20was%20measured%20against%20bacterial%20culture%20and%20PCR.%20The%20VIDAS%20TB-IGRA%20produced%20fewer%20indeterminate%20results%20than%20the%20QFT-Plus%20%281%5C%2F104%20vs%2023%5C%2F104%29%20in%20the%20TB%20disease%20population%20and%20exhibited%20a%20sensitivity%20of%2095.0%25%20against%20bacterial%20culture.%20Furthermore%2C%20a%2098.2%25%20PPA%20was%20obtained%20in%20comparison%20to%20QFT-Plus.%20In%20the%20low-risk%20population%2C%20the%20VIDAS%20TB-IGRA%20demonstrated%20high%20specificity%20%2894.9%25%29%20and%20a%20strong%20NPA%20%2898.2%25%29%20compared%20to%20QFT-Plus.%20In%20the%20high-risk%20population%2C%20the%20VIDAS%20TB-IGRA%20exhibited%20a%20strong%20PPA%20%2894.4%25%29%20with%20the%20QFT-Plus.%20A%20lower%20NPA%20was%20observed%20%2885.2%25%29%20compared%20to%20QFT-Plus%2C%20which%20may%20be%20due%20to%20a%20higher%20sensitivity%20demonstrated%20in%20the%20TB%20disease%20population.%20The%20fully%20automated%20VIDAS%20TB-IGRA%20is%20a%20promising%20aid%20in%20the%20diagnosis%20of%20individuals%20infected%20with%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mycobacterium%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%28latent%20infection%20and%20active%20disease%29.%20It%20exhibits%20higher%20sensitivity%20while%20maintaining%20specificity%20and%20produces%20fewer%20indeterminate%20interpretations%20than%20QFT-Plus.%20Its%20easy-to-use%2C%20single-patient%20format%20may%20lead%20to%20increased%20TB%20testing%20to%20aid%20in%20the%20adequate%20diagnosis%20and%20management%20of%20the%20disease.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20IMPORTANCE%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20This%20study%20presents%20a%20comprehensive%20evaluation%20of%20the%20VIDAS%20TB-IGRA%20diagnostic%20test.%20This%20test%20is%20compared%20with%20the%20established%20QuantiFERON-TB%20Gold%20Plus%20to%20assess%20its%20effectiveness%20in%20diagnosing%20both%20latent%20and%20active%20tuberculosis%20%28TB%29%20infections.%20The%20study%20highlights%20the%20VIDAS%20TB-IGRA%5Cu2019s%20higher%20sensitivity%2C%20fewer%20indeterminate%20results%2C%20and%20robust%20performance%20across%20different%20patient%20populations%2C%20including%20those%20with%20confirmed%20TB%20disease%2C%20high-risk%2C%20and%20low-risk%20groups.%20The%20findings%20suggest%20that%20the%20VIDAS%20TB-IGRA%20could%20enhance%20TB%20diagnosis%20and%20management%2C%20offering%20a%20fully%20automated%2C%20easy-to-use%20solution%20that%20reduces%20human%20error%20and%20result%20variability.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%2C%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20This%20study%20presents%20a%20comprehensive%20evaluation%20of%20the%20VIDAS%20TB-IGRA%20diagnostic%20test.%20This%20test%20is%20compared%20with%20the%20established%20QuantiFERON-TB%20Gold%20Plus%20to%20assess%20its%20effectiveness%20in%20diagnosing%20both%20latent%20and%20active%20tuberculosis%20%28TB%29%20infections.%20The%20study%20highlights%20the%20VIDAS%20TB-IGRA%5Cu2019s%20higher%20sensitivity%2C%20fewer%20indeterminate%20results%2C%20and%20robust%20performance%20across%20different%20patient%20populations%2C%20including%20those%20with%20confirmed%20TB%20disease%2C%20high-risk%2C%20and%20low-risk%20groups.%20The%20findings%20suggest%20that%20the%20VIDAS%20TB-IGRA%20could%20enhance%20TB%20diagnosis%20and%20management%2C%20offering%20a%20fully%20automated%2C%20easy-to-use%20solution%20that%20reduces%20human%20error%20and%20result%20variability.%22%2C%22date%22%3A%222025-06-11%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1128%5C%2Fjcm.01641-24%22%2C%22ISSN%22%3A%220095-1137%2C%201098-660X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.asm.org%5C%2Fdoi%5C%2F10.1128%5C%2Fjcm.01641-24%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-09-30T15%3A02%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22UG42N69S%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Seddon%20et%20al.%22%2C%22parsedDate%22%3A%222025-06-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSeddon%2C%20J.%20A.%2C%20Achar%2C%20J.%2C%20Malik%2C%20A.%20A.%2C%20Hughes%2C%20J.%2C%20Burzynski%2C%20J.%2C%20Chen%2C%20C.%2C%20Denholm%2C%20J.%20T.%2C%20Dravniece%2C%20G.%2C%20Fox%2C%20G.%20J.%2C%20Furin%2C%20J.%2C%20Geliukh%2C%20E.%2C%20Goncharova%2C%20O.%2C%20Guglielmetti%2C%20L.%2C%20Harries%2C%20A.%20D.%2C%20Hesseling%2C%20A.%20C.%2C%20Nguyen%2C%20B.%20H.%2C%20Kavenga%2C%20F.%2C%20Khan%2C%20U.%2C%20Kherabi%2C%20Y.%2C%20Kiria%2C%20N.%2C%20Kock%2C%20Y.%2C%20Liu%2C%20Q.%2C%20Mesic%2C%20A.%2C%20Moore%2C%20D.%20A.%20J.%2C%20Mubanga%2C%20A.%2C%20Naidoo%2C%20L.%2C%20Nilsen%2C%20D.%2C%20Piubello%2C%20A.%2C%20Reuter%2C%20A.%2C%20Rich%2C%20M.%20L.%2C%20Satyanarayana%2C%20S.%2C%20Schaaf%2C%20H.%20S.%2C%20Schoeman%2C%20I.%2C%20Skrahina%2C%20A.%2C%20Udwadia%2C%20Z.%2C%20Khan%2C%20P.%20Y.%2C%20Esmail%2C%20H.%20and%20Martinez%2C%20L.%20%282025%29.%20%26lt%3Bb%26gt%3BManagement%20of%20individuals%20exposed%20to%20multidrug-resistant%20or%20rifampicin-resistant%20tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20The%20Lancet%20Infectious%20Diseases%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2825%2900157-4%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2825%2900157-4%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Management%20of%20individuals%20exposed%20to%20multidrug-resistant%20or%20rifampicin-resistant%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20A%22%2C%22lastName%22%3A%22Seddon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jay%22%2C%22lastName%22%3A%22Achar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amyn%20A%22%2C%22lastName%22%3A%22Malik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Hughes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Burzynski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cheng%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justin%20T%22%2C%22lastName%22%3A%22Denholm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunta%22%2C%22lastName%22%3A%22Dravniece%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Greg%20J%22%2C%22lastName%22%3A%22Fox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Furin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evgenia%22%2C%22lastName%22%3A%22Geliukh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Goncharova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%20D%22%2C%22lastName%22%3A%22Harries%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anneke%20C%22%2C%22lastName%22%3A%22Hesseling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Binh%20Hoa%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fungai%22%2C%22lastName%22%3A%22Kavenga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Uzma%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yousra%22%2C%22lastName%22%3A%22Kherabi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nana%22%2C%22lastName%22%3A%22Kiria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yulene%22%2C%22lastName%22%3A%22Kock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiao%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anita%22%2C%22lastName%22%3A%22Mesic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A%20J%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angel%22%2C%22lastName%22%3A%22Mubanga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lenny%22%2C%22lastName%22%3A%22Naidoo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%22%2C%22lastName%22%3A%22Nilsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alberto%22%2C%22lastName%22%3A%22Piubello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anja%22%2C%22lastName%22%3A%22Reuter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20L%22%2C%22lastName%22%3A%22Rich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srinath%22%2C%22lastName%22%3A%22Satyanarayana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%20Simon%22%2C%22lastName%22%3A%22Schaaf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ingrid%22%2C%22lastName%22%3A%22Schoeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alena%22%2C%22lastName%22%3A%22Skrahina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zarir%22%2C%22lastName%22%3A%22Udwadia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Palwasha%20Y%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanif%22%2C%22lastName%22%3A%22Esmail%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonardo%22%2C%22lastName%22%3A%22Martinez%22%7D%5D%2C%22abstractNote%22%3A%22Individuals%20exposed%20to%20a%20person%20with%20infectious%20multidrug-resistant%20or%20rifampicin-resistant%20%28MDR-RR%29%20tuberculosis%20are%20at%20risk%20of%20developing%20tuberculosis%20disease.%20Historically%2C%20insufficient%20empirical%20evidence%20for%20preventive%20treatment%20in%20this%20group%20has%20permitted%20inadequate%20guidance%20for%20clinical%20decision%20making.%20However%2C%20several%20high-quality%20studies%20have%20been%20published%20detailing%20preventive%20treatment%20options%20for%20these%20contacts%20at%20high%20risk.%20In%20this%20Review%2C%20we%20discuss%20the%20management%20of%20individuals%20exposed%20to%20patients%20with%20infectious%20MDR-RR%20tuberculosis.%20We%20pay%20particular%20attention%20to%20the%20entire%20spectrum%20of%20clinical%20care%20for%20this%20population%2C%20including%20baseline%20assessment%2C%20possible%20preventive%20treatments%2C%20follow-up%2C%20and%20shared%20decision%20making.%20We%20discuss%20the%20available%20evidence%2C%20the%20rationales%20for%20different%20management%20strategies%2C%20and%20the%20interactions%20with%20%28and%20implications%20of%29%20secondary%20comorbidities%20such%20as%20HIV%20or%20malnutrition.%22%2C%22date%22%3A%222025-06-06%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2FS1473-3099%2825%2900157-4%22%2C%22ISSN%22%3A%221473-3099%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1473309925001574%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-08-21T13%3A31%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22P98GJIV5%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bonnet%20et%20al.%22%2C%22parsedDate%22%3A%222025-05-22%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBonnet%2C%20I.%2C%20Orgeur%2C%20M.%2C%20Brossier%2C%20F.%2C%20Sayes%2C%20F.%2C%20Frigui%2C%20W.%2C%20Madacki%2C%20J.%2C%20Varet%2C%20H.%2C%20Chauffour%2C%20A.%2C%20Aubry%2C%20A.%2C%20Veziris%2C%20N.%2C%20Sougakoff%2C%20W.%2C%20Brosch%2C%20R.%20and%20Tournebize%2C%20R.%20%282025%29.%20%26lt%3Bb%26gt%3BEvaluation%20of%20the%20role%20of%20%26lt%3Bi%26gt%3BwhiB6%26lt%3B%5C%2Fi%26gt%3B%20and%20%26lt%3Bi%26gt%3BkdpDE%26lt%3B%5C%2Fi%26gt%3B%20in%20the%20dominant%20multidrug-resistant%20clone%20%26lt%3Bi%26gt%3BMycobacterium%20tuberculosis%26lt%3B%5C%2Fi%26gt%3B%20B0%5C%2FW148%26lt%3B%5C%2Fb%26gt%3B%20Ed.%20Doucet-Populaire%2C%20F.%20C.%20Microbiol%20Spectr%20e03224-24%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Fspectrum.03224-24%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Fspectrum.03224-24%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evaluation%20of%20the%20role%20of%20%3Ci%3EwhiB6%3C%5C%2Fi%3E%20and%20%3Ci%3EkdpDE%3C%5C%2Fi%3E%20in%20the%20dominant%20multidrug-resistant%20clone%20%3Ci%3EMycobacterium%20tuberculosis%3C%5C%2Fi%3E%20B0%5C%2FW148%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mickael%22%2C%22lastName%22%3A%22Orgeur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fadel%22%2C%22lastName%22%3A%22Sayes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wafa%22%2C%22lastName%22%3A%22Frigui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Madacki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugo%22%2C%22lastName%22%3A%22Varet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roland%22%2C%22lastName%22%3A%22Brosch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%5Cu00e9gis%22%2C%22lastName%22%3A%22Tournebize%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Florence%20Claude%22%2C%22lastName%22%3A%22Doucet-Populaire%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Multidrug-resistant%20%28MDR%29%20strains%20of%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mycobacterium%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20represent%20an%20obstacle%20to%20eradicating%20tuberculosis%20%28TB%29%20due%20to%20the%20low%20treatment%20success%20rate%20of%20MDR%20TB.%20Among%20them%2C%20the%20MDR%20B0%5C%2FW148%20clone%20has%20recently%20evolved%20from%20the%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Beijing%20lineage%202%20and%20is%20widely%20disseminated%20in%20Russia%20and%20Europe.%20To%20get%20more%20insights%20into%20the%20genetic%20factors%20underlying%20the%20evolutionary%20success%20of%20the%20MDR%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20B0%5C%2FW148%20clone%20in%20addition%20to%20environmental%20and%20patient-related%20features%2C%20we%20focused%20on%20two%20mutations%20specific%20to%20this%20clone%20that%20are%20found%20in%20the%20transcriptional%20regulators%20WhiB6%20and%20KdpDE%20and%20investigated%20in%20a%20H37Rv%20strain%20background%20the%20transcriptional%20profile%20associated%20with%20these%20mutations%20and%20their%20impact%20on%20the%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20in%20vitro%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20and%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20in%20vivo%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20growth%20characteristics.%20Through%20the%20construction%20and%20use%20of%20H37Rv%5Cu2206%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20whiB6%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20H37Rv%5Cu2206%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20kdpDE%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20and%20complemented%20strains%2C%20neither%20mutation%20impaired%20the%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20in%20vitro%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20growth%20of%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20in%20standard%20mycobacterial%20growth%20media.%20The%20mutation%20T51P%20in%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20whiB6%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20prevented%20the%20upregulation%20of%209%20genes%20in%20the%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20esx-1%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20core%20region%20and%2044%20genes%20elsewhere%20in%20the%20genome%2C%20while%20the%20deletion%20of%20two%20nucleotides%20in%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20kdpD%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20leads%20to%20a%20fusion%20protein%20of%20KdpD%20with%20KdpE%20that%20inhibits%20the%20transcriptional%20activity%20of%20KdpE.%20Neither%20mutation%20led%20to%20hypervirulence%20in%20a%20mouse%20infection%20model.%20These%20results%20point%20to%20the%20role%20of%20other%20MDR%20B0%5C%2FW148%20specific%20mutations%20in%20the%20wide%20geographic%20diffusion%20of%20this%20clone%20and%5C%2For%20put%20in%20question%20a%20hypothesized%20hypervirulence%20as%20a%20driving%20factor%20for%20this%20large%20dissemination.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20IMPORTANCE%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Human%20tuberculosis%20%28TB%29%2C%20caused%20by%20the%20bacterium%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mycobacterium%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20remains%20a%20global%20public%20health%20issue%20estimated%20to%20have%20been%20responsible%20for%201.25%20million%20deaths%20in%202023.%20Multidrug-resistant%20%28MDR%29%20strains%20of%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20resistant%20to%20rifampicin%20and%20isoniazid%2C%20lead%20to%20lower%20treatment%20success.%20Among%20them%2C%20the%20MDR%20B0%5C%2FW148%20clone%20has%20widely%20disseminated%20in%20Russia%20and%20Europe.%20To%20get%20more%20insights%20into%20the%20genetic%20factors%20underlying%20the%20evolutionary%20success%20of%20this%20clone%2C%20we%20investigated%20two%20strain-specific%20mutations%20found%20in%20the%20transcriptional%20regulators%20WhiB6%20and%20KdpDE.%20By%20constructing%20and%20analyzing%20laboratory%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20strains%20carrying%20these%20specific%20mutations%2C%20we%20found%20numerous%20changes%20in%20their%20transcriptional%20profiles%2C%20whereas%20we%20observed%20only%20a%20little%20impact%20of%20these%20mutations%20on%20the%20virulence%20of%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20in%20a%20mouse%20infection%20model.%20Our%20study%20provides%20new%20insights%20into%20the%20transcriptional%20landscape%20of%20the%20selected%20MDR%20strains%2C%20although%20no%20direct%20connection%20to%20virulence%20could%20be%20established.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%2C%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Human%20tuberculosis%20%28TB%29%2C%20caused%20by%20the%20bacterium%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mycobacterium%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20remains%20a%20global%20public%20health%20issue%20estimated%20to%20have%20been%20responsible%20for%201.25%20million%20deaths%20in%202023.%20Multidrug-resistant%20%28MDR%29%20strains%20of%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20resistant%20to%20rifampicin%20and%20isoniazid%2C%20lead%20to%20lower%20treatment%20success.%20Among%20them%2C%20the%20MDR%20B0%5C%2FW148%20clone%20has%20widely%20disseminated%20in%20Russia%20and%20Europe.%20To%20get%20more%20insights%20into%20the%20genetic%20factors%20underlying%20the%20evolutionary%20success%20of%20this%20clone%2C%20we%20investigated%20two%20strain-specific%20mutations%20found%20in%20the%20transcriptional%20regulators%20WhiB6%20and%20KdpDE.%20By%20constructing%20and%20analyzing%20laboratory%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20strains%20carrying%20these%20specific%20mutations%2C%20we%20found%20numerous%20changes%20in%20their%20transcriptional%20profiles%2C%20whereas%20we%20observed%20only%20a%20little%20impact%20of%20these%20mutations%20on%20the%20virulence%20of%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20in%20a%20mouse%20infection%20model.%20Our%20study%20provides%20new%20insights%20into%20the%20transcriptional%20landscape%20of%20the%20selected%20MDR%20strains%2C%20although%20no%20direct%20connection%20to%20virulence%20could%20be%20established.%22%2C%22date%22%3A%222025-05-22%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1128%5C%2Fspectrum.03224-24%22%2C%22ISSN%22%3A%222165-0497%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.asm.org%5C%2Fdoi%5C%2F10.1128%5C%2Fspectrum.03224-24%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-05-23T07%3A24%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22WTTLP6PD%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sadowski%20et%20al.%22%2C%22parsedDate%22%3A%222025-04-11%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSadowski%2C%20E.%2C%20Pietrancosta%2C%20N.%2C%20Veyron-Churlet%2C%20R.%2C%20Boucher%2C%20J.-L.%2C%20Pionneau%2C%20C.%2C%20Clodic%2C%20G.%2C%20Matheron%2C%20L.%2C%20Poch%2C%20O.%2C%20Mayer%2C%20C.%2C%20Sachon%2C%20E.%20and%20Aubry%2C%20A.%20%282025%29.%20%26lt%3Bb%26gt%3BCharacterization%20of%20the%20Orphan%20Cytochrome%20P450%20CYP135B1%20from%20%26lt%3Bi%26gt%3BMycobacterium%20tuberculosis%26lt%3B%5C%2Fi%26gt%3B%26%23x202F%3B%3A%20Involvement%20in%20Metabolism%20but%20Not%20in%20the%20Antibacterial%20Activity%20of%20the%20Antitubercular%20Drug%20SQ109%26lt%3B%5C%2Fb%26gt%3B.%20ACS%20Infect%20Dis%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%2C%20869%26%23x2013%3B881%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facsinfecdis.4c00893%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facsinfecdis.4c00893%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Characterization%20of%20the%20Orphan%20Cytochrome%20P450%20CYP135B1%20from%20%3Ci%3EMycobacterium%20tuberculosis%3C%5C%2Fi%3E%20%3A%20Involvement%20in%20Metabolism%20but%20Not%20in%20the%20Antibacterial%20Activity%20of%20the%20Antitubercular%20Drug%20SQ109%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elodie%22%2C%22lastName%22%3A%22Sadowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Pietrancosta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romain%22%2C%22lastName%22%3A%22Veyron-Churlet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Luc%22%2C%22lastName%22%3A%22Boucher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9dric%22%2C%22lastName%22%3A%22Pionneau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Clodic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucr%5Cu00e8ce%22%2C%22lastName%22%3A%22Matheron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Poch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudine%22%2C%22lastName%22%3A%22Mayer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Sachon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222025-04-11%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1021%5C%2Facsinfecdis.4c00893%22%2C%22ISSN%22%3A%222373-8227%2C%202373-8227%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fpubs.acs.org%5C%2Fdoi%5C%2F10.1021%5C%2Facsinfecdis.4c00893%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-05-09T12%3A38%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22QG4CZPV6%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Verma%20et%20al.%22%2C%22parsedDate%22%3A%222025-04-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BVerma%2C%20A.%20K.%2C%20Kim%2C%20R.%20Q.%2C%20Lamprecht%2C%20D.%20A.%2C%20Aguilar-P%26%23xE9%3Brez%2C%20C.%2C%20Wong%2C%20S.%2C%20Veziris%2C%20N.%2C%20Aubry%2C%20A.%2C%20Bartolom%26%23xE9%3B-Nebreda%2C%20J.%20M.%2C%20Carbajo%2C%20R.%20J.%2C%20Wetzel%2C%20J.%20and%20Lamers%2C%20M.%20H.%20%282025%29.%20%26lt%3Bb%26gt%3BStructural%20and%20mechanistic%20study%20of%20a%20novel%20inhibitor%20analogue%20of%20M.%20tuberculosis%20cytochrome%20bc1%3Aaa3%26lt%3B%5C%2Fb%26gt%3B.%20npj%20Drug%20Discov%20%26lt%3Bi%26gt%3B2%26lt%3B%5C%2Fi%26gt%3B%2C%206%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs44386-025-00008-3%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs44386-025-00008-3%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Structural%20and%20mechanistic%20study%20of%20a%20novel%20inhibitor%20analogue%20of%20M.%20tuberculosis%20cytochrome%20bc1%3Aaa3%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amit%20K.%22%2C%22lastName%22%3A%22Verma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robbert%20Q.%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dirk%20A.%22%2C%22lastName%22%3A%22Lamprecht%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara%22%2C%22lastName%22%3A%22Aguilar-P%5Cu00e9rez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Wong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20M.%22%2C%22lastName%22%3A%22Bartolom%5Cu00e9-Nebreda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigo%20J.%22%2C%22lastName%22%3A%22Carbajo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennefer%22%2C%22lastName%22%3A%22Wetzel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meindert%20H.%22%2C%22lastName%22%3A%22Lamers%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Drug-resistant%20tuberculosis%20%28TB%29%20continues%20to%20challenge%20treatment%20options%2C%20necessitating%20the%20exploration%20of%20new%20compounds%20of%20novel%20targets.%20The%20mycobacterial%20respiratory%20complex%20cytochrome%20bc%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%201%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%3Aaa%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%203%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20has%20emerged%20as%20a%20promising%20target%2C%20exemplified%20by%20the%20success%20of%20first-in-class%20inhibitor%20Q203%20in%20phase%202%20clinical%20trials.%20However%2C%20to%20fully%20exploit%20the%20potential%20of%20this%20target%20and%20to%20identify%20the%20best-in-class%20inhibitor%20more%20compounds%20need%20evaluation.%20Here%2C%20we%20introduce%20JNJ-2901%2C%20a%20novel%20Q203%20analogue%2C%20that%20demonstrates%20activity%20against%20multidrug-resistant%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20clinical%20strains%20at%20sub-nanomolar%20concentration%20and%204-log%20reduction%20in%20bacterial%20burden%20in%20a%20mouse%20model%20of%20TB%20infection.%20Inhibitory%20studies%20on%20purified%20enzymes%20validate%20the%20nanomolar%20inhibitions%20observed%20in%20mycobacterial%20cells.%20Additionally%2C%20cryo-EM%20structure%20analysis%20of%20cytochrome%20bc%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%201%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%3Aaa%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%203%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20bound%20to%20JNJ-2901%20reveals%20the%20binding%20pocket%20at%20the%20menaquinol%20oxidation%20site%20%28Qp%29%2C%20akin%20to%20other%20substate%20analogue%20inhibitors%20like%20Q203%20and%20TB47.%20Validation%20of%20the%20binding%20site%20is%20further%20achieved%20by%20generating%20and%20isolating%20the%20JNJ-2901%20resistant%20mutations%20in%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20followed%20by%20purification%20and%20resistance%20analysis%20of%20the%20resistant%20cytochrome%20bc%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%201%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%3Aaa%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%203%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20complex.%20Our%20comprehensive%20work%20lays%20the%20foundation%20for%20further%20clinical%20validations%20of%20JNJ-2901.%22%2C%22date%22%3A%222025-04-02%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs44386-025-00008-3%22%2C%22ISSN%22%3A%223005-1452%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs44386-025-00008-3%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-05-09T12%3A36%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22M5HX4KAL%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lange%20et%20al.%22%2C%22parsedDate%22%3A%222025-03-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLange%2C%20C.%2C%20Bothamley%2C%20G.%2C%20G%26%23xFC%3Bnther%2C%20G.%2C%20Guglielmetti%2C%20L.%2C%20Kontsevaya%2C%20I.%2C%20Kuksa%2C%20L.%2C%20Lange%2C%20B.%2C%20Lorent%2C%20N.%2C%20Saluzzo%2C%20F.%2C%20Sester%2C%20M.%2C%20Tebruegge%2C%20M.%2C%20Tunesi%2C%20S.%20and%20Tweed%2C%20C.%20%282025%29.%20%26lt%3Bb%26gt%3BA%20Year%20in%20Review%20on%20Tuberculosis%20and%20Non-tuberculous%20Mycobacteria%20Disease%3A%20A%202025%20Update%20for%20Clinicians%20and%20Scientists%26lt%3B%5C%2Fb%26gt%3B.%20PAI%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%2C%201%26%23x2013%3B45%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.20411%5C%2Fpai.v10i2.791%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.20411%5C%2Fpai.v10i2.791%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20Year%20in%20Review%20on%20Tuberculosis%20and%20Non-tuberculous%20Mycobacteria%20Disease%3A%20A%202025%20Update%20for%20Clinicians%20and%20Scientists%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Graham%22%2C%22lastName%22%3A%22Bothamley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunar%22%2C%22lastName%22%3A%22G%5Cu00fcnther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irina%22%2C%22lastName%22%3A%22Kontsevaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liga%22%2C%22lastName%22%3A%22Kuksa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Berit%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%22%2C%22lastName%22%3A%22Lorent%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Saluzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Sester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Tebruegge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simone%22%2C%22lastName%22%3A%22Tunesi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Conor%22%2C%22lastName%22%3A%22Tweed%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20In%20the%20field%20of%20tuberculosis%20and%20non-tuberculous%20mycobacterial%20%28NTM%29%20disease%20we%20are%20looking%20back%20on%20an%20exciting%20year%202024%20with%20more%20than%2010%2C000%20publications%20listed%20in%20PubMed.%20%5CnMethods%3A%20Our%20aim%2C%20to%20review%20the%20scientific%20literature%20of%20the%20year%202024%2C%20is%20challenged%20by%20the%20enormous%20number%20of%20publications.%20Therefore%2C%20if%20your%20article%20is%20not%20included%20or%20your%20favorite%20field%20of%20mycobacteriology%20not%20covered%2C%20please%20forgive%20us.%20Our%20%5Cu201cYear%20in%20Review%5Cu201d%20is%20very%20much%20clinically%20oriented%20with%20lesser%20emphasis%20on%20basic%20science%2C%20microbiology%2C%20and%20biotechnology.%20%5CnResults%3A%20Members%20of%20the%20steering%20committee%20of%20the%20Tuberculosis%20Network%20European%20Trials%20group%20%28TBnet%3B%20www.tbnet.eu%29%20report%20on%20139%20publications%20in%20the%20fields%20of%20epidemiology%2C%20prevention%2C%20diagnosis%2C%20and%20treatment%20of%20tuberculosis%20and%20NTM%20diseases%20published%20in%202024%20that%20we%20found%20particularly%20important.%20We%20report%20publications%20separately%20for%20tuberculosis%20in%20children%20and%20adults%20and%20for%20NTM%20disease%20and%20provide%20a%20brief%20overview%20of%20newer%20technologies%20in%20the%20diagnostic%20pipeline.%20Furthermore%2C%20we%20summarize%20priorities%20for%20tuberculosis%20and%20NTM%20disease%20research%2C%20development%2C%20and%20implementation%2C%20all%20of%20which%20represent%20the%20perspective%20of%20our%20combined%20clinical%20experience.%20%5CnConclusions%3A%20This%20Year%20in%20Review%20provides%20a%20concise%20summary%20of%20the%20clinically%20relevant%20highlights%20of%20the%20published%20literature%20in%20tuberculosis%20and%20NTM%20diseases%20in%202024.%22%2C%22date%22%3A%222025-03-02%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.20411%5C%2Fpai.v10i2.791%22%2C%22ISSN%22%3A%222469-2964%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.paijournal.com%5C%2Findex.php%5C%2Fpaijournal%5C%2Farticle%5C%2Fview%5C%2F791%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-05-09T13%3A30%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22BY43HBWY%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kuksa%20et%20al.%22%2C%22parsedDate%22%3A%222025-03-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKuksa%2C%20L.%2C%20Andrejak%2C%20C.%2C%20Haecker%2C%20B.%2C%20Bothamley%2C%20G.%2C%20Calcagno%2C%20A.%2C%20Cirillo%2C%20D.%20M.%2C%20Duarte%2C%20R.%2C%20Fatima%2C%20R.%2C%20Ferlazzo%2C%20G.%2C%20Guglielmetti%2C%20L.%2C%20G%26%23xFC%3Bnther%2C%20G.%2C%20Hewison%2C%20C.%2C%20Horsburgh%2C%20C.%20R.%2C%20J%26%23xE4%3Bger%2C%20T.%2C%20Kalancha%2C%20Y.%2C%20Otto-Knapp%2C%20R.%2C%20Kranzer%2C%20K.%2C%20Lillebaek%2C%20T.%2C%20Marks%2C%20G.%2C%20Middelkoop%2C%20K.%2C%20Motta%2C%20I.%2C%20Rabinova%2C%20V.%2C%20Sommerfeld%2C%20P.%2C%20Tattevin%2C%20P.%20and%20Lange%2C%20C.%20%282025%29.%20%26lt%3Bb%26gt%3BUrgent%20request%20for%20pretomanid%20label%20expansion%20to%20align%20with%20WHO%20guidelines%20and%20improve%20treatment%20accessibility%20and%20efficacy%26lt%3B%5C%2Fb%26gt%3B.%20IJTLD%20OPEN%20%26lt%3Bi%26gt%3B2%26lt%3B%5C%2Fi%26gt%3B%2C%20117%26%23x2013%3B119%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtldopen.25.0152%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtldopen.25.0152%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Urgent%20request%20for%20pretomanid%20label%20expansion%20to%20align%20with%20WHO%20guidelines%20and%20improve%20treatment%20accessibility%20and%20efficacy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Kuksa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Andrejak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Haecker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Bothamley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Calcagno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.M.%22%2C%22lastName%22%3A%22Cirillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Fatima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Ferlazzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22G%5Cu00fcnther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Hewison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.R.%22%2C%22lastName%22%3A%22Horsburgh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22J%5Cu00e4ger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y.%22%2C%22lastName%22%3A%22Kalancha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Otto-Knapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Kranzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Lillebaek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Marks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Middelkoop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.%22%2C%22lastName%22%3A%22Motta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Rabinova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Sommerfeld%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Tattevin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Lange%22%7D%5D%2C%22abstractNote%22%3A%22Pretomanid%20is%20a%20key%20anti-TB%20drug%20included%20in%20the%20WHO%20list%20of%20essential%20medications.%20The%20current%20EMA-approved%20label%20for%20pretomanid%20restricts%20its%20use%20to%20the%20regimen%20comprising%20bedaquiline%2C%20pretomanid%20and%20linezolid%20%28BPaL%29%20and%20only%20for%20extensively%20drug-resistant-TB%20or%20multidrug-resistant%20%5Cn%20TB%2C%20%5Cu201cwhen%20antibiotics%20used%20for%20the%20latter%20form%20of%20TB%20do%20not%20work%20or%20cause%20unacceptable%20side%20effects.%5Cu201d%20This%20restricted%20use%20implies%20that%20the%20older%2C%20prolonged%20and%20poorly%20tolerated%20regimens%20remain%20the%20recommended%20treatment%20for%20most%20cases%20of%20drug-resistant%20TB.%20The%20authors%2C%20representing%20%5Cn%20many%20respiratory%20groups%20and%20societies%2C%20call%20for%20the%20label%20expansion%20of%20pretomanid%20to%20align%20with%20global%20guidelines%2C%20allowing%20for%20broader%20use.%22%2C%22date%22%3A%222025-03-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtldopen.25.0152%22%2C%22ISSN%22%3A%223005-7590%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ingentaconnect.com%5C%2Fcontent%5C%2F10.5588%5C%2Fijtldopen.25.0152%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-05-09T13%3A31%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22SV4N7KNK%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222025-01-30%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuglielmetti%2C%20L.%2C%20Khan%2C%20U.%2C%20Vel%26%23xE1%3Bsquez%2C%20G.%20E.%2C%20Gouillou%2C%20M.%2C%20Abubakirov%2C%20A.%2C%20Baudin%2C%20E.%2C%20Berikova%2C%20E.%2C%20Berry%2C%20C.%2C%20Bonnet%2C%20M.%2C%20Cellamare%2C%20M.%2C%20Chavan%2C%20V.%2C%20Cox%2C%20V.%2C%20Dakenova%2C%20Z.%2C%20De%20Jong%2C%20B.%20C.%2C%20Ferlazzo%2C%20G.%2C%20Karabayev%2C%20A.%2C%20Kirakosyan%2C%20O.%2C%20Kiria%2C%20N.%2C%20Kunda%2C%20M.%2C%20Lachenal%2C%20N.%2C%20Lecca%2C%20L.%2C%20McIlleron%2C%20H.%2C%20Motta%2C%20I.%2C%20Toscano%2C%20S.%20M.%2C%20Mushtaque%2C%20H.%2C%20Nahid%2C%20P.%2C%20Oyewusi%2C%20L.%2C%20Panda%2C%20S.%2C%20Patil%2C%20S.%2C%20Phillips%2C%20P.%20P.%20J.%2C%20Ruiz%2C%20J.%2C%20Salahuddin%2C%20N.%2C%20Garavito%2C%20E.%20S.%2C%20Seung%2C%20K.%20J.%2C%20Ticona%2C%20E.%2C%20Trippa%2C%20L.%2C%20Vasquez%2C%20D.%20E.%20V.%2C%20Wasserman%2C%20S.%2C%20Rich%2C%20M.%20L.%2C%20Varaine%2C%20F.%20and%20Mitnick%2C%20C.%20D.%20%282025%29.%20%26lt%3Bb%26gt%3BOral%20Regimens%20for%20Rifampin-Resistant%2C%20Fluoroquinolone-Susceptible%20Tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20N%20Engl%20J%20Med%20%26lt%3Bi%26gt%3B392%26lt%3B%5C%2Fi%26gt%3B%2C%20468%26%23x2013%3B482%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa2400327%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa2400327%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Oral%20Regimens%20for%20Rifampin-Resistant%2C%20Fluoroquinolone-Susceptible%20Tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Uzma%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%20E.%22%2C%22lastName%22%3A%22Vel%5Cu00e1squez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maelenn%22%2C%22lastName%22%3A%22Gouillou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanzhan%22%2C%22lastName%22%3A%22Abubakirov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Baudin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elmira%22%2C%22lastName%22%3A%22Berikova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Berry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maryline%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matteo%22%2C%22lastName%22%3A%22Cellamare%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%22%2C%22lastName%22%3A%22Chavan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivian%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhanna%22%2C%22lastName%22%3A%22Dakenova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bouke%20Catherine%22%2C%22lastName%22%3A%22De%20Jong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriella%22%2C%22lastName%22%3A%22Ferlazzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aydarkhan%22%2C%22lastName%22%3A%22Karabayev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ohanna%22%2C%22lastName%22%3A%22Kirakosyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nana%22%2C%22lastName%22%3A%22Kiria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mikanda%22%2C%22lastName%22%3A%22Kunda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Lachenal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonid%22%2C%22lastName%22%3A%22Lecca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22McIlleron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilaria%22%2C%22lastName%22%3A%22Motta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergio%20Mucching%22%2C%22lastName%22%3A%22Toscano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hebah%22%2C%22lastName%22%3A%22Mushtaque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Payam%22%2C%22lastName%22%3A%22Nahid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lawrence%22%2C%22lastName%22%3A%22Oyewusi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samiran%22%2C%22lastName%22%3A%22Panda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandip%22%2C%22lastName%22%3A%22Patil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20P.%20J.%22%2C%22lastName%22%3A%22Phillips%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jimena%22%2C%22lastName%22%3A%22Ruiz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naseem%22%2C%22lastName%22%3A%22Salahuddin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Epifanio%20Sanchez%22%2C%22lastName%22%3A%22Garavito%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kwonjune%20J.%22%2C%22lastName%22%3A%22Seung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Ticona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Trippa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dante%20E.%20Vargas%22%2C%22lastName%22%3A%22Vasquez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%22%2C%22lastName%22%3A%22Wasserman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20L.%22%2C%22lastName%22%3A%22Rich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francis%22%2C%22lastName%22%3A%22Varaine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carole%20D.%22%2C%22lastName%22%3A%22Mitnick%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222025-01-30%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1056%5C%2FNEJMoa2400327%22%2C%22ISSN%22%3A%220028-4793%2C%201533-4406%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.nejm.org%5C%2Fdoi%5C%2F10.1056%5C%2FNEJMoa2400327%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-02-13T10%3A18%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22GYDNQB7I%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Soutou%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSoutou%2C%20M.%20A.%2C%20Allam%2C%20C.%2C%20Abi%20Fadel%2C%20M.%2C%20Najjar%2C%20J.%2C%20Guyeux%2C%20C.%2C%20Cambau%2C%20E.%20and%20Sola%2C%20C.%20%282025%29.%20%26lt%3Bb%26gt%3BAn%20insight%20into%20the%20characterization%20of%20L2%20Beijing%20multi-drug%20resistant%20tuberculosis%3A%20Description%20of%20resistance-associated-variants%20and%20discovery%20of%20Modern%207%20L2%20sublineage%26lt%3B%5C%2Fb%26gt%3B.%20Infection%2C%20Genetics%20and%20Evolution%20%26lt%3Bi%26gt%3B134%26lt%3B%5C%2Fi%26gt%3B%2C%20105797%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.meegid.2025.105797%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.meegid.2025.105797%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20insight%20into%20the%20characterization%20of%20L2%20Beijing%20multi-drug%20resistant%20tuberculosis%3A%20Description%20of%20resistance-associated-variants%20and%20discovery%20of%20Modern%207%20L2%20sublineage%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marianne%20Antar%22%2C%22lastName%22%3A%22Soutou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Allam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marianne%22%2C%22lastName%22%3A%22Abi%20Fadel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Josette%22%2C%22lastName%22%3A%22Najjar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Guyeux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Sola%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2210%5C%2F2025%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.meegid.2025.105797%22%2C%22ISSN%22%3A%2215671348%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS1567134825000863%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-09-30T14%3A59%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22XRN4SZWD%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuglielmetti%2C%20L.%2C%20Panda%2C%20S.%2C%20Abubakirov%2C%20A.%2C%20Salahuddin%2C%20N.%2C%20Perrin%2C%20C.%20and%20Mitnick%2C%20C.%20D.%20%282025%29.%20%26lt%3Bb%26gt%3BEquitable%2C%20personalised%20medicine%20for%20tuberculosis%3A%20treating%20patients%2C%20not%20diseases%26lt%3B%5C%2Fb%26gt%3B.%20The%20Lancet%20Respiratory%20Medicine%20%26lt%3Bi%26gt%3B13%26lt%3B%5C%2Fi%26gt%3B%2C%20382%26%23x2013%3B385%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2213-2600%2825%2900080-3%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2213-2600%2825%2900080-3%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Equitable%2C%20personalised%20medicine%20for%20tuberculosis%3A%20treating%20patients%2C%20not%20diseases%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samiran%22%2C%22lastName%22%3A%22Panda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanzhan%22%2C%22lastName%22%3A%22Abubakirov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naseem%22%2C%22lastName%22%3A%22Salahuddin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Perrin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carole%20D%22%2C%22lastName%22%3A%22Mitnick%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2205%5C%2F2025%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2FS2213-2600%2825%2900080-3%22%2C%22ISSN%22%3A%2222132600%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2213260025000803%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-05-09T13%3A32%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22BLP8X3WW%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gerussi%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGerussi%2C%20V.%2C%20Petersen%2C%20T.%2C%20Bonnet%2C%20I.%2C%20Aubry%2C%20A.%2C%20Bachir%2C%20M.%2C%20Gyde%2C%20E.%2C%20Morel%2C%20F.%2C%20Poignon%2C%20C.%2C%20Rached%2C%20B.%2C%20Pourcher%2C%20V.%2C%20Rioux%2C%20C.%2C%20Vallois%2C%20D.%2C%20Veziris%2C%20N.%2C%20Robert%2C%20J.%20and%20Guglielmetti%2C%20L.%20%282025%29.%20%26lt%3Bb%26gt%3BEvaluation%20of%20High-Dose%20Isoniazid%20in%20Multidrug-Resistant%20Tuberculosis%20Treatment%26lt%3B%5C%2Fb%26gt%3B.%20Emerg%20Infect%20Dis%20%26lt%3Bi%26gt%3B31%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid3103.241473%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid3103.241473%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evaluation%20of%20High-Dose%20Isoniazid%20in%20Multidrug-Resistant%20Tuberculosis%20Treatment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valentina%22%2C%22lastName%22%3A%22Gerussi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tania%22%2C%22lastName%22%3A%22Petersen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marwa%22%2C%22lastName%22%3A%22Bachir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Esther%22%2C%22lastName%22%3A%22Gyde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Morel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corentin%22%2C%22lastName%22%3A%22Poignon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brigitte%22%2C%22lastName%22%3A%22Rached%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9rie%22%2C%22lastName%22%3A%22Pourcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Rioux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Doroth%5Cu00e9e%22%2C%22lastName%22%3A%22Vallois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2203%5C%2F2025%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.3201%5C%2Feid3103.241473%22%2C%22ISSN%22%3A%221080-6040%2C%201080-6059%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwwwnc.cdc.gov%5C%2Feid%5C%2Farticle%5C%2F31%5C%2F3%5C%2F24-1473_article%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-03-04T14%3A01%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22MV2MSRDB%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guthmann%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuthmann%2C%20J.-P.%2C%20Robert%2C%20J.%2C%20Viriot%2C%20D.%20and%20Parent%20Du%20Chatelet%2C%20I.%20%282025%29.%20%26lt%3Bb%26gt%3BIncidence%2C%20severity%20and%20treatment%20outcome%20of%20tuberculosis%20in%20the%20era%20of%20the%20COVID-19%20pandemic%2C%20France%2C%202018%26%23x2013%3B2023%26lt%3B%5C%2Fb%26gt%3B.%20Journal%20of%20Epidemiology%20and%20Population%20Health%20%26lt%3Bi%26gt%3B73%26lt%3B%5C%2Fi%26gt%3B%2C%20202795%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jeph.2024.202795%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jeph.2024.202795%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Incidence%2C%20severity%20and%20treatment%20outcome%20of%20tuberculosis%20in%20the%20era%20of%20the%20COVID-19%20pandemic%2C%20France%2C%202018%5Cu20132023%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Paul%22%2C%22lastName%22%3A%22Guthmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Delphine%22%2C%22lastName%22%3A%22Viriot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Parent%20Du%20Chatelet%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2202%5C%2F2025%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jeph.2024.202795%22%2C%22ISSN%22%3A%2229504333%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2950433324006049%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-02-13T10%3A17%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22JW4QBU8M%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kunst%20et%20al.%22%2C%22parsedDate%22%3A%222024-12-13%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKunst%2C%20H.%2C%20Lange%2C%20B.%2C%20Hovardovska%2C%20O.%2C%20Bockey%2C%20A.%2C%20Zenner%2C%20D.%2C%20Andersen%2C%20A.%20B.%2C%20Hargreaves%2C%20S.%2C%20Pareek%2C%20M.%2C%20Friedland%2C%20J.%20S.%2C%20Wejse%2C%20C.%2C%20Bothamley%2C%20G.%2C%20Guglielmetti%2C%20L.%2C%20Chesov%2C%20D.%2C%20Tiberi%2C%20S.%2C%20Matteelli%2C%20A.%2C%20Mandalakas%2C%20A.%20M.%2C%20Heyckendorf%2C%20J.%2C%20Eimer%2C%20J.%2C%20Malhotra%2C%20A.%2C%20Zamora%2C%20J.%2C%20Vasiliu%2C%20A.%2C%20Lange%2C%20C.%20and%20for%20the%20TBnet%20%282024%29.%20%26lt%3Bb%26gt%3BTuberculosis%20in%20adult%20migrants%20in%20Europe%3A%20a%20TBnet%20consensus%20statement%26lt%3B%5C%2Fb%26gt%3B.%20Eur%20Respir%20J%202401612%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.01612-2024%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.01612-2024%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tuberculosis%20in%20adult%20migrants%20in%20Europe%3A%20a%20TBnet%20consensus%20statement%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heinke%22%2C%22lastName%22%3A%22Kunst%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Berit%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Hovardovska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annabelle%22%2C%22lastName%22%3A%22Bockey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominik%22%2C%22lastName%22%3A%22Zenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aase%20B%22%2C%22lastName%22%3A%22Andersen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sally%22%2C%22lastName%22%3A%22Hargreaves%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manish%22%2C%22lastName%22%3A%22Pareek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jon%20S%22%2C%22lastName%22%3A%22Friedland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chrsitain%22%2C%22lastName%22%3A%22Wejse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Graham%22%2C%22lastName%22%3A%22Bothamley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dima%22%2C%22lastName%22%3A%22Chesov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Tiberi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alberto%22%2C%22lastName%22%3A%22Matteelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20M%22%2C%22lastName%22%3A%22Mandalakas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Heyckendorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%22%2C%22lastName%22%3A%22Eimer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akanksha%22%2C%22lastName%22%3A%22Malhotra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Javier%22%2C%22lastName%22%3A%22Zamora%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anca%22%2C%22lastName%22%3A%22Vasiliu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22for%20the%20TBnet%22%7D%5D%2C%22abstractNote%22%3A%22Introduction%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Global%20migration%20has%20increased%20in%20recent%20decades%20due%20to%20war%2C%20conflict%2C%20persecutions%2C%20and%20natural%20disasters%2C%20but%20also%20secondary%20to%20increased%20opportunities%20related%20to%20work%20or%20study.%20Migrants%5Cu2019%20risk%20of%20tuberculosis%20%28TB%29%20differs%20by%20reasons%20for%20migration%2C%20socioeconomic%20status%2C%20mode%20of%20travel%20and%20TB%20risk%20in%20transit%2C%20TB%20incidence%20and%20healthcare%20provision%20in%20country%20of%20origin.%20Despite%20advances%20in%20TB%20care%20for%20migrants%20and%20new%20treatment%20strategies%2C%20decisions%20for%20the%20management%20of%20migrants%20at%20risk%20of%20TB%20often%20rely%20on%20expert%20opinions%2C%20rather%20than%20clinical%20evidence.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Methods%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20A%20systematic%20literature%20search%20was%20conducted%2C%20studies%20were%20mapped%20to%20different%20recommendation%20groups%20and%20included%20studies%20were%20synthesized%20by%20meta-analysis%20where%20appropriate.%20Current%20evidence%20on%20diagnosis%20of%20active%20TB%20in%20migrants%20entering%20the%20European%20Union%20%5C%2FEuropean%20Economic%20Area%20%28EU%5C%2FEEA%29%20%26amp%3BUK%20including%20the%20clinical%20presentation%20and%20diagnostic%20delay%2C%20treatment%20outcomes%20of%20drug%20susceptible%20TB%2C%20prevalence%20and%20treatment%20outcomes%20of%20multidrug%5C%2Frifampicin-resistant%20%28MDR%5C%2FRR%29-TB%20and%20TB%5C%2FHIV%20co-infection%20was%20summarised.%20A%20consensus%20process%20was%20used%20based%20on%20the%20evidence.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Results%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20We%20document%20a%20higher%20vulnerability%20of%20migrants%20for%20TB%2C%20including%20an%20increased%20risk%20of%20extrapulmonary%20TB%2C%20MDR%5C%2FRR-TB%2C%20TB%5C%2FHIV%20co-infection%20and%20worse%20TB%20treatment%20outcomes%20compared%20to%20host%20populations.%20Consensus%20recommendations%20include%20screening%20of%20migrants%20for%20TB%5C%2F%20latent%20TB%20infection%20%28LTBI%29%20according%20to%20country%20data%3B%20a%20minimal%20package%20for%20TB%20care%20in%20drug%20susceptible%20and%20MDR%5C%2FRR-TB%3B%20implementation%20of%20migrant-sensitive%20strategies%3B%20free%20healthcare%20and%20preventive%20treatment%20for%20migrants%20with%20HIV%20co-infection.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Conclusion%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Dedicated%20care%20for%20TB%20prevention%20and%20treatment%20in%20migrant%20populations%20within%20the%20EU%5C%2FEEA%20%26amp%3BUK%20is%20essential.%22%2C%22date%22%3A%222024-12-13%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1183%5C%2F13993003.01612-2024%22%2C%22ISSN%22%3A%220903-1936%2C%201399-3003%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fpublications.ersnet.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1183%5C%2F13993003.01612-2024%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-12-26T17%3A11%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22IHKWS8TE%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Maitre%20et%20al.%22%2C%22parsedDate%22%3A%222024-10-16%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMaitre%2C%20T.%2C%20Godmer%2C%20A.%2C%20Mory%2C%20C.%2C%20Chauffour%2C%20A.%2C%20Mai%2C%20T.%20C.%2C%20El%20Helali%2C%20N.%2C%20Aubry%2C%20A.%20and%20Veziris%2C%20N.%20%282024%29.%20%26lt%3Bb%26gt%3BLevofloxacin%20activity%20at%20increasing%20doses%20in%20a%20murine%20model%20of%20fluoroquinolone-susceptible%20and%20-resistant%20tuberculosis%26lt%3B%5C%2Fb%26gt%3B%20Ed.%20Wasserman%2C%20S.%20Antimicrob%20Agents%20Chemother%20e00583-24%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Faac.00583-24%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Faac.00583-24%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Levofloxacin%20activity%20at%20increasing%20doses%20in%20a%20murine%20model%20of%20fluoroquinolone-susceptible%20and%20-resistant%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Maitre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Godmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9line%22%2C%22lastName%22%3A%22Mory%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Cuc%22%2C%22lastName%22%3A%22Mai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Najoua%22%2C%22lastName%22%3A%22El%20Helali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Sean%22%2C%22lastName%22%3A%22Wasserman%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20High-dose%20levofloxacin%20was%20explored%20in%20a%20clinical%20trial%20against%20multidrug-resistant%20tuberculosis%20and%20failed%20to%20show%20increased%20efficacy.%20In%20this%20study%2C%20we%20used%20a%20murine%20model%20to%20explore%20the%20efficacy%20of%20a%20dose%20increase%20in%20levofloxacin%20monotherapy%20beyond%20the%20maximum%20dose%20evaluated%20in%20humans.%20A%20total%20of%20120%204-week-old%20female%20BALB%5C%2Fc%20mice%20were%20intravenously%20infected%20with%2010%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%206%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20CFU%20of%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mycobacterium%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20H37Rv%20wild-type%20%28WT%29%20or%20isogenic%20H37Rv%20mutants%20harboring%20GyrA%20A90V%20or%20D94G%20substitutions%3B%20the%20MICs%20were%200.25%2C%204%2C%20and%206%20%5Cu00b5g%5C%2FmL%2C%20respectively.%20Levofloxacin%20250%20and%20500%20mg%5C%2Fkg%20were%20given%20every%2012%20h%20%28q12h%29%20orally%20for%204%20weeks.%20Pharmacokinetic%20parameters%20were%20determined%20after%20five%20doses.%20These%20two%20regimens%20decreased%20lung%20bacillary%20load%20in%20mice%20infected%20with%20H37Rv%20WT%20but%20not%20in%20mice%20infected%20with%20the%20A90V%20and%20D94G%20mutants.%20Levofloxacin%20250%20mg%5C%2Fkg%20q12h%20in%20mice%20generated%20pharmacokinetic%20parameters%20equivalent%20to%201%2C000%20mg%5C%2Fd%20in%20humans%2C%20whereas%20500%20mg%5C%2Fkg%20q12h%20generated%20a%20twofold%20greater%20exposure%20than%20the%20highest%20equivalent%20dose%20tested%20in%20humans%20%281%2C500%20mg%5C%2Fd%29.%20In%20our%20dose%5Cu2013response%20model%2C%20the%20effective%20concentration%20at%2050%25%20%28EC%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2050%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%29%20produced%20an%20AUC%5C%2FMIC%20%28AUC%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%200%5Cu201324h%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5C%2FMIC%29%20ratio%20of%20167.9%20%5Cu00b1%2027.5%2C%20and%20at%20EC%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2080%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20it%20was%20281.2%20%5Cu00b1%2097.3.%20Based%20on%20this%20model%2C%20high-dose%20levofloxacin%20regimens%20above%201%2C000%20mg%5C%2Fd%20are%20not%20expected%20to%20cause%20a%20significant%20increase%20in%20bactericidal%20activity.%20This%20study%20suggests%20no%20benefit%20of%20high-dose%20levofloxacin%20above%201%2C000%20mg%5C%2Fd%20in%20the%20treatment%20of%20fluoroquinolone-susceptible%20or%20-resistant%20tuberculosis.%22%2C%22date%22%3A%222024-10-16%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1128%5C%2Faac.00583-24%22%2C%22ISSN%22%3A%220066-4804%2C%201098-6596%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.asm.org%5C%2Fdoi%5C%2F10.1128%5C%2Faac.00583-24%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-10-17T10%3A19%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22ULGLVJW6%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Godefroy%20et%20al.%22%2C%22parsedDate%22%3A%222024-07-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGodefroy%2C%20N.%2C%20Monsel%2C%20G.%2C%20Jaur%26%23xE9%3Bguiberry%2C%20S.%2C%20Henry%2C%20B.%2C%20V%26%23xE9%3Bziris%2C%20N.%2C%20Aubry%2C%20A.%2C%20Robert%2C%20J.%2C%20Jachym%2C%20M.%2C%20Caumes%2C%20E.%20and%20Pourcher%2C%20V.%20%282024%29.%20%26lt%3Bb%26gt%3BLessons%20learned%20from%20treating%20drug-resistant%20TB%20and%20how%20to%20apply%20these%20to%20drug-susceptible%20TB%26lt%3B%5C%2Fb%26gt%3B.%20int%20j%20tuberc%20lung%20dis%20%26lt%3Bi%26gt%3B28%26lt%3B%5C%2Fi%26gt%3B%2C%20357%26%23x2013%3B359%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.23.0548%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.23.0548%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lessons%20learned%20from%20treating%20drug-resistant%20TB%20and%20how%20to%20apply%20these%20to%20drug-susceptible%20TB%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Godefroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Monsel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Jaur%5Cu00e9guiberry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Henry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22V%5Cu00e9ziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Jachym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Caumes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Pourcher%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024-07-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.23.0548%22%2C%22ISSN%22%3A%221027-3719%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ingentaconnect.com%5C%2Fcontent%5C%2F10.5588%5C%2Fijtld.23.0548%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-07-17T14%3A19%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22V67C548F%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rupasinghe%20et%20al.%22%2C%22parsedDate%22%3A%222024-05-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRupasinghe%2C%20P.%2C%20Ashraf%2C%20A.%2C%20Barreda%2C%20N.%2C%20Parveen%2C%20S.%2C%20Zubair%2C%20M.%2C%20Calderon%2C%20R.%2C%20Asif%2C%20S.%2C%20Hirani%2C%20N.%2C%20Chingisova%2C%20L.%2C%20Bulane%2C%20A.%2C%20Hang%2C%20P.%20T.%2C%20Ha%2C%20D.%20T.%2C%20Ardizzoni%2C%20E.%2C%20Kursheed%2C%20N.%2C%20De%20Rijk%2C%20W.%20B.%2C%20Rigouts%2C%20L.%2C%20Guglielmetti%2C%20L.%2C%20Mitnick%2C%20C.%20and%20De%20Jong%2C%20B.%20C.%20%282024%29.%20%26lt%3Bb%26gt%3BReduced%20critical%20concentration%20might%20not%20have%20improved%20MGIT-based%20DST%26%23x2019%3Bs%20sensitivity%20to%20rifampicin%26lt%3B%5C%2Fb%26gt%3B%20Ed.%20Wasserman%2C%20S.%20Antimicrob%20Agents%20Chemother%20%26lt%3Bi%26gt%3B68%26lt%3B%5C%2Fi%26gt%3B%2C%20e01701-23%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Faac.01701-23%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Faac.01701-23%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Reduced%20critical%20concentration%20might%20not%20have%20improved%20MGIT-based%20DST%5Cu2019s%20sensitivity%20to%20rifampicin%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Praharshinie%22%2C%22lastName%22%3A%22Rupasinghe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azka%22%2C%22lastName%22%3A%22Ashraf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadia%22%2C%22lastName%22%3A%22Barreda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shafiqua%22%2C%22lastName%22%3A%22Parveen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Zubair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roger%22%2C%22lastName%22%3A%22Calderon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunil%22%2C%22lastName%22%3A%22Asif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nilma%22%2C%22lastName%22%3A%22Hirani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Layila%22%2C%22lastName%22%3A%22Chingisova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atang%22%2C%22lastName%22%3A%22Bulane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pham%20Thu%22%2C%22lastName%22%3A%22Hang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Doan%20Thu%22%2C%22lastName%22%3A%22Ha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisa%22%2C%22lastName%22%3A%22Ardizzoni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nazia%22%2C%22lastName%22%3A%22Kursheed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Willem%20Bram%22%2C%22lastName%22%3A%22De%20Rijk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leen%22%2C%22lastName%22%3A%22Rigouts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carol%22%2C%22lastName%22%3A%22Mitnick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bouke%20C.%22%2C%22lastName%22%3A%22De%20Jong%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Sean%22%2C%22lastName%22%3A%22Wasserman%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024-05-02%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1128%5C%2Faac.01701-23%22%2C%22ISSN%22%3A%220066-4804%2C%201098-6596%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.asm.org%5C%2Fdoi%5C%2F10.1128%5C%2Faac.01701-23%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-10-18T16%3A22%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22RHYL4NM9%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Paulowski%20et%20al.%22%2C%22parsedDate%22%3A%222024-04-16%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPaulowski%2C%20L.%2C%20Filip%2C%20R.%2C%20Jankovic%20Makek%2C%20M.%2C%20Guglielmetti%2C%20L.%2C%20Goletti%2C%20D.%2C%20Van%20Ingen%2C%20J.%2C%20Kranzer%2C%20K.%2C%20Maurer%2C%20F.%20P.%20and%20on%20behalf%20of%20ESGMYC%20%282024%29.%20%26lt%3Bb%26gt%3BImpact%20of%20the%20COVID-19%20pandemic%20on%20the%20real-world%20diagnostic%20infrastructure%20for%20tuberculosis%26%23x2014%3BAn%20ESGMYC%20collaborative%20study%26lt%3B%5C%2Fb%26gt%3B%20Ed.%20Wang%2C%20M.-S.%20PLoS%20ONE%20%26lt%3Bi%26gt%3B19%26lt%3B%5C%2Fi%26gt%3B%2C%20e0291404%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0291404%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0291404%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20the%20COVID-19%20pandemic%20on%20the%20real-world%20diagnostic%20infrastructure%20for%20tuberculosis%5Cu2014An%20ESGMYC%20collaborative%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Paulowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxana%22%2C%22lastName%22%3A%22Filip%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mateja%22%2C%22lastName%22%3A%22Jankovic%20Makek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Delia%22%2C%22lastName%22%3A%22Goletti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jakko%22%2C%22lastName%22%3A%22Van%20Ingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katharina%22%2C%22lastName%22%3A%22Kranzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florian%20P.%22%2C%22lastName%22%3A%22Maurer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22on%20behalf%20of%20ESGMYC%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Mao-Shui%22%2C%22lastName%22%3A%22Wang%22%7D%5D%2C%22abstractNote%22%3A%22We%20determined%20the%20impact%20of%20the%20COVID-19%20pandemic%20on%20mycobacterial%20diagnostic%20services.%2040%20laboratories%20from%2022%20countries%20completed%20an%20online%20questionnaire%20covering%20the%20redeployment%20of%20the%20laboratory%20infrastructure%20and%5C%2For%20staff%20for%20SARS-CoV-2%20testing%2C%20staff%20shortages%20and%20supply%20chain%20disruptions.%2028%20laboratories%20reported%20monthly%20numbers%20of%20samples%20processed%20for%20mycobacterial%20investigations%20and%20monthly%20numbers%20of%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20M%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20complex%20%28MTBC%29%20PCRs%20performed%20between%20October%201st%202018%20and%20October%2031st%202020.%20More%20than%20half%20%2823%5C%2F40%29%20of%20the%20participating%20TB%20laboratories%20reported%20having%20performed%20COVID-19%20diagnostics%20in%20the%20early%20phase%20of%20the%20pandemic%2C%20in%20part%20with%20negative%20impact%20on%20the%20mycobacterial%20service%20activities.%20All%20participating%20laboratories%20reported%20shortages%20of%20consumables%20and%20laboratory%20equipment%20due%20to%20supply%20chain%20issues.%20Average%20monthly%20sample%20numbers%20decreased%20by%2024%25%20between%20January%202020%20and%20October%202020%20compared%20to%20pre-pandemic%20averages.%20At%20the%20end%20of%20the%20study%20period%2C%20most%20participating%20laboratories%20had%20not%20returned%20to%20pre-pandemic%20average%20MTBC%20PCR%20throughput.%22%2C%22date%22%3A%222024-4-16%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0291404%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdx.plos.org%5C%2F10.1371%5C%2Fjournal.pone.0291404%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-12-26T17%3A13%3A54Z%22%7D%7D%2C%7B%22key%22%3A%222HSDN9QD%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Veziris%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-19%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BVeziris%2C%20N.%2C%20Aubry%2C%20A.%2C%20Bonnet%2C%20I.%2C%20Petersen%2C%20T.%2C%20Poignon%2C%20C.%2C%20Gyd%26%23xE9%3B%2C%20E.%2C%20Guglielmetti%2C%20L.%20and%20Robert%2C%20J.%20%282024%29.%20%26lt%3Bb%26gt%3BActualit%26%23xE9%3Bs%20sur%20la%20tuberculose%20%26%23xE0%3B%20bacilles%20multir%26%23xE9%3Bsistants%20aux%20antibiotiques%20et%20ses%20nouveaux%20traitements%26lt%3B%5C%2Fb%26gt%3B.%20Bull%20%26%23xC9%3Bpid%20Hebdo%20127%26%23x2013%3B131%2C%20URL%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fbeh.santepubliquefrance.fr%5C%2Fbeh%5C%2F2024%5C%2F6-7%5C%2F2024_6-7_4.html%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fbeh.santepubliquefrance.fr%5C%2Fbeh%5C%2F2024%5C%2F6-7%5C%2F2024_6-7_4.html%26lt%3B%5C%2Fa%26gt%3B%20%5BAccessed%20March%202024%5D.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Actualit%5Cu00e9s%20sur%20la%20tuberculose%20%5Cu00e0%20bacilles%20multir%5Cu00e9sistants%20aux%20antibiotiques%20et%20ses%20nouveaux%20traitements%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T%22%2C%22lastName%22%3A%22Petersen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Poignon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Gyd%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%22%2C%22lastName%22%3A%22Robert%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024-03-19%22%2C%22language%22%3A%22French%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbeh.santepubliquefrance.fr%5C%2Fbeh%5C%2F2024%5C%2F6-7%5C%2F2024_6-7_4.html%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-03-19T17%3A03%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22RYJ5THDR%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22B%5Cu00e9rot%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BB%26%23xE9%3Brot%2C%20V.%2C%20Monsel%2C%20G.%2C%20Lecorche%2C%20E.%2C%20Halabi-Tawil%2C%20M.%2C%20Maalouf%2C%20D.%2C%20Pourcher%2C%20V.%2C%20Aubry%2C%20A.%2C%20Cambaud%2C%20E.%2C%20Petit%2C%20A.%20and%20Caumes%2C%20E.%20%282024%29.%20%26lt%3Bb%26gt%3BClinical%20relevance%20and%20prognostic%20impact%20of%20the%20classification%20between%20multibacillary%20and%20paucibacillary%20forms%20of%20cutaneous%20tuberculosis%3A%20A%2024-year%20retrospective%20multicenter%20study%26lt%3B%5C%2Fb%26gt%3B.%20Annales%20de%20Dermatologie%20et%20de%20V%26%23xE9%3Bn%26%23xE9%3Br%26%23xE9%3Bologie%20%26lt%3Bi%26gt%3B151%26lt%3B%5C%2Fi%26gt%3B%2C%20103324%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.annder.2024.103324%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.annder.2024.103324%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20relevance%20and%20prognostic%20impact%20of%20the%20classification%20between%20multibacillary%20and%20paucibacillary%20forms%20of%20cutaneous%20tuberculosis%3A%20A%2024-year%20retrospective%20multicenter%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22B%5Cu00e9rot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Monsel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Lecorche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Halabi-Tawil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Maalouf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Pourcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Cambaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Petit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Caumes%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2212%5C%2F2024%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.annder.2024.103324%22%2C%22ISSN%22%3A%2201519638%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS0151963824000802%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-12-26T17%3A04%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22P7NUG964%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guyeux%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuyeux%2C%20C.%2C%20Senelle%2C%20G.%2C%20Le%20Meur%2C%20A.%2C%20Supply%2C%20P.%2C%20Gaudin%2C%20C.%2C%20Phelan%2C%20J.%20E.%2C%20Clark%2C%20T.%20G.%2C%20Rigouts%2C%20L.%2C%20De%20Jong%2C%20B.%2C%20Sola%2C%20C.%20and%20Refr%26%23xE9%3Bgier%2C%20G.%20%282024%29.%20%26lt%3Bb%26gt%3BNewly%20Identified%20Mycobacterium%20africanum%20Lineage%2010%2C%20Central%20Africa%26lt%3B%5C%2Fb%26gt%3B.%20Emerg%20Infect%20Dis%20%26lt%3Bi%26gt%3B30%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid3003.231466%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid3003.231466%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Newly%20Identified%20Mycobacterium%20africanum%20Lineage%2010%2C%20Central%20Africa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Guyeux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaetan%22%2C%22lastName%22%3A%22Senelle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrien%22%2C%22lastName%22%3A%22Le%20Meur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philip%22%2C%22lastName%22%3A%22Supply%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cyril%22%2C%22lastName%22%3A%22Gaudin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jody%20E.%22%2C%22lastName%22%3A%22Phelan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taane%20G%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leen%22%2C%22lastName%22%3A%22Rigouts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bouke%22%2C%22lastName%22%3A%22De%20Jong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Sola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guislaine%22%2C%22lastName%22%3A%22Refr%5Cu00e9gier%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2210%5C%2F2024%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.3201%5C%2Feid3003.231466%22%2C%22ISSN%22%3A%221080-6040%2C%201080-6059%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwwwnc.cdc.gov%5C%2Feid%5C%2Farticle%5C%2F30%5C%2F3%5C%2F23-1466_article%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-04-03T14%3A39%3A03Z%22%7D%7D%2C%7B%22key%22%3A%229L3HNICX%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gedeon%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGedeon%2C%20A.%2C%20Yab%2C%20E.%2C%20Dinut%2C%20A.%2C%20Sadowski%2C%20E.%2C%20Capton%2C%20E.%2C%20Dreneau%2C%20A.%2C%20Petit%2C%20J.%2C%20Gioia%2C%20B.%2C%20Piveteau%2C%20C.%2C%20Djaout%2C%20K.%2C%20Lecat%2C%20E.%2C%20Wehenkel%2C%20A.%20M.%2C%20Gubellini%2C%20F.%2C%20Mechaly%2C%20A.%2C%20Alzari%2C%20P.%20M.%2C%20Deprez%2C%20B.%2C%20Baulard%2C%20A.%2C%20Aubry%2C%20A.%2C%20Willand%2C%20N.%20and%20Petrella%2C%20S.%20%282024%29.%20%26lt%3Bb%26gt%3BMolecular%20mechanism%20of%20a%20triazole-containing%20inhibitor%20of%20Mycobacterium%20tuberculosis%20DNA%20gyrase%26lt%3B%5C%2Fb%26gt%3B.%20iScience%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%2C%20110967%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.isci.2024.110967%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.isci.2024.110967%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Molecular%20mechanism%20of%20a%20triazole-containing%20inhibitor%20of%20Mycobacterium%20tuberculosis%20DNA%20gyrase%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Gedeon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilie%22%2C%22lastName%22%3A%22Yab%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aurelia%22%2C%22lastName%22%3A%22Dinut%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elodie%22%2C%22lastName%22%3A%22Sadowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Estelle%22%2C%22lastName%22%3A%22Capton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aurore%22%2C%22lastName%22%3A%22Dreneau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julienne%22%2C%22lastName%22%3A%22Petit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruna%22%2C%22lastName%22%3A%22Gioia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Piveteau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kamel%22%2C%22lastName%22%3A%22Djaout%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Estelle%22%2C%22lastName%22%3A%22Lecat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20Marie%22%2C%22lastName%22%3A%22Wehenkel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Gubellini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ariel%22%2C%22lastName%22%3A%22Mechaly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%20M.%22%2C%22lastName%22%3A%22Alzari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beno%5Cu00eet%22%2C%22lastName%22%3A%22Deprez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alain%22%2C%22lastName%22%3A%22Baulard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Willand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Petrella%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2210%5C%2F2024%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.isci.2024.110967%22%2C%22ISSN%22%3A%2225890042%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2589004224021928%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-12-26T17%3A06%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22Q8Q2WRP9%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22G%5Cu00fcnther%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BG%26%23xFC%3Bnther%2C%20G.%2C%20Guglielmetti%2C%20L.%2C%20Kherabi%2C%20Y.%2C%20Duarte%2C%20R.%20and%20Lange%2C%20C.%20%282024%29.%20%26lt%3Bb%26gt%3BAvailability%20of%20drugs%20and%20resistance%20testing%20for%20bedaquiline%2C%20pretomanid%2C%20linezolid%2C%20and%20moxifloxacin%20%28BPaL%28M%29%29%20regimen%20for%20rifampicin-resistant%20tuberculosis%20in%20Europe%26lt%3B%5C%2Fb%26gt%3B.%20Clinical%20Microbiology%20and%20Infection%20%26lt%3Bi%26gt%3B30%26lt%3B%5C%2Fi%26gt%3B%2C%201197.e1-1197.e4%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2024.03.009%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2024.03.009%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Availability%20of%20drugs%20and%20resistance%20testing%20for%20bedaquiline%2C%20pretomanid%2C%20linezolid%2C%20and%20moxifloxacin%20%28BPaL%28M%29%29%20regimen%20for%20rifampicin-resistant%20tuberculosis%20in%20Europe%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunar%22%2C%22lastName%22%3A%22G%5Cu00fcnther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yousra%22%2C%22lastName%22%3A%22Kherabi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%22%2C%22lastName%22%3A%22Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2209%5C%2F2024%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2024.03.009%22%2C%22ISSN%22%3A%221198743X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS1198743X24001216%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-12-26T17%3A14%3A59Z%22%7D%7D%2C%7B%22key%22%3A%224PJRSDDI%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lange%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLange%2C%20C.%2C%20Kherabi%2C%20Y.%2C%20Guglielmetti%2C%20L.%2C%20Duarte%2C%20R.%20and%20G%26%23xFC%3Bnther%2C%20G.%20%282024%29.%20%26lt%3Bb%26gt%3BAvailability%20of%20drugs%20and%20resistance%20testing%20for%20bedaquiline%2C%20pretomanid%2C%20linezolid%2C%20and%20moxifloxacin%20%28BPaL%28M%29%29%20regimen%20for%20rifampicin-resistant%20tuberculosis%20in%20Europe%3A%20author%26%23x2019%3Bs%20response%26lt%3B%5C%2Fb%26gt%3B.%20Clinical%20Microbiology%20and%20Infection%20%26lt%3Bi%26gt%3B30%26lt%3B%5C%2Fi%26gt%3B%2C%201207%26%23x2013%3B1208%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2024.06.009%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2024.06.009%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Availability%20of%20drugs%20and%20resistance%20testing%20for%20bedaquiline%2C%20pretomanid%2C%20linezolid%2C%20and%20moxifloxacin%20%28BPaL%28M%29%29%20regimen%20for%20rifampicin-resistant%20tuberculosis%20in%20Europe%3A%20author%27s%20response%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yousra%22%2C%22lastName%22%3A%22Kherabi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%22%2C%22lastName%22%3A%22Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunar%22%2C%22lastName%22%3A%22G%5Cu00fcnther%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2209%5C%2F2024%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2024.06.009%22%2C%22ISSN%22%3A%221198743X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS1198743X24002891%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-10-17T10%3A25%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22VNSB8L8Y%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Friesen%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFriesen%2C%20I.%2C%20Saluzzo%2C%20F.%2C%20Groenheit%2C%20R.%2C%20Aubry%2C%20A.%2C%20Anthony%2C%20R.%2C%20Niemann%2C%20S.%2C%20Mathys%2C%20V.%2C%20Cirillo%2C%20D.%20M.%2C%20Indra%2C%20A.%2C%20Mathys%2C%20V.%2C%20Atanasova%2C%20Y.%2C%20Obrovac%2C%20M.%2C%20%26%23x17D%3Bmak%2C%20L.%2C%20Pieridou%2C%20D.%2C%20Dvo%26%23x159%3B%26%23xE1%3Bkov%2C%20V.%2C%20Troels%20Lilleb%26%23xE6%3Bk%2C%20Kummik%2C%20T.%2C%20Klaos%2C%20K.%2C%20Soini%2C%20H.%2C%20Haanper%26%23xE4%3B-Heikkinen%2C%20M.%2C%20Mentula%2C%20S.%2C%20J%26%23xE9%3Br%26%23xF4%3Bme%2C%20R.%2C%20Cambau%2C%20E.%2C%20Niemann%2C%20S.%2C%20Panayotis%2C%20I.%2C%20Papaventsis%2C%20D.%2C%20Bakos%2C%20%26%23xC1%3B.%2C%20Sz%26%23xE9%3Bl%2C%20V.%2C%20L%26%23x151%3Brinczi%2C%20L.%20K.%2C%20Fitzgibbon%2C%20M.%2C%20Boyle%2C%20B.%2C%20Cirillo%2C%20D.%20M.%2C%20Giannoni%2C%20F.%2C%20Pole%2C%20I.%2C%20Norvai%26%23x161%3Ba%2C%20I.%2C%20Vasiliauskaite%2C%20L.%2C%20Perrin%2C%20M.%2C%20Deguara%2C%20C.%2C%20Anthony%2C%20R.%2C%20Mengshoel%2C%20A.%20T.%2C%20Augustynowicz-Kope%26%23x107%3B%2C%20E.%2C%20Macedo%2C%20R.%2C%20Coriu%2C%20R.%20M.%2C%20Porvaznik%2C%20I.%2C%20Klemen%2C%20%26%23x160%3B.%2C%20Herrera-Le%26%23xF3%3Bn%2C%20L.%2C%20Groenheit%2C%20R.%20and%20Werngren%2C%20J.%20%282024%29.%20%26lt%3Bb%26gt%3BRe%3A%20%26%23x201C%3BAvailability%20of%20drugs%20and%20resistance%20testing%20for%20BPaLM%20regimen%20for%20rifampicin-resistant%20tuberculosis%20in%20Europe%26%23x201D%3B%20by%20Lange%20et%20al.%26lt%3B%5C%2Fb%26gt%3B%20Clinical%20Microbiology%20and%20Infection%20S1198743X24002775%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2024.06.001%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2024.06.001%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Re%3A%20%5Cu2018Availability%20of%20drugs%20and%20resistance%20testing%20for%20BPaLM%20regimen%20for%20rifampicin-resistant%20tuberculosis%20in%20Europe%5Cu2019%20by%20Lange%20et%20al.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inna%22%2C%22lastName%22%3A%22Friesen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Saluzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ramona%22%2C%22lastName%22%3A%22Groenheit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Anthony%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Niemann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Mathys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%20Maria%22%2C%22lastName%22%3A%22Cirillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Indra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Mathys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuliana%22%2C%22lastName%22%3A%22Atanasova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mihaela%22%2C%22lastName%22%3A%22Obrovac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ljiljiana%22%2C%22lastName%22%3A%22%5Cu017dmak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Despo%22%2C%22lastName%22%3A%22Pieridou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%5Cu011bra%22%2C%22lastName%22%3A%22Dvo%5Cu0159%5Cu00e1kov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Troels%20Lilleb%5Cu00e6k%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiina%22%2C%22lastName%22%3A%22Kummik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kadri%22%2C%22lastName%22%3A%22Klaos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanna%22%2C%22lastName%22%3A%22Soini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marjo%22%2C%22lastName%22%3A%22Haanper%5Cu00e4-Heikkinen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Silja%22%2C%22lastName%22%3A%22Mentula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Niemann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ioannidis%22%2C%22lastName%22%3A%22Panayotis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dimitrios%22%2C%22lastName%22%3A%22Papaventsis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%5Cu00c1gnes%22%2C%22lastName%22%3A%22Bakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vikt%5Cu00f3ria%22%2C%22lastName%22%3A%22Sz%5Cu00e9l%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lilla%20Katalin%22%2C%22lastName%22%3A%22L%5Cu0151rinczi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margaret%22%2C%22lastName%22%3A%22Fitzgibbon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Breida%22%2C%22lastName%22%3A%22Boyle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%20Maria%22%2C%22lastName%22%3A%22Cirillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Federico%22%2C%22lastName%22%3A%22Giannoni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilva%22%2C%22lastName%22%3A%22Pole%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inga%22%2C%22lastName%22%3A%22Norvai%5Cu0161a%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laima%22%2C%22lastName%22%3A%22Vasiliauskaite%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monique%22%2C%22lastName%22%3A%22Perrin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catriona%22%2C%22lastName%22%3A%22Deguara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Anthony%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20Torunn%22%2C%22lastName%22%3A%22Mengshoel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ewa%22%2C%22lastName%22%3A%22Augustynowicz-Kope%5Cu0107%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rita%22%2C%22lastName%22%3A%22Macedo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxana%20Mihaela%22%2C%22lastName%22%3A%22Coriu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Igor%22%2C%22lastName%22%3A%22Porvaznik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%5Cu0160pela%22%2C%22lastName%22%3A%22Klemen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Herrera-Le%5Cu00f3n%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ramona%22%2C%22lastName%22%3A%22Groenheit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jim%22%2C%22lastName%22%3A%22Werngren%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%226%5C%2F2024%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2024.06.001%22%2C%22ISSN%22%3A%221198743X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS1198743X24002775%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-07-17T14%3A23%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22TGPHGG7Y%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Maitre%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMaitre%2C%20T.%2C%20Baulard%2C%20A.%2C%20Aubry%2C%20A.%20and%20Veziris%2C%20N.%20%282024%29.%20%26lt%3Bb%26gt%3BOptimizing%20the%20use%20of%20current%20antituberculosis%20drugs%20to%20overcome%20drug%20resistance%20in%20Mycobacterium%20tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20Infectious%20Diseases%20Now%20%26lt%3Bi%26gt%3B54%26lt%3B%5C%2Fi%26gt%3B%2C%20104807%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.idnow.2023.104807%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.idnow.2023.104807%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Optimizing%20the%20use%20of%20current%20antituberculosis%20drugs%20to%20overcome%20drug%20resistance%20in%20Mycobacterium%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Maitre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alain%22%2C%22lastName%22%3A%22Baulard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2202%5C%2F2024%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.idnow.2023.104807%22%2C%22ISSN%22%3A%2226669919%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2666991923001690%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-11-13T09%3A44%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22V2XSRDIF%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Maitre%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMaitre%2C%20T.%2C%20Guglielmetti%2C%20L.%2C%20Robert%2C%20J.%2C%20Aubry%2C%20A.%20and%20Veziris%2C%20N.%20%282024%29.%20%26lt%3Bb%26gt%3BAvanc%26%23xE9%3Bes%20dans%20l%26%23x2019%3Bantibioth%26%23xE9%3Brapie%20de%20la%20tuberculose%26lt%3B%5C%2Fb%26gt%3B.%20Rev%20Prat%20%26lt%3Bi%26gt%3B74%26lt%3B%5C%2Fi%26gt%3B%2C%20239%26%23x2013%3B244.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Avanc%5Cu00e9es%20dans%20l%5Cu2019antibioth%5Cu00e9rapie%20de%20la%20tuberculose%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T%22%2C%22lastName%22%3A%22Maitre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-03-19T17%3A06%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22WVC2IXYE%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Campbell%20et%20al.%22%2C%22parsedDate%22%3A%222023-12-22%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCampbell%2C%20J.%20R.%2C%20Brode%2C%20S.%20K.%2C%20Barry%2C%20P.%2C%20Bastos%2C%20M.%20L.%2C%20Bonnet%2C%20M.%2C%20Guglielmetti%2C%20L.%2C%20Kempker%2C%20R.%2C%20Klimuk%2C%20D.%2C%20Labor%26%23xED%3Bn%2C%20R.%20L.%2C%20Milanov%2C%20V.%2C%20Singla%2C%20R.%2C%20Skrahina%2C%20A.%2C%20Trajman%2C%20A.%2C%20Van%20Der%20Werf%2C%20T.%20S.%2C%20Viiklepp%2C%20P.%20and%20Menzies%2C%20D.%20%282023%29.%20%26lt%3Bb%26gt%3BAssociation%20of%20indicators%20of%20extensive%20disease%20and%20rifampin-resistant%20tuberculosis%20treatment%20outcomes%3A%20an%20individual%20participant%20data%20meta-analysis%26lt%3B%5C%2Fb%26gt%3B.%20Thorax%20thorax-2023-220249%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fthorax-2023-220249%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fthorax-2023-220249%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20of%20indicators%20of%20extensive%20disease%20and%20rifampin-resistant%20tuberculosis%20treatment%20outcomes%3A%20an%20individual%20participant%20data%20meta-analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathon%20R%22%2C%22lastName%22%3A%22Campbell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20K%22%2C%22lastName%22%3A%22Brode%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pennan%22%2C%22lastName%22%3A%22Barry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mayara%20Lisboa%22%2C%22lastName%22%3A%22Bastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maryline%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Russell%22%2C%22lastName%22%3A%22Kempker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dzmitry%22%2C%22lastName%22%3A%22Klimuk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rafael%20Laniado%22%2C%22lastName%22%3A%22Labor%5Cu00edn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vladimir%22%2C%22lastName%22%3A%22Milanov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rupak%22%2C%22lastName%22%3A%22Singla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alena%22%2C%22lastName%22%3A%22Skrahina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anete%22%2C%22lastName%22%3A%22Trajman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tjip%20S%22%2C%22lastName%22%3A%22Van%20Der%20Werf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Piret%22%2C%22lastName%22%3A%22Viiklepp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dick%22%2C%22lastName%22%3A%22Menzies%22%7D%5D%2C%22abstractNote%22%3A%22Background%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Indicators%20of%20extensive%20disease%5Cu2014acid%20fast%20bacilli%20%28AFB%29%20smear%20positivity%20and%20lung%20cavitation%5Cu2014have%20been%20inconsistently%20associated%20with%20clinical%20rifampin-resistant%5C%2Fmultidrug-resistant%20tuberculosis%20%28RR%5C%2FMDR-TB%29%20outcomes.%20We%20evaluated%20the%20association%20of%20these%20indicators%20with%20end-of-treatment%20outcomes.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Methods%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20We%20did%20an%20individual%20participant%20data%20meta-analysis%20of%20people%20treated%20for%20RR%5C%2FMDR-TB%20with%20longer%20regimens%20with%20documented%20AFB%20smear%20and%20chest%20radiography%20findings.%20We%20compared%20people%20AFB%20smear-negative%20without%20cavities%20to%20people%3A%20%281%29%20smear-negative%20with%20lung%20cavities%3B%20%282%29%20smear-positive%20without%20lung%20cavities%20and%20%283%29%20AFB%20smear-positive%20with%20lung%20cavities.%20Using%20multivariable%20logistic%20regression%20accounting%20for%20demographic%2C%20treatment%20and%20clinical%20factors%2C%20we%20calculated%20adjusted%20ORs%20%28aOR%29%20for%20any%20unfavourable%20outcome%20%28death%2C%20lost%20to%20follow-up%2C%20failure%5C%2Frecurrence%29%2C%20and%20mortality%20and%20treatment%20failure%5C%2Frecurrence%20alone.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Results%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20We%20included%205596%20participants%3B%20included%20participants%20significantly%20differed%20from%20excluded%20participants.%20Overall%2C%20774%20%2813.8%25%29%20were%20AFB%20smear-negative%20without%20cavities%2C%20647%20%2811.6%25%29%20only%20had%20cavities%2C%201424%20%2825.4%25%29%20were%20AFB%20smear-positive%20alone%20and%202751%20%2849.2%25%29%20were%20AFB%20smear-positive%20with%20cavities.%20The%20median%20age%20was%2037%20years%20%28IQR%3A%2028%5Cu201347%29%2C%203580%20%2864%25%29%20were%20male%20and%20686%20%2812.5%25%29%20had%20HIV.%20Compared%20with%20participants%20AFB%20smear-negative%20without%20cavities%2C%20aOR%20%2895%25%20CI%29%20for%20any%20unfavourable%20outcome%20was%201.0%20%280.8%20to%201.4%29%20for%20participants%20smear-negative%20with%20lung%20cavities%2C%201.2%20%280.9%20to%201.5%29%20if%20smear-positive%20without%20cavities%20and%201.6%20%281.3%20to%202.0%29%20if%20AFB%20smear-positive%20with%20lung%20cavities.%20Odds%20were%20only%20significantly%20increased%20for%20mortality%20%281.5%2C%2095%25%20CI%201.1%20to%202.1%29%20and%20failure%5C%2Frecurrence%20%282.2%2C%2095%25%20CI%201.5%20to%203.3%29%20among%20participants%20AFB%20smear-positive%20with%20lung%20cavities.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Conclusion%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Only%20the%20combination%20of%20AFB%20smear-positivity%20and%20lung%20cavitation%20was%20associated%20with%20unfavourable%20outcomes%2C%20suggesting%20they%20may%20benefit%20from%20stronger%20regimens.%22%2C%22date%22%3A%222023-12-22%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1136%5C%2Fthorax-2023-220249%22%2C%22ISSN%22%3A%220040-6376%2C%201468-3296%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fthorax.bmj.com%5C%2Flookup%5C%2Fdoi%5C%2F10.1136%5C%2Fthorax-2023-220249%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-12-31T15%3A24%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22AYT74SVL%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Du%20Cros%20et%20al.%22%2C%22parsedDate%22%3A%222023-12-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDu%20Cros%2C%20P.%2C%20Greig%2C%20J.%2C%20Alffenaar%2C%20J.-W.%20C.%2C%20Cross%2C%20G.%20B.%2C%20Cousins%2C%20C.%2C%20Berry%2C%20C.%2C%20Khan%2C%20U.%2C%20Phillips%2C%20P.%20P.%20J.%2C%20Vel%26%23xE1%3Bsquez%2C%20G.%20E.%2C%20Furin%2C%20J.%2C%20Spigelman%2C%20M.%2C%20Denholm%2C%20J.%20T.%2C%20Thi%2C%20S.%20S.%2C%20Tiberi%2C%20S.%2C%20Huang%2C%20G.%20K.%20L.%2C%20Marks%2C%20G.%20B.%2C%20Turkova%2C%20A.%2C%20Guglielmetti%2C%20L.%2C%20Chew%2C%20K.%20L.%2C%20Nguyen%2C%20H.%20T.%2C%20Ong%2C%20C.%20W.%20M.%2C%20Brigden%2C%20G.%2C%20Singh%2C%20K.%20P.%2C%20Motta%2C%20I.%2C%20Lange%2C%20C.%2C%20Seddon%2C%20J.%20A.%2C%20Nyang%26%23x2019%3Bwa%2C%20B.-T.%2C%20Maug%2C%20A.%20K.%20J.%2C%20Gler%2C%20M.%20T.%2C%20Dooley%2C%20K.%20E.%2C%20Quelapio%2C%20M.%2C%20Tsogt%2C%20B.%2C%20Menzies%2C%20D.%2C%20Cox%2C%20V.%2C%20Upton%2C%20C.%20M.%2C%20Skrahina%2C%20A.%2C%20McKenna%2C%20L.%2C%20Horsburgh%2C%20C.%20R.%2C%20Dheda%2C%20K.%20and%20Marais%2C%20B.%20J.%20%282023%29.%20%26lt%3Bb%26gt%3BStandards%20for%20clinical%20trials%20for%20treating%20TB%26lt%3B%5C%2Fb%26gt%3B.%20int%20j%20tuberc%20lung%20dis%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%2C%20885%26%23x2013%3B898%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.23.0341%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.23.0341%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Standards%20for%20clinical%20trials%20for%20treating%20TB%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Du%20Cros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Greig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.-W.%20C.%22%2C%22lastName%22%3A%22Alffenaar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20B.%22%2C%22lastName%22%3A%22Cross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Cousins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Berry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20P.%20J.%22%2C%22lastName%22%3A%22Phillips%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20E.%22%2C%22lastName%22%3A%22Vel%5Cu00e1squez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Furin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Spigelman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20T.%22%2C%22lastName%22%3A%22Denholm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20S.%22%2C%22lastName%22%3A%22Thi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Tiberi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20K.%20L.%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20B.%22%2C%22lastName%22%3A%22Marks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Turkova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20L.%22%2C%22lastName%22%3A%22Chew%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20T.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20W.%20M.%22%2C%22lastName%22%3A%22Ong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Brigden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20P.%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.%22%2C%22lastName%22%3A%22Motta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20A.%22%2C%22lastName%22%3A%22Seddon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B-T.%22%2C%22lastName%22%3A%22Nyang%5Cu2019wa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20K.%20J.%22%2C%22lastName%22%3A%22Maug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20T.%22%2C%22lastName%22%3A%22Gler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20E.%22%2C%22lastName%22%3A%22Dooley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Quelapio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Tsogt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Menzies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20M.%22%2C%22lastName%22%3A%22Upton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Skrahina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22McKenna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20R.%22%2C%22lastName%22%3A%22Horsburgh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Dheda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20J.%22%2C%22lastName%22%3A%22Marais%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20The%20value%2C%20speed%20of%20completion%20and%20robustness%20of%20the%20evidence%20generated%20by%20TB%20treatment%20trials%20could%20be%20improved%20by%20implementing%20standards%20for%20best%20practice.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20METHODS%3A%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20A%20global%20panel%20of%20experts%20participated%20in%20a%20Delphi%20process%2C%20using%20a%207-point%20Likert%20scale%20%5Cn%20to%20score%20and%20revise%20draft%20standards%20until%20consensus%20was%20reached.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20RESULTS%3A%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Eleven%20standards%20were%20defined%3A%20Standard%201%2C%20high%20quality%20data%20on%20TB%20regimens%20are%20essential%20to%20inform%20clinical%20and%20programmatic%20management%3B%20Standard%202%2C%20the%20research%20questions%20addressed%20by%20TB%20trials%20should%20be%20%5Cn%20relevant%20to%20affected%20communities%2C%20who%20should%20be%20included%20in%20all%20trial%20stages%3B%20Standard%203%2C%20trials%20should%20make%20every%20effort%20to%20be%20as%20inclusive%20as%20possible%3B%20Standard%204%2C%20the%20most%20efficient%20trial%20designs%20should%20be%20considered%20to%20improve%20the%20evidence%20base%20as%20quickly%20and%20cost%20effectively%20as%20possible%2C%20%5Cn%20without%20compromising%20quality%3B%20Standard%205%2C%20trial%20governance%20should%20be%20in%20line%20with%20accepted%20good%20clinical%20practice%3B%20Standard%206%2C%20trials%20should%20investigate%20and%20report%20strategies%20that%20promote%20optimal%20engagement%20in%20care%3B%20Standard%207%2C%20where%20possible%2C%20TB%20trials%20should%20include%20pharmacokinetic%20and%20pharmacodynamic%20%5Cn%20components%3B%20Standard%208%2C%20outcomes%20should%20include%20frequency%20of%20disease%20recurrence%20and%20post-treatment%20sequelae%3B%20Standard%209%2C%20TB%20trials%20should%20aim%20to%20harmonise%20key%20outcomes%20and%20data%20structures%20across%20studies%3B%20Standard%2010%2C%20TB%20trials%20should%20include%20biobanking%3B%20Standard%2011%2C%20treatment%20trials%20should%20%5Cn%20invest%20in%20capacity%20strengthening%20of%20local%20trial%20and%20TB%20programme%20staff.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20CONCLUSION%3A%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20These%20standards%20should%20improve%20the%20efficiency%20and%20effectiveness%20of%20evidence%20generation%2C%20as%20well%20as%20the%20translation%20of%20research%20into%20policy%20and%20practice.%22%2C%22date%22%3A%222023-12-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.23.0341%22%2C%22ISSN%22%3A%221027-3719%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ingentaconnect.com%5C%2Fcontent%5C%2F10.5588%5C%2Fijtld.23.0341%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-12-31T15%3A25%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22NLTQM49X%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Patil%20et%20al.%22%2C%22parsedDate%22%3A%222023-11-30%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPatil%2C%20S.%20B.%2C%20Tamirat%2C%20M.%2C%20Khazhidinov%2C%20K.%2C%20Ardizzoni%2C%20E.%2C%20Atger%2C%20M.%2C%20Austin%2C%20A.%2C%20Baudin%2C%20E.%2C%20Bekhit%2C%20M.%2C%20Bektasov%2C%20S.%2C%20Berikova%2C%20E.%2C%20Bonnet%2C%20M.%2C%20Caboclo%2C%20R.%2C%20Chaudhry%2C%20M.%2C%20Chavan%2C%20V.%2C%20Cloez%2C%20S.%2C%20Coit%2C%20J.%2C%20Coutisson%2C%20S.%2C%20Dakenova%2C%20Z.%2C%20De%20Jong%2C%20B.%20C.%2C%20Delifer%2C%20C.%2C%20Demaisons%2C%20S.%2C%20Do%2C%20J.%20M.%2C%20Dos%20Santos%20Tozzi%2C%20D.%2C%20Ducher%2C%20V.%2C%20Ferlazzo%2C%20G.%2C%20Gouillou%2C%20M.%2C%20Khan%2C%20U.%2C%20Kunda%2C%20M.%2C%20Lachenal%2C%20N.%2C%20LaHood%2C%20A.%20N.%2C%20Lecca%2C%20L.%2C%20Mazmanian%2C%20M.%2C%20McIlleron%2C%20H.%2C%20Moreau%2C%20M.%2C%20Moschioni%2C%20M.%2C%20Nahid%2C%20P.%2C%20Osso%2C%20E.%2C%20Oyewusi%2C%20L.%2C%20Panda%2C%20S.%2C%20P%26%23xE2%3Bquet%2C%20A.%2C%20Thuong%20Huu%2C%20P.%2C%20Pichon%2C%20L.%2C%20Rich%2C%20M.%20L.%2C%20Rupasinghe%2C%20P.%2C%20Salahuddin%2C%20N.%2C%20Sanchez%20Garavito%2C%20E.%2C%20Seung%2C%20K.%20J.%2C%20Vel%26%23xE1%3Bsquez%2C%20G.%20E.%2C%20Vallet%2C%20M.%2C%20Varaine%2C%20F.%2C%20Yuya-Septoh%2C%20F.%20J.%2C%20Mitnick%2C%20C.%20D.%20and%20Guglielmetti%2C%20L.%20%282023%29.%20%26lt%3Bb%26gt%3BEvaluating%20newly%20approved%20drugs%20in%20combination%20regimens%20for%20multidrug-resistant%20tuberculosis%20with%20fluoroquinolone%20resistance%20%28endTB-Q%29%3A%20study%20protocol%20for%20a%20multi-country%20randomized%20controlled%20trial%26lt%3B%5C%2Fb%26gt%3B.%20Trials%20%26lt%3Bi%26gt%3B24%26lt%3B%5C%2Fi%26gt%3B%2C%20773%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs13063-023-07701-6%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs13063-023-07701-6%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evaluating%20newly%20approved%20drugs%20in%20combination%20regimens%20for%20multidrug-resistant%20tuberculosis%20with%20fluoroquinolone%20resistance%20%28endTB-Q%29%3A%20study%20protocol%20for%20a%20multi-country%20randomized%20controlled%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20B.%22%2C%22lastName%22%3A%22Patil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Tamirat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Khazhidinov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Ardizzoni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Atger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Austin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Baudin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Bekhit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Bektasov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Berikova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Caboclo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Chaudhry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Chavan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Cloez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Coit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Coutisson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Z.%22%2C%22lastName%22%3A%22Dakenova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20C.%22%2C%22lastName%22%3A%22De%20Jong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Delifer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Demaisons%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20M.%22%2C%22lastName%22%3A%22Do%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Dos%20Santos%20Tozzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Ducher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Ferlazzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Gouillou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Kunda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Lachenal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20N.%22%2C%22lastName%22%3A%22LaHood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Lecca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Mazmanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22McIlleron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Moreau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Moschioni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Nahid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Osso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Oyewusi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Panda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22P%5Cu00e2quet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Thuong%20Huu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Pichon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20L.%22%2C%22lastName%22%3A%22Rich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Rupasinghe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Salahuddin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Sanchez%20Garavito%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20J.%22%2C%22lastName%22%3A%22Seung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20E.%22%2C%22lastName%22%3A%22Vel%5Cu00e1squez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Vallet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Varaine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%20J.%22%2C%22lastName%22%3A%22Yuya-Septoh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20D.%22%2C%22lastName%22%3A%22Mitnick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Background%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Treatment%20for%20fluoroquinolone-resistant%20multidrug-resistant%5C%2Frifampicin-resistant%20tuberculosis%20%28pre-XDR%20TB%29%20often%20lasts%20longer%20than%20treatment%20for%20less%20resistant%20strains%2C%20yields%20worse%20efficacy%20results%2C%20and%20causes%20substantial%20toxicity.%20The%20newer%20anti-tuberculosis%20drugs%2C%20bedaquiline%20and%20delamanid%2C%20and%20repurposed%20drugs%20clofazimine%20and%20linezolid%2C%20show%20great%20promise%20for%20combination%20in%20shorter%2C%20less-toxic%2C%20and%20effective%20regimens.%20To%20date%2C%20there%20has%20been%20no%20randomized%2C%20internally%20and%20concurrently%20controlled%20trial%20of%20a%20shorter%2C%20all-oral%20regimen%20comprising%20these%20newer%20and%20repurposed%20drugs%20sufficiently%20powered%20to%20produce%20results%20for%20pre-XDR%20TB%20patients.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Methods%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20endTB-Q%20is%20a%20phase%20III%2C%20multi-country%2C%20randomized%2C%20controlled%2C%20parallel%2C%20open-label%20clinical%20trial%20evaluating%20the%20efficacy%20and%20safety%20of%20a%20treatment%20strategy%20for%20patients%20with%20pre-XDR%20TB.%20Study%20participants%20are%20randomized%202%3A1%20to%20experimental%20or%20control%20arms%2C%20respectively.%20The%20experimental%20arm%20contains%20bedaquiline%2C%20linezolid%2C%20clofazimine%2C%20and%20delamanid.%20The%20control%20comprises%20the%20contemporaneous%20WHO%20standard%20of%20care%20for%20pre-XDR%20TB.%20Experimental%20arm%20duration%20is%20determined%20by%20a%20composite%20of%20smear%20microscopy%20and%20chest%20radiographic%20imaging%20at%20baseline%20and%20re-evaluated%20at%206%5Cu00a0months%20using%20sputum%20culture%20results%3A%20participants%20with%20less%20extensive%20disease%20receive%206%5Cu00a0months%20and%20participants%20with%20more%20extensive%20disease%20receive%209%5Cu00a0months%20of%20treatment.%20Randomization%20is%20stratified%20by%20country%20and%20by%20participant%20extent-of-TB-disease%20phenotype%20defined%20according%20to%20screening%5C%2Fbaseline%20characteristics.%20Study%20participation%20lasts%20up%20to%20104%5Cu00a0weeks%20post%20randomization.%20The%20primary%20objective%20is%20to%20assess%20whether%20the%20efficacy%20of%20experimental%20regimens%20at%2073%5Cu00a0weeks%20is%20non-inferior%20to%20that%20of%20the%20control.%20A%20sample%20size%20of%20324%20participants%20across%202%20arms%20affords%20at%20least%2080%25%20power%20to%20show%20the%20non-inferiority%2C%20with%20a%20one-sided%20alpha%20of%200.025%20and%20a%20non-inferiority%20margin%20of%2012%25%2C%20against%20the%20control%20in%20both%20modified%20intention-to-treat%20and%20per-protocol%20populations.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Discussion%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20This%20internally%20controlled%20study%20of%20shortened%20treatment%20for%20pre-XDR%20TB%20will%20provide%20urgently%20needed%20data%20and%20evidence%20for%20clinical%20and%20policy%20decision-making%20around%20the%20treatment%20of%20pre-XDR%20TB%20with%20a%20four-drug%2C%20all-oral%2C%20shortened%20regimen.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Trial%20registration%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20ClinicalTrials.Gov%20NCT03896685.%20Registered%20on%201%20April%202018%3B%20the%20record%20was%20last%20updated%20for%20study%20protocol%20version%204.3%20on%2017%20March%202023.%22%2C%22date%22%3A%222023-11-30%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1186%5C%2Fs13063-023-07701-6%22%2C%22ISSN%22%3A%221745-6215%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Ftrialsjournal.biomedcentral.com%5C%2Farticles%5C%2F10.1186%5C%2Fs13063-023-07701-6%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-12-31T15%3A25%3A49Z%22%7D%7D%2C%7B%22key%22%3A%229EZSBXQY%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sahal%20et%20al.%22%2C%22parsedDate%22%3A%222023-10-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSahal%2C%20M.%20R.%2C%20Senelle%2C%20G.%2C%20La%2C%20K.%2C%20Panda%2C%20T.%20W.%2C%20Taura%2C%20D.%20W.%2C%20Guyeux%2C%20C.%2C%20Cambau%2C%20E.%20and%20Sola%2C%20C.%20%282023%29.%20%26lt%3Bb%26gt%3BMycobacterium%20tuberculosis%20complex%20drug-resistance%2C%20phylogenetics%2C%20and%20evolution%20in%20Nigeria%3A%20Comparison%20with%20Ghana%20and%20Cameroon%26lt%3B%5C%2Fb%26gt%3B%20Ed.%20Rayner%2C%20S.%20PLoS%20Negl%20Trop%20Dis%20%26lt%3Bi%26gt%3B17%26lt%3B%5C%2Fi%26gt%3B%2C%20e0011619%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0011619%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0011619%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mycobacterium%20tuberculosis%20complex%20drug-resistance%2C%20phylogenetics%2C%20and%20evolution%20in%20Nigeria%3A%20Comparison%20with%20Ghana%20and%20Cameroon%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammed%20Rabiu%22%2C%22lastName%22%3A%22Sahal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaetan%22%2C%22lastName%22%3A%22Senelle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22La%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tukur%20Wada%22%2C%22lastName%22%3A%22Panda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dalha%20Wada%22%2C%22lastName%22%3A%22Taura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Guyeux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Sola%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Rayner%22%7D%5D%2C%22abstractNote%22%3A%22In%20this%20article%2C%20we%20provide%20an%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20in-depth%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20analysis%20on%20the%20drug-resistance%20phenotypic%20characteristics%20of%20a%20cohort%20of%20325%20tuberculosis%20and%20characterize%20by%20Whole%20Genome%20Sequencing%2024%20isolates%20from%20Nigeria%20belonging%20to%20L4%2C%20L5%20and%20L6.%20Our%20results%20suggest%20an%20alarming%20rate%20of%20drug-resistance%20of%20the%20L4.6.2.2%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mycobacterium%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20complex%20%28MTBC%29%20lineage%20and%20a%20high%20diversity%20of%20L5.%20We%20compiled%20these%20new%20Sequence%20Read%20Archives%20%28SRAs%29%20to%20previously%20published%20ones%20from%20available%20Bioprojects%20run%20in%20Nigeria.%20We%20performed%20RAxML%20phylogenetic%20reconstructions%20of%20larger%20samples%20that%20include%20public%20NCBI%20SRAs%20from%20some%20neighboring%20countries%20%28Cameroon%2C%20Ghana%29.%20To%20confront%20phylogenetic%20reconstruction%20to%20metadata%2C%20we%20used%20a%20new%20proprietary%20database%20named%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20TB-Annotator%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20.%20We%20show%20that%20L5%20genomes%20in%20Northern%20Nigeria%20belong%20to%20new%20clades%20as%20the%20ones%20described%20until%20now%20and%20allow%20an%20update%20of%20the%20taxonomy%20of%20L5.%20In%20addition%2C%20we%20describe%20the%20L4.6.2.2%20lineage%20in%20Nigeria%2C%20Cameroon%20and%20Ghana.%20We%20provide%20computations%20on%20the%20likely%20divergence%20time%20of%20L4.6.2.2%20and%20suggest%20a%20new%20hypothesis%20concerning%20its%20origin.%20Finally%20we%20provide%20a%20short%20overview%20on%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20M%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20bovis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20diversity%20in%20Nigeria.%20This%20study%20constitutes%20a%20baseline%20knowledge%20on%20the%20global%20genomic%20diversity%2C%20phylogeography%20and%20phylodynamics%20of%20MTBC%20in%20Nigeria%2C%20as%20well%20as%20on%20the%20natural%20history%20of%20this%20largely%20ignored%20but%20densely%20populated%20country%20of%20Africa.%20These%20results%20highlight%20the%20need%20of%20sequencing%20additional%20MTBC%20genomes%20in%20Nigeria%20and%20more%20generally%20in%20West-Africa%2C%20both%20for%20public%20health%20and%20for%20academic%20reasons.%20The%20likelihood%20of%20replacement%20of%20L5-L6%20by%20L4.6.2.2%20isolates%2C%20leave%20potentially%20little%20time%20to%20gather%20historical%20knowledge%20informative%20on%20the%20ancient%20history%20of%20tuberculosis%20in%20West-Africa.%22%2C%22date%22%3A%222023-10-12%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pntd.0011619%22%2C%22ISSN%22%3A%221935-2735%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdx.plos.org%5C%2F10.1371%5C%2Fjournal.pntd.0011619%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-12-31T15%3A29%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22CUDV3QRA%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22G%5Cu00fcnther%20et%20al.%22%2C%22parsedDate%22%3A%222023-05-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BG%26%23xFC%3Bnther%2C%20G.%2C%20Guglielmetti%2C%20L.%2C%20Leu%2C%20C.%2C%20van%20Leth%2C%20F.%20and%20Lange%2C%20C.%20%282023%29.%20%26lt%3Bb%26gt%3BRelative%20cost%20of%20multidrug-resistant%20TB%20medicines%20in%20Europe%26lt%3B%5C%2Fb%26gt%3B.%20The%20International%20Journal%20of%20Tuberculosis%20and%20Lung%20Disease%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%2C%20341%26%23x2013%3B344%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.23.0026%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.23.0026%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Relative%20cost%20of%20multidrug-resistant%20TB%20medicines%20in%20Europe%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22G%5Cu00fcnther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Leu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22van%20Leth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Lange%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-05-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.23.0026%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-06-28T12%3A40%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22CPD8NT5H%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Campbell%20et%20al.%22%2C%22parsedDate%22%3A%222023-04-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCampbell%2C%20J.%20R.%2C%20Chan%2C%20E.%20D.%2C%20Anderson%2C%20L.%20F.%2C%20Bonnet%2C%20M.%2C%20Brode%2C%20S.%20K.%2C%20Cegielski%2C%20J.%20P.%2C%20Guglielmetti%2C%20L.%2C%20Singla%2C%20R.%2C%20Fox%2C%20G.%20J.%2C%20Skrahina%2C%20A.%2C%20Rodrigues%2C%20D.%2C%20Kuksa%2C%20L.%2C%20Viiklepp%2C%20P.%20and%20Menzies%2C%20D.%20%282023%29.%20%26lt%3Bb%26gt%3BAssociation%20of%20smoking%20and%20alcohol%20use%20with%20rifampin-resistant%20TB%20treatment%20outcomes%26lt%3B%5C%2Fb%26gt%3B.%20The%20International%20Journal%20of%20Tuberculosis%20and%20Lung%20Disease%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%2C%20338%26%23x2013%3B340%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.22.0678%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.22.0678%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20of%20smoking%20and%20alcohol%20use%20with%20rifampin-resistant%20TB%20treatment%20outcomes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20R.%22%2C%22lastName%22%3A%22Campbell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20D.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20F.%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20K.%22%2C%22lastName%22%3A%22Brode%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20P.%22%2C%22lastName%22%3A%22Cegielski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Singla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20J.%22%2C%22lastName%22%3A%22Fox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Skrahina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Rodrigues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Kuksa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Viiklepp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Menzies%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-04-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.22.0678%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-06-28T12%3A41%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22WNCRMSUT%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guthmann%20et%20al.%22%2C%22parsedDate%22%3A%222023-03-23%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuthmann%2C%20J.-P.%2C%20Fraisse%2C%20P.%2C%20Bonnet%2C%20I.%20and%20Robert%2C%20J.%20%282023%29.%20%26lt%3Bb%26gt%3BActive%20tuberculosis%20screening%20among%20the%20displaced%20population%20fleeing%20Ukraine%2C%20France%2C%20February%20to%20October%202022%26lt%3B%5C%2Fb%26gt%3B.%20Eurosurveillance%20%26lt%3Bi%26gt%3B28%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2807%5C%2F1560-7917.ES.2023.28.12.2300155%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2807%5C%2F1560-7917.ES.2023.28.12.2300155%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Active%20tuberculosis%20screening%20among%20the%20displaced%20population%20fleeing%20Ukraine%2C%20France%2C%20February%20to%20October%202022%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Paul%22%2C%22lastName%22%3A%22Guthmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Fraisse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%5D%2C%22abstractNote%22%3A%22Persons%20fleeing%20Ukraine%20since%20February%202022%20have%20potentially%20higher%20risk%20of%20tuberculosis%20%28TB%29%20vs%20all%20European%20Union%20countries.%20Interest%20of%20active%20TB%20screening%20among%20this%20population%20is%20debated%20and%20not%20widely%20adopted.%20In%20this%20screening%20intervention%20by%20a%20network%20of%20TB%20centres%20in%20France%2C%20the%20number%20needed%20to%20screen%20%28NNS%29%20was%20862%20to%20find%20one%20case.%20This%20experience%20shows%20that%20this%20strategy%20may%20be%20relevant%20for%20TB%20control%20in%20situations%20of%20massive%20displacement%2C%20similar%20to%20that%20following%20the%20Russian%20invasion.%22%2C%22date%22%3A%222023-03-23%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.2807%5C%2F1560-7917.ES.2023.28.12.2300155%22%2C%22ISSN%22%3A%221560-7917%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.eurosurveillance.org%5C%2Fcontent%5C%2F10.2807%5C%2F1560-7917.ES.2023.28.12.2300155%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-03-27T15%3A02%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22UJGH7XG2%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Aubry%20and%20Veziris%22%2C%22parsedDate%22%3A%222023-03-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAubry%2C%20A.%20and%20Veziris%2C%20N.%20%282023%29.%20%26lt%3Bb%26gt%3BLa%20tuberculose%2C%20l%26%23x2019%3Bune%20des%20plus%20anciennes%20maladies%20infectieuses%26%23x202F%3B%3A%20quelles%20avanc%26%23xE9%3Bes%20r%26%23xE9%3Bcentes%20majeures%26%23x202F%3B%3F%26lt%3B%5C%2Fb%26gt%3B%20Med%20Sci%20%28Paris%29%20%26lt%3Bi%26gt%3B39%26lt%3B%5C%2Fi%26gt%3B%2C%20203%26%23x2013%3B204%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1051%5C%2Fmedsci%5C%2F2023054%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1051%5C%2Fmedsci%5C%2F2023054%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22La%20tuberculose%2C%20l%5Cu2019une%20des%20plus%20anciennes%20maladies%20infectieuses%20%3A%20quelles%20avanc%5Cu00e9es%20r%5Cu00e9centes%20majeures%20%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22m%26eacute%3Bdecine%5C%2Fsciences%20%28M%5C%2FS%29%2C%20revue%20internationale%20dans%20le%20domaine%20de%20la%20recherche%20biologique%2C%20m%26eacute%3Bdicale%20et%20en%20sant%26eacute%3B%22%2C%22date%22%3A%222023%5C%2F03%5C%2F01%22%2C%22language%22%3A%22fr%22%2C%22DOI%22%3A%2210.1051%5C%2Fmedsci%5C%2F2023054%22%2C%22ISSN%22%3A%220767-0974%2C%201958-5381%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.medecinesciences.org%5C%2Farticles%5C%2Fmedsci%5C%2Fabs%5C%2F2023%5C%2F03%5C%2Fmsc230068%5C%2Fmsc230068.html%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-06-28T12%3A27%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22GXEAIVT5%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Masini%20et%20al.%22%2C%22parsedDate%22%3A%222023-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMasini%2C%20T.%2C%20Furin%2C%20J.%2C%20Udwadia%2C%20Z.%20and%20Guglielmetti%2C%20L.%20%282023%29.%20%26lt%3Bb%26gt%3BOptimal%20management%20of%20drug-resistant%20tuberculosis%3A%20Can%20India%20lead%20the%20way%3F%26lt%3B%5C%2Fb%26gt%3B%20Indian%20Journal%20of%20Medical%20Research%20%26lt%3Bi%26gt%3B157%26lt%3B%5C%2Fi%26gt%3B%2C%20220%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.4103%5C%2Fijmr.ijmr_300_23%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.4103%5C%2Fijmr.ijmr_300_23%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Optimal%20management%20of%20drug-resistant%20tuberculosis%3A%20Can%20India%20lead%20the%20way%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiziana%22%2C%22lastName%22%3A%22Masini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Furin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zarir%22%2C%22lastName%22%3A%22Udwadia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%5D%2C%22abstractNote%22%3A%22An%20abstract%20is%20unavailable.%22%2C%22date%22%3A%22Feb-Mar%202023%22%2C%22language%22%3A%22en-US%22%2C%22DOI%22%3A%2210.4103%5C%2Fijmr.ijmr_300_23%22%2C%22ISSN%22%3A%220971-5916%20%28Print%29%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.lww.com%5C%2Fijmr%5C%2FFulltext%5C%2F2023%5C%2F02000%5C%2FOptimal_management_of_drug_resistant_tuberculosis_.17.aspx%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-06-28T12%3A40%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22Q5BS6SYV%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Dom%5Cu00ednguez%20et%20al.%22%2C%22parsedDate%22%3A%222023-02-28%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDom%26%23xED%3Bnguez%2C%20Jos%26%23xE9%3B%2C%20Boeree%2C%20M.%20J.%2C%20Cambau%2C%20E.%2C%20Chesov%2C%20D.%2C%20Conradie%2C%20F.%2C%20Cox%2C%20V.%2C%20Dheda%2C%20K.%2C%20Dudnyk%2C%20A.%2C%20Farhat%2C%20M.%20R.%2C%20Gagneux%2C%20S.%2C%20Grobusch%2C%20M.%20P.%2C%20Gr%26%23xF6%3Bschel%2C%20M.%20I.%2C%20Guglielmetti%2C%20L.%2C%20Kontsevaya%2C%20I.%2C%20Lange%2C%20B.%2C%20van%20Leth%2C%20F.%2C%20Lienhardt%2C%20C.%2C%20Mandalakas%2C%20Anna%20M%2C%20Maurer%2C%20F.%20P.%2C%20Merker%2C%20M.%2C%20Miotto%2C%20P.%2C%20Molina-Moya%2C%20B.%2C%20Morel%2C%20F.%2C%20Niemann%2C%20S.%2C%20Veziris%2C%20N.%2C%20Whitelaw%2C%20A.%2C%20Horsburgh%2C%20Charles%20R%2C%20Lange%2C%20C.%2C%20Dom%26%23xED%3Bnguez%2C%20Jose%2C%20Boeree%2C%20M.%20J.%2C%20Cambau%2C%20E.%2C%20Chesov%2C%20D.%2C%20Conradie%2C%20F.%2C%20Cox%2C%20V.%2C%20Dheda%2C%20K.%2C%20Dudnyk%2C%20A.%2C%20Farhat%2C%20M.%20R.%2C%20Gagneux%2C%20S.%2C%20Grobusch%2C%20M.%20P.%2C%20Gr%26%23xF6%3Bschel%2C%20M.%20I.%2C%20Guglielmetti%2C%20L.%2C%20Kontsevaya%2C%20I.%2C%20Lange%2C%20B.%2C%20van%20Leth%2C%20F.%2C%20Lienhardt%2C%20C.%2C%20Mandalakas%2C%20Anna%20Maria%2C%20Maurer%2C%20F.%2C%20Merker%2C%20M.%2C%20Miotto%2C%20P.%2C%20Molina-Moya%2C%20B.%2C%20Morel%2C%20F.%2C%20Niemann%2C%20S.%2C%20Veziris%2C%20N.%2C%20Whitelaw%2C%20A.%2C%20Horsburgh%2C%20Charles%20Robert%20and%20Lange%2C%20C.%20%282023%29.%20%26lt%3Bb%26gt%3BClinical%20implications%20of%20molecular%20drug%20resistance%20testing%20for%20Mycobacterium%20tuberculosis%3A%20a%202023%20TBnet%5C%2FRESIST-TB%20consensus%20statement%26lt%3B%5C%2Fb%26gt%3B.%20The%20Lancet%20Infectious%20Diseases%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2822%2900875-1%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2822%2900875-1%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20implications%20of%20molecular%20drug%20resistance%20testing%20for%20Mycobacterium%20tuberculosis%3A%20a%202023%20TBnet%5C%2FRESIST-TB%20consensus%20statement%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%22%2C%22lastName%22%3A%22Dom%5Cu00ednguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20J%22%2C%22lastName%22%3A%22Boeree%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dumitru%22%2C%22lastName%22%3A%22Chesov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Conradie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivian%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keertan%22%2C%22lastName%22%3A%22Dheda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrii%22%2C%22lastName%22%3A%22Dudnyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%20R%22%2C%22lastName%22%3A%22Farhat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastien%22%2C%22lastName%22%3A%22Gagneux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20P%22%2C%22lastName%22%3A%22Grobusch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%20I%22%2C%22lastName%22%3A%22Gr%5Cu00f6schel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irina%22%2C%22lastName%22%3A%22Kontsevaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Berit%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22van%20Leth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Lienhardt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20M%22%2C%22lastName%22%3A%22Mandalakas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florian%20P%22%2C%22lastName%22%3A%22Maurer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Merker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paolo%22%2C%22lastName%22%3A%22Miotto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Molina-Moya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Morel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Niemann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Whitelaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20R%22%2C%22lastName%22%3A%22Horsburgh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%22%2C%22lastName%22%3A%22Dom%5Cu00ednguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20J.%22%2C%22lastName%22%3A%22Boeree%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dumitru%22%2C%22lastName%22%3A%22Chesov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Conradie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivian%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keertan%22%2C%22lastName%22%3A%22Dheda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrii%22%2C%22lastName%22%3A%22Dudnyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%20R.%22%2C%22lastName%22%3A%22Farhat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastien%22%2C%22lastName%22%3A%22Gagneux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20P.%22%2C%22lastName%22%3A%22Grobusch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%20I.%22%2C%22lastName%22%3A%22Gr%5Cu00f6schel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irina%22%2C%22lastName%22%3A%22Kontsevaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Berit%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22van%20Leth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Lienhardt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20Maria%22%2C%22lastName%22%3A%22Mandalakas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florian%22%2C%22lastName%22%3A%22Maurer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Merker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paolo%22%2C%22lastName%22%3A%22Miotto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Molina-Moya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Morel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Niemann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Whitelaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Robert%22%2C%22lastName%22%3A%22Horsburgh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%5D%2C%22abstractNote%22%3A%22Drug-resistant%20tuberculosis%20is%20a%20substantial%20health-care%20concern%20worldwide.%20Despite%20culture-based%20methods%20being%20considered%20the%20gold%20standard%20for%20drug%20susceptibility%20testing%2C%20molecular%20methods%20provide%20rapid%20information%20about%20the%20Mycobacterium%20tuberculosis%20mutations%20associated%20with%20resistance%20to%20anti-tuberculosis%20drugs.%20This%20consensus%20document%20was%20developed%20on%20the%20basis%20of%20a%20comprehensive%20literature%20search%2C%20by%20the%20TBnet%20and%20RESIST-TB%20networks%2C%20about%20reporting%20standards%20for%20the%20clinical%20use%20of%20molecular%20drug%20susceptibility%20testing.%20Review%20and%20the%20search%20for%20evidence%20included%20hand-searching%20journals%20and%20searching%20electronic%20databases.%20The%20panel%20identified%20studies%20that%20linked%20mutations%20in%20genomic%20regions%20of%20M%20tuberculosis%20with%20treatment%20outcome%20data.%20Implementation%20of%20molecular%20testing%20for%20the%20prediction%20of%20drug%20resistance%20in%20M%20tuberculosis%20is%20key.%20Detection%20of%20mutations%20in%20clinical%20isolates%20has%20implications%20for%20the%20clinical%20management%20of%20patients%20with%20multidrug-resistant%20or%20rifampicin-resistant%20tuberculosis%2C%20especially%20in%20situations%20when%20phenotypic%20drug%20susceptibility%20testing%20is%20not%20available.%20A%20multidisciplinary%20team%20including%20clinicians%2C%20microbiologists%2C%20and%20laboratory%20scientists%20reached%20a%20consensus%20on%20key%20questions%20relevant%20to%20molecular%20prediction%20of%20drug%20susceptibility%20or%20resistance%20to%20M%20tuberculosis%2C%20and%20their%20implications%20for%20clinical%20practice.%20This%20consensus%20document%20should%20help%20clinicians%20in%20the%20management%20of%20patients%20with%20tuberculosis%2C%20providing%20guidance%20for%20the%20design%20of%20treatment%20regimens%20and%20optimising%20outcomes.%22%2C%22date%22%3A%222023-02-28%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2FS1473-3099%2822%2900875-1%22%2C%22ISSN%22%3A%221473-3099%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1473309922008751%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-03-10T14%3A55%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22CVEKMV76%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Barbier%20et%20al.%22%2C%22parsedDate%22%3A%222023-02-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBarbier%2C%20E.%2C%20Fouchet%2C%20T.%2C%20Hartmann%2C%20A.%2C%20Cambau%2C%20E.%2C%20Mougari%2C%20F.%2C%20Dubois%2C%20C.%2C%20Lubetzki%2C%20M.%20and%20Rochelet%2C%20M.%20%282023%29.%20%26lt%3Bb%26gt%3BRapid%20electrochemical%20detection%20of%20Mycobacterium%20tuberculosis%20in%20sputum%20by%20measuring%20Ag85%20activity%20with%20disposable%20carbon%20sensors%26lt%3B%5C%2Fb%26gt%3B.%20Talanta%20%26lt%3Bi%26gt%3B253%26lt%3B%5C%2Fi%26gt%3B%2C%20123927%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.talanta.2022.123927%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.talanta.2022.123927%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rapid%20electrochemical%20detection%20of%20Mycobacterium%20tuberculosis%20in%20sputum%20by%20measuring%20Ag85%20activity%20with%20disposable%20carbon%20sensors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elodie%22%2C%22lastName%22%3A%22Barbier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Th%5Cu00e9o%22%2C%22lastName%22%3A%22Fouchet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alain%22%2C%22lastName%22%3A%22Hartmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cl%5Cu00e9ment%22%2C%22lastName%22%3A%22Dubois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maurice%22%2C%22lastName%22%3A%22Lubetzki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murielle%22%2C%22lastName%22%3A%22Rochelet%22%7D%5D%2C%22abstractNote%22%3A%22An%20electrochemical%20assay%20for%20the%20detection%20of%20the%20enzymatic%20activity%20of%20the%20antigen%2085%20%28Ag85%29%20tuberculosis%20%28TB%29%20biomarker%20was%20developed%20and%20evaluated%20for%20the%20qualitative%20detection%20of%20Mycobacterium%20tuberculosis%20in%20decontaminated%20sputum.%20For%20this%20purpose%2C%20the%20electroactive%20properties%20of%20both%20synthetic%20p-aminophenyl-6-O-octanoyl-3-d-glucopyranoside%20%28p-APOG%29%20substrate%20and%20p-aminophenyl-6-3-d-glucopyranoside%20%28p-APG%29%20product%20released%20after%20the%20removal%20of%20the%20octanoyl%20fatty%20acid%20by%20the%20Ag85%20were%20investigated%20with%20disposable%20carbon%20screen-printed%20electrodes%20by%20cyclic%20voltammetry.%20Since%20specific%20anodic%20responses%20were%20obtained%20for%20the%20p-APOG%20substrate%20and%20the%20p-APG%20product%2C%20the%20intensity%20of%20the%20oxidation%20peak%20of%20the%20p-APG%20%28E%5Cu00a0%3D%5Cu00a0%2B%200.35%5Cu00a0V%20vs.%20Ag%5C%2FAgCl%29%20was%20selected%20as%20the%20analytical%20response%20for%20the%20detection%20of%20the%20Ag85%20acyltransferase%20activity.%20Once%20the%20proof%20of%20concept%20of%20the%20Ag85%20electrochemical%20assay%20was%20validated%20with%20a%20commercially-available%20Ag85B%20protein%2C%20its%20specificity%20was%20further%20assessed%20by%20analyzing%20pure%20cultures%20of%20various%20bacteria%20including%20tuberculous%20and%20non-tuberculous%20mycobacteria%20as%20well%20as%20different%20species%20found%20in%20patients%26%23039%3B%20sputum.%20Finally%2C%20with%20a%20specificity%20of%2078%25%20and%20a%20sensitivity%20of%2089%25%2C%20the%20method%20was%20successfully%20compared%20to%20microscopy%20and%20culture%20routine%20tests%20for%20TB%20testing%20in%2036%20frozen%20fluidized%20and%20decontaminated%20sputum.%20This%20suggests%20that%20owing%20to%20its%20convenience%2C%20rapidity%2C%20low-cost%20and%20portability%2C%20the%20reported%20Ag85%20electrochemical%20assay%20is%20a%20promising%20tool%20to%20screen%20patients%20for%20TB.%22%2C%22date%22%3A%222023-02-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.talanta.2022.123927%22%2C%22ISSN%22%3A%220039-9140%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0039914022007238%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-12-28T16%3A13%3A06Z%22%7D%7D%2C%7B%22key%22%3A%226W5JQ546%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Khan%20and%20Guglielmetti%22%2C%22parsedDate%22%3A%222023-01-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKhan%2C%20U.%20and%20Guglielmetti%2C%20L.%20%282023%29.%20%26lt%3Bb%26gt%3BTailored%20TPT%20for%20drug-resistant%20TB%20-%20promoting%20equity%20and%20access%20to%20optimal%20care%26lt%3B%5C%2Fb%26gt%3B.%20Int%20J%20Tuberc%20Lung%20Dis%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%2C%2089b%26%23x2013%3B890%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.22.0538%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.22.0538%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tailored%20TPT%20for%20drug-resistant%20TB%20-%20promoting%20equity%20and%20access%20to%20optimal%20care%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-01-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.22.0538%22%2C%22ISSN%22%3A%221815-7920%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-03-10T14%3A58%3A55Z%22%7D%7D%2C%7B%22key%22%3A%2227ERGIBY%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22G%5Cu00fcnther%20et%20al.%22%2C%22parsedDate%22%3A%222023-01-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BG%26%23xFC%3Bnther%2C%20G.%2C%20Guglielmetti%2C%20L.%2C%20Leu%2C%20C.%2C%20Lange%2C%20C.%2C%20van%20Leth%2C%20F.%2C%20Hasan%20Hafizi%2C%20Khachatryan%2C%20N.%2C%20Aroyan%2C%20H.%2C%20Kabasakalyan%2C%20E.%2C%20Knappik%2C%20M.%2C%20Skrahina%2C%20A.%2C%20Klimuk%2C%20D.%2C%20Nikolenka%2C%20A.%2C%20Muylle%2C%20I.%2C%20Milanov%2C%20V.%2C%20Velkovska%2C%20D.%2C%20Tarinska%2C%20N.%2C%20Bachiyska%2C%20E.%2C%20Jankovic%2C%20M.%2C%20Pieridou%2C%20D.%2C%20Adamide%2C%20T.%2C%20Nicolaou%2C%20N.%2C%20Vasakova%2C%20M.%2C%20Sukholytka%2C%20M.%2C%20Kopeck%26%23xE0%3B%2C%20E.%2C%20Folkvardsen%2C%20D.%20B.%2C%20Svensson%2C%20E.%2C%20Danilovits%2C%20M.%2C%20Kummik%2C%20T.%2C%20Vasankari%2C%20T.%2C%20Fr%26%23xE9%3Bchet-Jachym%2C%20M.%2C%20Nahmiash%2C%20A.%2C%20Togonidze%2C%20T.%2C%20Avaliani%2C%20Z.%2C%20Kinkladze%2C%20I.%2C%20Aspindzelashvili%2C%20R.%2C%20Bichashvili%2C%20T.%2C%20Losaberidze%2C%20G.%2C%20Merabishvili%2C%20T.%2C%20Kalsdorf%2C%20B.%2C%20Manika%2C%20K.%2C%20Tsiakitzis%2C%20K.%2C%20Bakos%2C%20A.%2C%20%26%23xC6%3Bgisd%26%23xF3%3Bttir%2C%20T.%20R.%2C%20Michelsen%2C%20G.%20S.%2C%20Karlsd%26%23xF3%3Bttir%2C%20K.%2C%20McLaughlin%2C%20A.-M.%2C%20Fitzgibbon%2C%20M.%2C%20Chemtob%2C%20D.%2C%20Codecasa%2C%20L.%20R.%2C%20Ferrarese%2C%20M.%2C%20Torri%2C%20S.%2C%20Gjocaj%2C%20M.%2C%20Kuksa%2C%20L.%2C%20Davidaviciene%2C%20E.%2C%20Wirtz%2C%20G.%2C%20Perrin%2C%20M.%2C%20Asciak%2C%20A.%20P.%2C%20Chesov%2C%20D.%2C%20de%20Lange%2C%20W.%2C%20Akkerman%2C%20O.%2C%20Poposka%2C%20B.%20I.%2C%20Mack%2C%20U.%2C%20Jensenius%2C%20M.%2C%20Kvalvik%2C%20L.%2C%20Mengshoel%2C%20A.%20T.%2C%20Kruczak%2C%20K.%2C%20Duarte%2C%20R.%2C%20Ribeiro%2C%20N.%2C%20Ibraim%2C%20E.%2C%20Kaluzhenina%2C%20A.%2C%20Barkanova%2C%20O.%2C%20Pesut%2C%20D.%2C%20Solovic%2C%20I.%2C%20Svetina%2C%20P.%2C%20Souza-Galv%26%23xE3%3Bo%2C%20M.-L.%20de%2C%20Millet%2C%20J.-P.%2C%20Casas%2C%20X.%2C%20Vives%2C%20M.%2C%20Bruchfeld%2C%20J.%2C%20Dalemo%2C%20P.%2C%20Jonsson%2C%20J.%2C%20Aeschbacher%2C%20K.%2C%20Keller%2C%20P.%2C%20%26%23xD6%3Bzkara%2C%20S.%2C%20Tiberi%2C%20S.%2C%20Chen%2C%20C.%2C%20Terleeva%2C%20Y.%20and%20Dudnyk%2C%20A.%20%282023%29.%20%26lt%3Bb%26gt%3BAvailability%20and%20costs%20of%20medicines%20for%20the%20treatment%20of%20tuberculosis%20in%20Europe%26lt%3B%5C%2Fb%26gt%3B.%20Clinical%20Microbiology%20and%20Infection%20%26lt%3Bi%26gt%3B29%26lt%3B%5C%2Fi%26gt%3B%2C%2077%26%23x2013%3B84%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2022.07.026%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2022.07.026%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Availability%20and%20costs%20of%20medicines%20for%20the%20treatment%20of%20tuberculosis%20in%20Europe%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunar%22%2C%22lastName%22%3A%22G%5Cu00fcnther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claude%22%2C%22lastName%22%3A%22Leu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22van%20Leth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Hasan%20Hafizi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naira%22%2C%22lastName%22%3A%22Khachatryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harut%22%2C%22lastName%22%3A%22Aroyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduard%22%2C%22lastName%22%3A%22Kabasakalyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Knappik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alena%22%2C%22lastName%22%3A%22Skrahina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dzmitry%22%2C%22lastName%22%3A%22Klimuk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alena%22%2C%22lastName%22%3A%22Nikolenka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inge%22%2C%22lastName%22%3A%22Muylle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vladimir%22%2C%22lastName%22%3A%22Milanov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Desislava%22%2C%22lastName%22%3A%22Velkovska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neli%22%2C%22lastName%22%3A%22Tarinska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeta%22%2C%22lastName%22%3A%22Bachiyska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mateja%22%2C%22lastName%22%3A%22Jankovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Despo%22%2C%22lastName%22%3A%22Pieridou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tonia%22%2C%22lastName%22%3A%22Adamide%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicos%22%2C%22lastName%22%3A%22Nicolaou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Vasakova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariia%22%2C%22lastName%22%3A%22Sukholytka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilia%22%2C%22lastName%22%3A%22Kopeck%5Cu00e0%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dorte%20Bek%22%2C%22lastName%22%3A%22Folkvardsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%22%2C%22lastName%22%3A%22Svensson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manfred%22%2C%22lastName%22%3A%22Danilovits%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiina%22%2C%22lastName%22%3A%22Kummik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuula%22%2C%22lastName%22%3A%22Vasankari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Fr%5Cu00e9chet-Jachym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Audrey%22%2C%22lastName%22%3A%22Nahmiash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tamar%22%2C%22lastName%22%3A%22Togonidze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zaza%22%2C%22lastName%22%3A%22Avaliani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inga%22%2C%22lastName%22%3A%22Kinkladze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rusudan%22%2C%22lastName%22%3A%22Aspindzelashvili%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Teona%22%2C%22lastName%22%3A%22Bichashvili%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gulnazi%22%2C%22lastName%22%3A%22Losaberidze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tsitsino%22%2C%22lastName%22%3A%22Merabishvili%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Kalsdorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katerina%22%2C%22lastName%22%3A%22Manika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karyofyllis%22%2C%22lastName%22%3A%22Tsiakitzis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agnes%22%2C%22lastName%22%3A%22Bakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinna%20R%5Cu00e1n%22%2C%22lastName%22%3A%22%5Cu00c6gisd%5Cu00f3ttir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gu%5Cu00f0r%5Cu00fan%20Svanhv%5Cu00edt%22%2C%22lastName%22%3A%22Michelsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Krist%5Cu00edn%22%2C%22lastName%22%3A%22Karlsd%5Cu00f3ttir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne-Marie%22%2C%22lastName%22%3A%22McLaughlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margaret%22%2C%22lastName%22%3A%22Fitzgibbon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Chemtob%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luigi%20R.%22%2C%22lastName%22%3A%22Codecasa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maurizio%22%2C%22lastName%22%3A%22Ferrarese%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefania%22%2C%22lastName%22%3A%22Torri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Majlinda%22%2C%22lastName%22%3A%22Gjocaj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liga%22%2C%22lastName%22%3A%22Kuksa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edita%22%2C%22lastName%22%3A%22Davidaviciene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gil%22%2C%22lastName%22%3A%22Wirtz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monique%22%2C%22lastName%22%3A%22Perrin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Analita%20Pace%22%2C%22lastName%22%3A%22Asciak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dumitri%22%2C%22lastName%22%3A%22Chesov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wiel%22%2C%22lastName%22%3A%22de%20Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Onno%22%2C%22lastName%22%3A%22Akkerman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Biljana%20Ilievska%22%2C%22lastName%22%3A%22Poposka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ulrich%22%2C%22lastName%22%3A%22Mack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mogens%22%2C%22lastName%22%3A%22Jensenius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lajla%22%2C%22lastName%22%3A%22Kvalvik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20Torunn%22%2C%22lastName%22%3A%22Mengshoel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katarzyna%22%2C%22lastName%22%3A%22Kruczak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%22%2C%22lastName%22%3A%22Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadine%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elmira%22%2C%22lastName%22%3A%22Ibraim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Kaluzhenina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Barkanova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dragica%22%2C%22lastName%22%3A%22Pesut%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ivan%22%2C%22lastName%22%3A%22Solovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Petra%22%2C%22lastName%22%3A%22Svetina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria-Luiza%20de%22%2C%22lastName%22%3A%22Souza-Galv%5Cu00e3o%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joan-Pau%22%2C%22lastName%22%3A%22Millet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xavi%22%2C%22lastName%22%3A%22Casas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Montserrat%22%2C%22lastName%22%3A%22Vives%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22Bruchfeld%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paulina%22%2C%22lastName%22%3A%22Dalemo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jerker%22%2C%22lastName%22%3A%22Jonsson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katrin%22%2C%22lastName%22%3A%22Aeschbacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Keller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seref%22%2C%22lastName%22%3A%22%5Cu00d6zkara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Tiberi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christabelle%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yana%22%2C%22lastName%22%3A%22Terleeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrii%22%2C%22lastName%22%3A%22Dudnyk%22%7D%5D%2C%22abstractNote%22%3A%22Objectives%5CnTo%20evaluate%20the%20access%20to%20comprehensive%20diagnostics%20and%20novel%20antituberculosis%20medicines%20in%20European%20countries.%5CnMethods%5CnWe%20investigated%20the%20access%20to%20genotypic%20and%20phenotypic%20Mycobacterium%20tuberculosis%20drug%20susceptibility%20testing%20and%20the%20availability%20of%20antituberculosis%20drugs%20and%20calculated%20the%20cost%20of%20drugs%20and%20treatment%20regimens%20at%20major%20tuberculosis%20treatment%20centres%20in%20countries%20of%20the%20WHO%20European%20region%20where%20rates%20of%20drug-resistant%20tuberculosis%20are%20the%20highest%20among%20all%20WHO%20regions.%20Results%20were%20stratified%20by%20middle-income%20and%20high-income%20countries.%5CnResults%5CnOverall%2C%2043%20treatment%20centres%20from%2043%20countries%20participated%20in%20the%20study.%20For%20WHO%20group%20A%20drugs%2C%20the%20frequency%20of%20countries%20with%20the%20availability%20of%20phenotypic%20drug%20susceptibility%20testing%20was%20as%20follows%3A%20%28a%29%2075%25%20%2830%5C%2F40%29%20for%20levofloxacin%2C%20%28b%29%2082%25%20%2833%5C%2F40%29%20for%20moxifloxacin%2C%20%28c%29%2048%25%20%2819%5C%2F40%29%20for%20bedaquiline%2C%20and%20%28d%29%2072%25%20%2829%5C%2F40%29%20for%20linezolid.%20Overall%2C%20of%20the%2043%20countries%2C%2036%20%2884%25%29%20and%2024%20%2856%25%29%20countries%20had%20access%20to%20bedaquiline%20and%20delamanid%2C%20respectively%2C%20whereas%20only%206%20%2814%25%29%20countries%20had%20access%20to%20rifapentine.%20The%20treatment%20of%20patients%20with%20extensively%20drug-resistant%20tuberculosis%20with%20a%20regimen%20including%20a%20carbapenem%20was%20available%20only%20in%2017%20%2840%25%29%20of%20the%2043%20countries.%20The%20median%20cost%20of%20regimens%20for%20drug-susceptible%20tuberculosis%2C%20multidrug-resistant%5C%2Frifampicin-resistant%20tuberculosis%20%28shorter%20regimen%2C%20including%20bedaquiline%20for%206%5Cu00a0months%29%2C%20and%20extensively%20drug-resistant%20tuberculosis%20%28including%20bedaquiline%2C%20delamanid%2C%20and%20a%20carbapenem%29%20were%20%5Cu20ac44%20%28minimum%5Cu2013maximum%2C%20%5Cu20ac15%5Cu2013152%29%2C%20%5Cu20ac764%20%28minimum%5Cu2013maximum%2C%20%5Cu20ac542%5Cu201315152%29%2C%20and%20%5Cu20ac8709%20%28minimum%5Cu2013maximum%2C%20%5Cu20ac7965%5Cu201311759%29%20in%20middle-income%20countries%20%28n%5Cu00a0%3D%5Cu00a012%29%20and%20%5Cu20ac280%20%28minimum%5Cu2013maximum%2C%20%5Cu20ac78%5Cu20131084%29%2C%20%5Cu20ac29765%20%28minimum%5Cu2013maximum%2C%20%5Cu20ac11116%5Cu201340584%29%2C%20and%20%5Cu20ac217591%20%28minimum%5Cu2013maximum%2C%20%5Cu20ac82827%5Cu2013320146%29%20in%20high-income%20countries%20%28n%5Cu00a0%3D%5Cu00a029%29%2C%20respectively.%5CnDiscussion%5CnIn%20countries%20of%20the%20WHO%20European%20region%2C%20there%20is%20a%20widespread%20lack%20of%20drug%20susceptibility%20testing%20capacity%20to%20new%20and%20repurposed%20antituberculosis%20drugs%2C%20lack%20of%20access%20to%20essential%20medications%20in%20several%20countries%2C%20and%20a%20high%20cost%20for%20the%20treatment%20of%20drug-resistant%20tuberculosis.%22%2C%22date%22%3A%222023-01-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2022.07.026%22%2C%22ISSN%22%3A%221198-743X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1198743X22003949%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-12-28T16%3A07%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22KW8CU9JI%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Senelle%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSenelle%2C%20G.%2C%20Sahal%2C%20M.%20R.%2C%20La%2C%20K.%2C%20Billard-Pomares%2C%20T.%2C%20Marin%2C%20J.%2C%20Mougari%2C%20F.%2C%20Bridier-Nahmias%2C%20A.%2C%20Carbonnelle%2C%20E.%2C%20Cambau%2C%20E.%2C%20Refr%26%23xE9%3Bgier%2C%20G.%2C%20Guyeux%2C%20C.%20and%20Sola%2C%20C.%20%282023%29.%20%26lt%3Bb%26gt%3BTowards%20the%20reconstruction%20of%20a%20global%20TB%20history%20using%20a%20new%20pipeline%20%26%23x201C%3BTB-Annotator%26quot%3B%26lt%3B%5C%2Fb%26gt%3B.%20Tuberculosis%20%26lt%3Bi%26gt%3B143%26lt%3B%5C%2Fi%26gt%3B%2C%20102376%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.tube.2023.102376%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.tube.2023.102376%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Towards%20the%20reconstruction%20of%20a%20global%20TB%20history%20using%20a%20new%20pipeline%20%5Cu201cTB-Annotator%5C%22%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaetan%22%2C%22lastName%22%3A%22Senelle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammed%20Rabiu%22%2C%22lastName%22%3A%22Sahal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22La%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Typhaine%22%2C%22lastName%22%3A%22Billard-Pomares%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22Marin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Bridier-Nahmias%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Etienne%22%2C%22lastName%22%3A%22Carbonnelle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guislaine%22%2C%22lastName%22%3A%22Refr%5Cu00e9gier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Guyeux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Sola%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2212%5C%2F2023%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.tube.2023.102376%22%2C%22ISSN%22%3A%2214729792%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS1472979223000744%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-12-31T15%3A27%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22KN8HXK6R%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Motta%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMotta%2C%20I.%2C%20Boeree%2C%20M.%2C%20Chesov%2C%20D.%2C%20Dheda%2C%20K.%2C%20G%26%23xFC%3Bnther%2C%20G.%2C%20Horsburgh%2C%20C.%20R.%2C%20Kherabi%2C%20Y.%2C%20Lange%2C%20C.%2C%20Lienhardt%2C%20C.%2C%20McIlleron%2C%20H.%20M.%2C%20Paton%2C%20N.%20I.%2C%20Stagg%2C%20H.%20R.%2C%20Thwaites%2C%20G.%2C%20Udwadia%2C%20Z.%2C%20Van%20Crevel%2C%20R.%2C%20Vel%26%23xE1%3Bsquez%2C%20G.%20E.%2C%20Wilkinson%2C%20R.%20J.%2C%20Guglielmetti%2C%20L.%2C%20Motta%2C%20I.%2C%20Kherabi%2C%20Y.%2C%20Van%20Crevel%2C%20R.%20and%20Guglielmetti%2C%20L.%20%282023%29.%20%26lt%3Bb%26gt%3BRecent%20advances%20in%20the%20treatment%20of%20tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20Clinical%20Microbiology%20and%20Infection%20S1198743X23003397%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2023.07.013%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2023.07.013%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Recent%20advances%20in%20the%20treatment%20of%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilaria%22%2C%22lastName%22%3A%22Motta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Boeree%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dumitru%22%2C%22lastName%22%3A%22Chesov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keertan%22%2C%22lastName%22%3A%22Dheda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunar%22%2C%22lastName%22%3A%22G%5Cu00fcnther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Robert%22%2C%22lastName%22%3A%22Horsburgh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yousra%22%2C%22lastName%22%3A%22Kherabi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Lienhardt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%20M.%22%2C%22lastName%22%3A%22McIlleron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20I.%22%2C%22lastName%22%3A%22Paton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%20R.%22%2C%22lastName%22%3A%22Stagg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%22%2C%22lastName%22%3A%22Thwaites%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zarir%22%2C%22lastName%22%3A%22Udwadia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reinout%22%2C%22lastName%22%3A%22Van%20Crevel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%20E.%22%2C%22lastName%22%3A%22Vel%5Cu00e1squez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20J.%22%2C%22lastName%22%3A%22Wilkinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilaria%22%2C%22lastName%22%3A%22Motta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yousra%22%2C%22lastName%22%3A%22Kherabi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reinout%22%2C%22lastName%22%3A%22Van%20Crevel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%227%5C%2F2023%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2023.07.013%22%2C%22ISSN%22%3A%221198743X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS1198743X23003397%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-11-13T15%3A55%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22A2TD2VUD%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Holmgaard%20et%20al.%22%2C%22parsedDate%22%3A%222022-11-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHolmgaard%2C%20F.%20B.%2C%20Guglielmetti%2C%20L.%2C%20Lillebaek%2C%20T.%2C%20Andersen%2C%20%26%23xC5%3B.%20B.%2C%20Wejse%2C%20C.%20and%20Dahl%2C%20V.%20N.%20%282022%29.%20%26lt%3Bb%26gt%3BEfficacy%20and%20tolerability%20of%20concomitant%20use%20of%20bedaquiline%20and%20delamanid%20for%20multidrug-%20and%20extensively%20drug-resistant%20tuberculosis%3A%20a%20systematic%20review%20and%20meta-analysis%26lt%3B%5C%2Fb%26gt%3B.%20Clin%20Infect%20Dis%20ciac876%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciac876%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciac876%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Efficacy%20and%20tolerability%20of%20concomitant%20use%20of%20bedaquiline%20and%20delamanid%20for%20multidrug-%20and%20extensively%20drug-resistant%20tuberculosis%3A%20a%20systematic%20review%20and%20meta-analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Freja%20Breth%22%2C%22lastName%22%3A%22Holmgaard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Troels%22%2C%22lastName%22%3A%22Lillebaek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%5Cu00c5se%20Bengaard%22%2C%22lastName%22%3A%22Andersen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Wejse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victor%20Naestholt%22%2C%22lastName%22%3A%22Dahl%22%7D%5D%2C%22abstractNote%22%3A%22The%20introduction%20of%20two%20novel%20drugs%2C%20bedaquiline%20and%20delamanid%2C%20has%20given%20hope%20for%20better%20and%20shorter%20treatments%20of%20drug-resistant%20tuberculosis.%20A%20systematic%20review%20was%20conducted%20to%20evaluate%20the%20efficacy%20and%20safety%20of%20concomitant%20bedaquiline%20and%20delamanid%20administration.%20Pooled%20estimates%20of%20WHO-defined%20favorable%20treatment%20outcome%20and%20significant%20QTc-interval%20prolongation%20%28QTc%20%5Cu2265500%5Cu2005ms%20or%20%5Cu226560%5Cu2005ms%20increase%20from%20baseline%29%20were%20calculated%20using%20a%20random%20effects%20model.%20Thirteen%20studies%20including%20a%20total%20of%201031%20individuals%20with%20multidrug-resistant%5C%2Frifampicin-resistant%20tuberculosis%20who%20received%20bedaquiline%20and%20delamanid%20were%20included.%20The%20pooled%20estimate%20of%20favorable%20treatment%20outcome%20was%2073.1%25%20%2895%25CI%3A%2064.3-81.8%29.%20Sputum%20culture%20conversion%20at%20six%20months%20ranged%20from%2061-95%25.%20Overall%2C%20the%20pooled%20proportion%20of%20QTc-prolongation%20was%207.8%25%20%2895%25CI%3A%204.1-11.6%29%20and%20few%20cardiac%20events%20were%20reported%20%280.8%25%2C%20n%5Cu2009%3D%5Cu20096%5C%2F798%29.%20Rates%20of%20sputum%20culture%20conversion%20and%20favorable%20treatment%20outcome%20were%20high%20in%20patients%20treated%20concomitantly%20with%20bedaquiline%20and%20delamanid%2C%20and%20the%20treatment%20seemed%20tolerable%20with%20low%20rates%20of%20clinically%20significant%20cardiac%20toxicity.%22%2C%22date%22%3A%222022-11-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciac876%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-03-10T14%3A59%3A47Z%22%7D%7D%2C%7B%22key%22%3A%228NJBYM8Z%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wetzstein%20et%20al.%22%2C%22parsedDate%22%3A%222022-10-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BWetzstein%2C%20N.%2C%20Drummer%2C%20A.-P.%2C%20Bockey%2C%20A.%2C%20Herrmann%2C%20E.%2C%20K%26%23xFC%3Bpper-Tetzel%2C%20C.%20P.%2C%20Graf%2C%20C.%2C%20Koch%2C%20B.%2C%20Goetsch%2C%20U.%2C%20Vehreschild%2C%20M.%20J.%20G.%20T.%2C%20Guglielmetti%2C%20L.%2C%20Lange%2C%20B.%2C%20Wichelhaus%2C%20T.%20A.%20and%20Stephan%2C%20C.%20%282022%29.%20%26lt%3Bb%26gt%3BOccurrence%20of%20extrapulmonary%20tuberculosis%20is%20associated%20with%20geographical%20origin%3A%20spatial%20characteristics%20of%20the%20Frankfurt%20TB%20cohort%202013%26%23x2013%3B2018%26lt%3B%5C%2Fb%26gt%3B.%20Infection%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs15010-022-01921-9%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs15010-022-01921-9%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Occurrence%20of%20extrapulmonary%20tuberculosis%20is%20associated%20with%20geographical%20origin%3A%20spatial%20characteristics%20of%20the%20Frankfurt%20TB%20cohort%202013%5Cu20132018%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nils%22%2C%22lastName%22%3A%22Wetzstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alena-Pauline%22%2C%22lastName%22%3A%22Drummer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annabelle%22%2C%22lastName%22%3A%22Bockey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eva%22%2C%22lastName%22%3A%22Herrmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claus%20Philippe%22%2C%22lastName%22%3A%22K%5Cu00fcpper-Tetzel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christiana%22%2C%22lastName%22%3A%22Graf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Koch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Udo%22%2C%22lastName%22%3A%22Goetsch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20J.%20G.%20T.%22%2C%22lastName%22%3A%22Vehreschild%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Berit%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20A.%22%2C%22lastName%22%3A%22Wichelhaus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Stephan%22%7D%5D%2C%22abstractNote%22%3A%22Tuberculosis%20%28TB%29%20is%20caused%20by%20M.%20tuberculosis%20complex%20%28MTB%29%20and%20pulmonary%20tuberculosis%20%28PTB%29%20is%20its%20classical%20manifestation.%20However%2C%20in%20some%20regions%20of%20the%20world%2C%20extrapulmonary%20TB%20%28EPTB%29%20seems%20to%20be%20more%20frequent.%22%2C%22date%22%3A%222022-10-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1007%5C%2Fs15010-022-01921-9%22%2C%22ISSN%22%3A%221439-0973%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs15010-022-01921-9%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-12-28T16%3A07%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22JXJYY2QR%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kherabi%20et%20al.%22%2C%22parsedDate%22%3A%222022-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKherabi%2C%20Y.%2C%20Tunesi%2C%20S.%2C%20Kay%2C%20A.%20and%20Guglielmetti%2C%20L.%20%282022%29.%20%26lt%3Bb%26gt%3BPreventive%20Therapy%20for%20Contacts%20of%20Drug-Resistant%20Tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20Pathogens%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%2C%201189%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fpathogens11101189%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fpathogens11101189%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Preventive%20Therapy%20for%20Contacts%20of%20Drug-Resistant%20Tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yousra%22%2C%22lastName%22%3A%22Kherabi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simone%22%2C%22lastName%22%3A%22Tunesi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Kay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%5D%2C%22abstractNote%22%3A%22Preventing%20the%20progression%20of%20a%20drug-resistant%20tuberculosis%20%28DR-TB%29%20infection%20to%20disease%20is%20an%20important%20pillar%20of%20the%20DR-TB%20elimination%20strategy.%20International%20guidelines%20have%20recently%20proposed%20fluoroquinolones%20for%20tuberculosis%20preventive%20therapy%20%28TPT%29%20in%20DR-TB%20contacts%2C%20although%20the%20available%20evidence%20is%20low%20quality.%20The%20pooled%20data%20from%20small%20observational%20studies%20suggest%20that%20a%20fluoroquinolone-based%20TPT%20is%20safe%2C%20effective%20and%20cost-effective%20as%20a%20preventive%20treatment%20in%20DR-TB%20contacts.%20Three%20clinical%20trials%20are%20currently%20ongoing%20to%20generate%20higher%20quality%20evidence%20on%20the%20efficacy%20of%20levofloxacin%20and%20delamanid%20as%20a%20DR-TB%20preventive%20therapy.%20Additional%20evidence%20is%20also%20needed%2C%20regarding%20TPT%20treatment%20in%20fluoroquinolone-resistant-TB%20contacts%2C%20patient%20and%20health%20care%20worker%20perceptions%20on%20DR-TB%20preventive%20therapy%20for%20contacts%2C%20and%20the%20service%20delivery%20models%20to%20increase%20DR-TPT%20access.%20This%20state-of-the-art%20review%20presents%20the%20current%20literature%20on%20TPT%20for%20contacts%20of%20DR-TB%20cases%2C%20focusing%20on%20the%20available%20evidence%20and%20international%20guidelines.%22%2C%22date%22%3A%222022%5C%2F10%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fpathogens11101189%22%2C%22ISSN%22%3A%222076-0817%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F2076-0817%5C%2F11%5C%2F10%5C%2F1189%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-12-28T16%3A07%3A55Z%22%7D%7D%2C%7B%22key%22%3A%224ND3DBVZ%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Khan%20and%20Guglielmetti%22%2C%22parsedDate%22%3A%222022-09-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKhan%2C%20U.%20and%20Guglielmetti%2C%20L.%20%282022%29.%20%26lt%3Bb%26gt%3BEvidence%20and%20ethical%20considerations%20for%20the%20treatment%20of%20contacts%20exposed%20to%20drug-resistant%20TB%26lt%3B%5C%2Fb%26gt%3B.%20The%20International%20Journal%20of%20Tuberculosis%20and%20Lung%20Disease%20%26lt%3Bi%26gt%3B26%26lt%3B%5C%2Fi%26gt%3B%2C%20900%26%23x2013%3B901%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.22.0328%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.22.0328%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evidence%20and%20ethical%20considerations%20for%20the%20treatment%20of%20contacts%20exposed%20to%20drug-resistant%20TB%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222022-09-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.22.0328%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-04-26T13%3A17%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22YKWPDBTM%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kherabi%20et%20al.%22%2C%22parsedDate%22%3A%222022-09%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKherabi%2C%20Y.%2C%20Fr%26%23xE9%3Bchet-Jachym%2C%20M.%2C%20Rioux%2C%20C.%2C%20Yazdanpanah%2C%20Y.%2C%20M%26%23xE9%3Bcha%26%23xEF%3B%2C%20F.%2C%20Pourcher%2C%20V.%2C%20Robert%2C%20J.%20and%20Guglielmetti%2C%20L.%20%282022%29.%20%26lt%3Bb%26gt%3BRevised%20Definitions%20of%20Tuberculosis%20Resistance%20and%20Treatment%20Outcomes%2C%20France%2C%202006%26%23x2013%3B2019%26lt%3B%5C%2Fb%26gt%3B.%20Emerg%20Infect%20Dis%20%26lt%3Bi%26gt%3B28%26lt%3B%5C%2Fi%26gt%3B%2C%201796%26%23x2013%3B1804%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid2809.220458%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid2809.220458%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Revised%20Definitions%20of%20Tuberculosis%20Resistance%20and%20Treatment%20Outcomes%2C%20France%2C%202006%5Cu20132019%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yousra%22%2C%22lastName%22%3A%22Kherabi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Fr%5Cu00e9chet-Jachym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Rioux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yazdan%22%2C%22lastName%22%3A%22Yazdanpanah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9d%5Cu00e9ric%22%2C%22lastName%22%3A%22M%5Cu00e9cha%5Cu00ef%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9rie%22%2C%22lastName%22%3A%22Pourcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%5D%2C%22abstractNote%22%3A%22Definitions%20of%20resistance%20in%20multidrug-resistant%20tuberculosis%20%28MDR%20TB%29%20and%20extensively%20drug-resistant%20tuberculosis%20%28XDR%20TB%29%20have%20been%20updated.%20Pre%5Cu2013XDR%20TB%2C%20defined%20as%20MDR%20TB%20with%20additional%20resistance%20to%20fluoroquinolones%2C%20and%20XDR%20TB%2C%20with%20additional%20resistance%20to%20bedaquiline%20or%20linezolid%2C%20are%20frequently%20associated%20with%20treatment%20failure%20and%20toxicity.%20We%20retrospectively%20determined%20the%20effects%20of%20pre-XDR%5C%2FXDR%20TB%20resistance%20on%20outcomes%20and%20safety%20of%20MDR%20TB%20treatment%20in%20France.%20The%20study%20included%20298%20patients%20treated%20for%20MDR%20TB%20at%203%20reference%20centers%20during%202006%5Cu20132019.%20Of%20those%2C%20205%20%2868.8%25%29%20cases%20were%20fluoroquinolone-susceptible%20MDR%20TB%20and%2093%20%2831.2%25%29%20were%20pre-XDR%5C%2FXDR%20TB.%20Compared%20with%20fluoroquinolone-susceptible%20MDR%20TB%2C%20pre-XDR%5C%2FXDR%20TB%20was%20associated%20with%20more%20cavitary%20lung%20lesions%20and%20bilateral%20disease%20and%20required%20longer%20treatment.%20Overall%2C%20202%20patients%20%2867.8%25%29%20had%20favorable%20treatment%20outcomes%2C%20with%20no%20significant%20difference%20between%20pre-XDR%5C%2FXDR%20TB%20%2867.7%25%29%20and%20fluoroquinolone-susceptible%20MDR%20TB%20%2867.8%25%3B%20p%20%3D%200.99%29.%20Pre-XDR%5C%2FXDR%20TB%20was%20not%20associated%20with%20higher%20risk%20for%20serious%20adverse%20events.%22%2C%22date%22%3A%222022-9%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.3201%5C%2Feid2809.220458%22%2C%22ISSN%22%3A%221080-6040%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC9423894%5C%2F%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-09-23T13%3A14%3A59Z%22%7D%7D%2C%7B%22key%22%3A%2232L5JEUW%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22De%20Castro%20et%20al.%22%2C%22parsedDate%22%3A%222022-08-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDe%20Castro%2C%20N.%2C%20Mecha%26%23xEF%3B%2C%20F.%2C%20Bachelet%2C%20D.%2C%20Canestri%2C%20A.%2C%20Joly%2C%20V.%2C%20Vandenhende%2C%20M.%2C%20Boutoille%2C%20D.%2C%20Kerjouan%2C%20M.%2C%20Veziris%2C%20N.%2C%20Molina%2C%20J.%20M.%2C%20Grall%2C%20N.%2C%20Tattevin%2C%20P.%2C%20Laou%26%23xE9%3Bnan%2C%20C.%2C%20Yazdanpanah%2C%20Y.%20and%20for%20the%20FAST%20TB%20Study%20Group%20%282022%29.%20%26lt%3Bb%26gt%3BTreatment%20With%20a%20Three-Drug%20Regimen%20for%20Pulmonary%20Tuberculosis%20Based%20on%20Rapid%20Molecular%20Detection%20of%20Isoniazid%20Resistance%3A%20A%20Noninferiority%20Randomized%20Trial%20%28FAST-TB%29%26lt%3B%5C%2Fb%26gt%3B.%20Open%20Forum%20Infectious%20Diseases%20%26lt%3Bi%26gt%3B9%26lt%3B%5C%2Fi%26gt%3B%2C%20ofac353%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fofid%5C%2Fofac353%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fofid%5C%2Fofac353%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Treatment%20With%20a%20Three-Drug%20Regimen%20for%20Pulmonary%20Tuberculosis%20Based%20on%20Rapid%20Molecular%20Detection%20of%20Isoniazid%20Resistance%3A%20A%20Noninferiority%20Randomized%20Trial%20%28FAST-TB%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22De%20Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F%22%2C%22lastName%22%3A%22Mecha%5Cu00ef%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Bachelet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Canestri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%22%2C%22lastName%22%3A%22Joly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Vandenhende%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Boutoille%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Kerjouan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%20M%22%2C%22lastName%22%3A%22Molina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Grall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P%22%2C%22lastName%22%3A%22Tattevin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Laou%5Cu00e9nan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y%22%2C%22lastName%22%3A%22Yazdanpanah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22for%20the%20FAST%20TB%20Study%20Group%22%7D%5D%2C%22abstractNote%22%3A%22The%20rationale%20behind%20the%20use%20of%20ethambutol%20in%20the%20standard%20tuberculosis%20treatment%20is%20to%20prevent%20the%20emergence%20of%20resistance%20to%20rifampicin%20in%20case%20of%20primary%20resistance%20to%20isoniazid.%20We%20evaluated%20whether%20early%20detection%20of%20isoniazid%20resistance%20using%20molecular%20testing%20allows%20the%20use%20an%20ethambutol-free%20regimen.FAST-TB%2C%20a%20phase%204%2C%20French%2C%20multicenter%2C%20open-label%2C%20non-inferiority%20trial%2C%20compared%202%20strategies%3A%20%281%29%20polymerase%20chain%20reaction%20%28PCR%29-based%20detection%20of%20isoniazid%20and%20rifampicin%20resistance%20at%20baseline%20using%20Genotype%20MTBDRplus%20version%202.0%20followed%20by%20ethambutol%20discontinuation%20if%20no%20resistance%20was%20detected%20%28PCR%20arm%29%20and%20%282%29%20a%20standard%204-drug%20combination%2C%20pending%20phenotypic%20drug-susceptibility%20results%20%28C%20arm%29.%20Adult%20patients%20with%20smear-positive%20pulmonary%20tuberculosis%20were%20enrolled.%20The%20primary%20endpoint%20was%20the%20proportion%20of%20patients%20with%20treatment%20success%20defined%20as%20bacteriological%20or%20clinical%20cure%20at%20the%20end%20of%20treatment.%20A%20non-inferiority%20margin%20of%2010%25%20was%20used.Two%20hundred%20three%20patients%20were%20randomized%2C%20104%20in%20the%20PCR%20arm%20and%2099%20in%20the%20C%20arm%3A%2026.6%25%20were%20female%2C%20median%20age%20was%2037%20%28interquartile%20range%2C%2028%5Cu201351%29%20years%2C%2072.4%25%20were%20born%20in%20Africa%2C%20and%205.4%25%20were%20infected%20with%20human%20immunodeficiency%20virus.%20Chest%20x-ray%20showed%20cavities%20in%2064.5%25%20of%20the%20cases.%20Overall%2C%20169%20patients%20met%20criteria%20of%20treatment%20success%3A%2087%20of%20104%20%2883.7%25%29%20in%20the%20PCR%20arm%20and%2082%20of%2099%20%2882.8%25%29%20in%20the%20C%20arm%20with%20a%20difference%20of%20%2B0.8%25%20%2890%25%20confidence%20interval%2C%20%5Cu22127.9%20to%209.6%29%2C%20meeting%20the%20noninferiority%20criteria%20in%20the%20intention-to-treat%20population%20%28P%5Cu2009%3D%5Cu2009.02%29.In%20a%20setting%20with%20low%20prevalence%20of%20primary%20isoniazid%20resistance%2C%20a%203-drug%20combination%20with%20isoniazid%2C%20rifampicin%2C%20and%20pyrazinamide%2C%20based%20on%20rapid%20detection%20of%20isoniazid%20resistance%20using%20molecular%20testing%2C%20was%20noninferior%20to%20starting%20the%20recommended%204-drug%20regimen.%22%2C%22date%22%3A%222022-08-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fofid%5C%2Fofac353%22%2C%22ISSN%22%3A%222328-8957%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fofid%5C%2Fofac353%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-09-23T13%3A20%3A00Z%22%7D%7D%5D%7D
Kherabi, Y., Skouvig Pedersen, O., Lange, C., Bénézit, F., Chesov, D., Codecasa, L. R., Dudnyk, A., Kiria, N., Konstantynovska, O., Marigot-Outtandy, D., Panciu, T.-C., Poignon, C., Sasi, S., Schaub, D., Solodovnikova, V., Vasiliauskaitè, L., Yeghiazaryan, L., Günther, G., Guglielmetti, L. and TBnet/ESGMYC XDR-TB Study Group (2025). Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study. Lancet Reg Health Eur 56, 101380, http://doi.org/10.1016/j.lanepe.2025.101380.
Benhard, J., Monsel, G., Dubée, V., Pavese, P., Rasoldier, V., Garrait, V., Talleux, M., Vuotto, F., Gueneau, R., Pouget-Abadie, X., Thy, M., Palacios, C., Bachir, M., Djossou, F., Tunesi, S., Jachym, M. F., Pourcher, V., Veziris, N. and Bourgarit, A. (2025). Standardized Infliximab Regimen to Treat Severe Central Nervous System Tuberculosis: A Case Series of 18 Patients. Open Forum Infectious Diseases 12, ofaf450, http://doi.org/10.1093/ofid/ofaf450.
Guglielmetti, L., Khan, U., Velásquez, G. E., Gouillou, M., Ali, M. H., Amjad, S., Kamal, F., Abubakirov, A., Ardizzoni, E., Baudin, E., Bektassov, S., Berry, C., Bonnet, M., Chavan, V., Coutisson, S., Dakenova, Z., de Jong, B. C., Dinh, L. V., Ferlazzo, G., Kirakosyan, O., Lachenal, N., Lecca, L., McIlleron, H., Mikanda, K. K., Mucching-Toscano, S., Mulders, W., Mushtaque, H., Nahid, P., Nguyen, D. V., Nguyen, N. V., Oyewusi, L., Motta, I., Panda, S., Patil, Sandip, Pham, T. H., Phan, D. T., Phan, H. T. T., Phillips, P. P. J., Ruiz, J., Rupasinghe, Praharshinie, Salahuddin, N., Sanchez-Garavito, E., Seung, K. J., Asfaw, M. T., Vargas Vasquez, D., Rich, M. L., Varaine, F., Mitnick, C. D., Arora, G., Ashara, V., Bhattacharjee, S., Borkar, R., Chincholikar, N., Choudhary, N., Davuluri, P., Desai, N., Dipika, Dhongade, S., Dulani, D., Ghule, S., Hirani, N., Hurali, P., Irani, R., Jadhav, K., Jadhav, P., Jadhav, R., Joseph, N., Joshi, A., Joshi, P., K, A., K, S., Kamble, M., Kate, R., Keer, T., S Kenche, M., Khandare, H., Koli, P., Kulkarni, A., Patra, S. K., Kuwar, A., Lande, P., Mane, N., Masalge, P., Mishra, P., Mitkari, R., More, A., Munot, P., Murgesh, R., Muthe, S., Nakashe, N., Natarajan, D., Paril, S., Patil, Supriya, Patil, V., Patwardhan, V., Posture, V., Pradeshi, A., Prasad, V., Pundir, B., Rajendran, S., Randhit, Y., Rekart, M., Samant, P., Shaikh, H., Sharma, A., Sharma, N., Sharma, S., Shinde, N., Shinde, S., Shingare, G., Shulka, A., Shriwas, A., Sonawane, L., Sudhindra, U., Suryavanshi, D., Thakare, A., Udare, D., Vaidya, G., Wagh, R., Isenova, L., Konigratbayeva, G., Nurtayeva, G., Zekeshov, N., Chenu, R., Garba, S., Tozzi, D., Yuya-Septoh, F.-J., Thi Tuyet Mai, B., Thi Hai, D., Thi Thuy, D., Thi Oanh, L., Do, B. T., Nguyen, D. T., Nguyen, P. H., Nguyen, T. M. A., Nguyen, Thi Thuy Hanh, Nguyen, T. K. N., Nguyen, T. N., Nguyen, V. K., Nog, N., Pham, T. N., Pham, T. L., Pham, T. A., Phung, T. B., Tran, B. T., Trinh, M. T., Chang, E., Coit, J., Do, J.-M., LaHood, A., O’Brien, K., Okunbor, E., Osso, E., Chávez, V., Larco, P., Mendoza, D., Robles, C., Rojas, A., Salazar, J., Santos, G., Sosa, J., Ticona, C., Carranza, S., Delgado, D., Galarza, C., Murga, G., Ramos, E., Cantaro, K., Huerta, A., Maldonado, J., Nuñez, R., Panduro, K., Rafael, R., Abdul, A., Abedin, S., Afreen, E., Ahmed, Sohail, Ahmed, U., Ali Shah, J., Ashraf, A., Aslam, F., Bashir, Z., Fayyaz, S., Hafeez, K., Hamid, M., Hassan, B., Hussain, M., Irfan, M., Omar, M., Parveen, S., Sunail, S., Farooq, M., Mazhar, B., Munir, S., Sonia, N., Yaseen, M., Zubair, M., Zehra, F., Zulfiqar, I., Abbasi, T., Akbar Abro, G., Ahmed, M., Ahmed, N., Hammad Ali, M., Ali, N., Danish, R., Farhat, A., Gill, S., Hafeez, M., Hussain, G., Inayat, H., Johnson, S., Kamal, F., Kamran, A., Kumar, Sanjeet, Maheshwari, M., Mamsa, S., Massey, S., Mehmood, A., Memon, A., Ali Mirani, A., Naz, S., Rafique Qureshi, T., Roop Moazzam Sheikh, Y., Rafi Siddiqui, M., Singh, B., Soomro, M., Ardizzoni, E., Rigouts, L., Rupasinghe, Praha, Aftab, A., Ahmed, Saman, Adnan Alamgir, M., Ali, Ayaz, Ali, Azhar, Ahmed Ali, S., Ali, S., Altaf, S., Amjad, S., Sahiba Arshad, M., Ausim, S., Basit, A., Ezik, H., Hussain, H., Hyder, S., Inayat, S., Janmohammed, A., Jaseem, K., Jawed, A., Maniar, L., Kumar, P., Kumar, Susheel, Latif, R., Liaqat, S., Ammar Nasser, M., Shakeel, M., Shaikh, S., Siddiqui, A., Singh, J., Sivan, K., Taimoor, M., Zia, N., Li, I., Otepbergenova, M., Dinh, T. H., Do, Thi Thu, Do, Thu Thuong, Le, T. N., Nguyen, K. C., Nguyen, T. T., Nguyen, V. H., Abildayeva, G., Maryash, O., Telegina, E., Tursynbekova, L., Amanzholova, Z., Bektassova, P., Belgozhanova, A., Birimkulova, N., Dyusebayeva, N., Erkut, N., Gusmanov, A., Kassenova, B., Kassym, A., Khazhidinov, K., Lee, T., Magzumova, A., Mussabayeva, M., Omarova, G., Ryapolova, N., Sagyndykova, L., Serekbay, A., Stambekova, A., Tanatarova, G., Uaisov, Z., Zhantuarova, Z., Zhumakairova, G., Arlyapova, N., Bogus, J., Cain, M., Carmona, M., Flanagan, C., McAnaw, S., Scharff, A., Soni, S., Striplin, M., Abebe, S., Alakaye, J., Bulane, A., Custodio, M., Hajison, P., Hetsa, M., Holtzman, D., Khesa, M., Lethola, M., Lebitsa, T., Mahamo, M., Makaka, J., Matoko, M., Mpinda, S., Mohoang, P., Monyaesa, D., Nkundayirazo, P., Ntsane Sesomo Mohale, M., Ntsibane, S., Phate, S., Radebe (Retsepile Tlali), M., Rakhetsi, M., Ranoosi, T., Tamirat, M., Thokoana, M., Alegre, E., Aguilar, C., Armuto, L., Barreda, N., Barreto, M., Cabrera, S., Calderon, R., Castro, M., Chavez, J., Chavez, L., Cheje, H., Cori, L., Dávalos, D., de la Gala, S., Delgadillo, K., Diaz, H., Flores, X., Galarza, J., García, D., Garcia, F., Gaspar, M., Godos, R., Gomez, P., Gonzales, L., Guerrero, L., Inga, S., Jasaycucho, J., Martel, B., Pro Martinez, A., Molina, R., Mugruza, R., Mundaca, H., Nuahan, M., Ore, K., Panduro, L., Peña, O., Perea, S., Pinedo, C., Ponce, Y., Quinte, C., Quiñones, M., Ramos, A., Ramirez, E., Reynoso, R., Reyes, C., Reyes, J., Riccio, V., Robles, B., Rojas, K., Sanabria, O., Saravia, M., Saravia, S., Senador, L., Soberon, J., Soncco, E., Soto, M., Suarez, C., Suarez, M., Suarez, V., Torpoco, E., Torres, O., Torrez, C., Tunque, G., Ugarte, A., Vaderrama, G., Valdivia, W., Valdivia, Y., Valverde, I., Vargas, C., Vargas, J., Vasquez, E., Veliz, J., Villa, D., Villafuerte, S., Villar, G., Villegas, S., Wong, M., Yataco, R., Pham, H., Truong, H., Nguyen, H., Huy, V., Nguyen, V. S., Nguyen, T. M. K., Minh, T., Bui, D. T. T., Truong, V. V., Nguyen, Thi Thu Ha, Coutisson, S., Atger, M., Nadia Baya, S., Bekhiet, M., Boissière, V., Caboclo, R., Chaudhry, M., Cloez, S., Collin, S., Delifer, C., Demaisons, S., Ducher, V., Hewison, C., Ibrahim, M., Lebeau, K., Mazmanian, M., Mirzayeva, R., Moreau, M., Moschioni, M., Pâquet, A., Perrin, C., Pichon, L., Roussel, J., Scotton, M., Austin, A. and Sun, P. (2025). Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial. The Lancet Respiratory Medicine, http://doi.org/10.1016/S2213-2600(25)00194-8.
Serge Diagbouga, P., Djibougou, A. D., Pease, C., Alcaide, A., Berthoux, A., Bruiners, N., Cirillo, D. M., Combary, A., Falchero, N., Handler, D., Kaboré, A., Lardizabal, A., Lopes, A., Loubet, M., Manivet, P., Margain, C., Meunier, V., Mougari, F., Onyuka, A., Rivoiron, S., Sagna, T., Sanvert, M., Sawadogo, L., Simporé, J., Cambau, E. and Gennaro, M. L. (2025). Preliminary performance of the VIDAS TB-IGRA as an aid in the diagnosis of individuals infected with Mycobacterium tuberculosis Ed. Miller, M. B. J Clin Microbiol 63, e01641-24, http://doi.org/10.1128/jcm.01641-24.
Seddon, J. A., Achar, J., Malik, A. A., Hughes, J., Burzynski, J., Chen, C., Denholm, J. T., Dravniece, G., Fox, G. J., Furin, J., Geliukh, E., Goncharova, O., Guglielmetti, L., Harries, A. D., Hesseling, A. C., Nguyen, B. H., Kavenga, F., Khan, U., Kherabi, Y., Kiria, N., Kock, Y., Liu, Q., Mesic, A., Moore, D. A. J., Mubanga, A., Naidoo, L., Nilsen, D., Piubello, A., Reuter, A., Rich, M. L., Satyanarayana, S., Schaaf, H. S., Schoeman, I., Skrahina, A., Udwadia, Z., Khan, P. Y., Esmail, H. and Martinez, L. (2025). Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis. The Lancet Infectious Diseases, http://doi.org/10.1016/S1473-3099(25)00157-4.
Bonnet, I., Orgeur, M., Brossier, F., Sayes, F., Frigui, W., Madacki, J., Varet, H., Chauffour, A., Aubry, A., Veziris, N., Sougakoff, W., Brosch, R. and Tournebize, R. (2025). Evaluation of the role of whiB6 and kdpDE in the dominant multidrug-resistant clone Mycobacterium tuberculosis B0/W148 Ed. Doucet-Populaire, F. C. Microbiol Spectr e03224-24, http://doi.org/10.1128/spectrum.03224-24.
Sadowski, E., Pietrancosta, N., Veyron-Churlet, R., Boucher, J.-L., Pionneau, C., Clodic, G., Matheron, L., Poch, O., Mayer, C., Sachon, E. and Aubry, A. (2025). Characterization of the Orphan Cytochrome P450 CYP135B1 from Mycobacterium tuberculosis : Involvement in Metabolism but Not in the Antibacterial Activity of the Antitubercular Drug SQ109. ACS Infect Dis 11, 869–881, http://doi.org/10.1021/acsinfecdis.4c00893.
Verma, A. K., Kim, R. Q., Lamprecht, D. A., Aguilar-Pérez, C., Wong, S., Veziris, N., Aubry, A., Bartolomé-Nebreda, J. M., Carbajo, R. J., Wetzel, J. and Lamers, M. H. (2025). Structural and mechanistic study of a novel inhibitor analogue of M. tuberculosis cytochrome bc1:aa3. npj Drug Discov 2, 6, http://doi.org/10.1038/s44386-025-00008-3.
Lange, C., Bothamley, G., Günther, G., Guglielmetti, L., Kontsevaya, I., Kuksa, L., Lange, B., Lorent, N., Saluzzo, F., Sester, M., Tebruegge, M., Tunesi, S. and Tweed, C. (2025). A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2025 Update for Clinicians and Scientists. PAI 10, 1–45, http://doi.org/10.20411/pai.v10i2.791.
Kuksa, L., Andrejak, C., Haecker, B., Bothamley, G., Calcagno, A., Cirillo, D. M., Duarte, R., Fatima, R., Ferlazzo, G., Guglielmetti, L., Günther, G., Hewison, C., Horsburgh, C. R., Jäger, T., Kalancha, Y., Otto-Knapp, R., Kranzer, K., Lillebaek, T., Marks, G., Middelkoop, K., Motta, I., Rabinova, V., Sommerfeld, P., Tattevin, P. and Lange, C. (2025). Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy. IJTLD OPEN 2, 117–119, http://doi.org/10.5588/ijtldopen.25.0152.
Guglielmetti, L., Khan, U., Velásquez, G. E., Gouillou, M., Abubakirov, A., Baudin, E., Berikova, E., Berry, C., Bonnet, M., Cellamare, M., Chavan, V., Cox, V., Dakenova, Z., De Jong, B. C., Ferlazzo, G., Karabayev, A., Kirakosyan, O., Kiria, N., Kunda, M., Lachenal, N., Lecca, L., McIlleron, H., Motta, I., Toscano, S. M., Mushtaque, H., Nahid, P., Oyewusi, L., Panda, S., Patil, S., Phillips, P. P. J., Ruiz, J., Salahuddin, N., Garavito, E. S., Seung, K. J., Ticona, E., Trippa, L., Vasquez, D. E. V., Wasserman, S., Rich, M. L., Varaine, F. and Mitnick, C. D. (2025). Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis. N Engl J Med 392, 468–482, http://doi.org/10.1056/NEJMoa2400327.
Soutou, M. A., Allam, C., Abi Fadel, M., Najjar, J., Guyeux, C., Cambau, E. and Sola, C. (2025). An insight into the characterization of L2 Beijing multi-drug resistant tuberculosis: Description of resistance-associated-variants and discovery of Modern 7 L2 sublineage. Infection, Genetics and Evolution 134, 105797, http://doi.org/10.1016/j.meegid.2025.105797.
Guglielmetti, L., Panda, S., Abubakirov, A., Salahuddin, N., Perrin, C. and Mitnick, C. D. (2025). Equitable, personalised medicine for tuberculosis: treating patients, not diseases. The Lancet Respiratory Medicine 13, 382–385, http://doi.org/10.1016/S2213-2600(25)00080-3.
Gerussi, V., Petersen, T., Bonnet, I., Aubry, A., Bachir, M., Gyde, E., Morel, F., Poignon, C., Rached, B., Pourcher, V., Rioux, C., Vallois, D., Veziris, N., Robert, J. and Guglielmetti, L. (2025). Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment. Emerg Infect Dis 31, http://doi.org/10.3201/eid3103.241473.
Guthmann, J.-P., Robert, J., Viriot, D. and Parent Du Chatelet, I. (2025). Incidence, severity and treatment outcome of tuberculosis in the era of the COVID-19 pandemic, France, 2018–2023. Journal of Epidemiology and Population Health 73, 202795, http://doi.org/10.1016/j.jeph.2024.202795.
Kunst, H., Lange, B., Hovardovska, O., Bockey, A., Zenner, D., Andersen, A. B., Hargreaves, S., Pareek, M., Friedland, J. S., Wejse, C., Bothamley, G., Guglielmetti, L., Chesov, D., Tiberi, S., Matteelli, A., Mandalakas, A. M., Heyckendorf, J., Eimer, J., Malhotra, A., Zamora, J., Vasiliu, A., Lange, C. and for the TBnet (2024). Tuberculosis in adult migrants in Europe: a TBnet consensus statement. Eur Respir J 2401612, http://doi.org/10.1183/13993003.01612-2024.
Maitre, T., Godmer, A., Mory, C., Chauffour, A., Mai, T. C., El Helali, N., Aubry, A. and Veziris, N. (2024). Levofloxacin activity at increasing doses in a murine model of fluoroquinolone-susceptible and -resistant tuberculosis Ed. Wasserman, S. Antimicrob Agents Chemother e00583-24, http://doi.org/10.1128/aac.00583-24.
Godefroy, N., Monsel, G., Jauréguiberry, S., Henry, B., Véziris, N., Aubry, A., Robert, J., Jachym, M., Caumes, E. and Pourcher, V. (2024). Lessons learned from treating drug-resistant TB and how to apply these to drug-susceptible TB. int j tuberc lung dis 28, 357–359, http://doi.org/10.5588/ijtld.23.0548.
Rupasinghe, P., Ashraf, A., Barreda, N., Parveen, S., Zubair, M., Calderon, R., Asif, S., Hirani, N., Chingisova, L., Bulane, A., Hang, P. T., Ha, D. T., Ardizzoni, E., Kursheed, N., De Rijk, W. B., Rigouts, L., Guglielmetti, L., Mitnick, C. and De Jong, B. C. (2024). Reduced critical concentration might not have improved MGIT-based DST’s sensitivity to rifampicin Ed. Wasserman, S. Antimicrob Agents Chemother 68, e01701-23, http://doi.org/10.1128/aac.01701-23.
Paulowski, L., Filip, R., Jankovic Makek, M., Guglielmetti, L., Goletti, D., Van Ingen, J., Kranzer, K., Maurer, F. P. and on behalf of ESGMYC (2024). Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis—An ESGMYC collaborative study Ed. Wang, M.-S. PLoS ONE 19, e0291404, http://doi.org/10.1371/journal.pone.0291404.
Veziris, N., Aubry, A., Bonnet, I., Petersen, T., Poignon, C., Gydé, E., Guglielmetti, L. and Robert, J. (2024). Actualités sur la tuberculose à bacilles multirésistants aux antibiotiques et ses nouveaux traitements. Bull Épid Hebdo 127–131, URL: http://beh.santepubliquefrance.fr/beh/2024/6-7/2024_6-7_4.html [Accessed March 2024].
Bérot, V., Monsel, G., Lecorche, E., Halabi-Tawil, M., Maalouf, D., Pourcher, V., Aubry, A., Cambaud, E., Petit, A. and Caumes, E. (2024). Clinical relevance and prognostic impact of the classification between multibacillary and paucibacillary forms of cutaneous tuberculosis: A 24-year retrospective multicenter study. Annales de Dermatologie et de Vénéréologie 151, 103324, http://doi.org/10.1016/j.annder.2024.103324.
Guyeux, C., Senelle, G., Le Meur, A., Supply, P., Gaudin, C., Phelan, J. E., Clark, T. G., Rigouts, L., De Jong, B., Sola, C. and Refrégier, G. (2024). Newly Identified Mycobacterium africanum Lineage 10, Central Africa. Emerg Infect Dis 30, http://doi.org/10.3201/eid3003.231466.
Gedeon, A., Yab, E., Dinut, A., Sadowski, E., Capton, E., Dreneau, A., Petit, J., Gioia, B., Piveteau, C., Djaout, K., Lecat, E., Wehenkel, A. M., Gubellini, F., Mechaly, A., Alzari, P. M., Deprez, B., Baulard, A., Aubry, A., Willand, N. and Petrella, S. (2024). Molecular mechanism of a triazole-containing inhibitor of Mycobacterium tuberculosis DNA gyrase. iScience 27, 110967, http://doi.org/10.1016/j.isci.2024.110967.
Günther, G., Guglielmetti, L., Kherabi, Y., Duarte, R. and Lange, C. (2024). Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe. Clinical Microbiology and Infection 30, 1197.e1-1197.e4, http://doi.org/10.1016/j.cmi.2024.03.009.
Lange, C., Kherabi, Y., Guglielmetti, L., Duarte, R. and Günther, G. (2024). Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe: author’s response. Clinical Microbiology and Infection 30, 1207–1208, http://doi.org/10.1016/j.cmi.2024.06.009.
Friesen, I., Saluzzo, F., Groenheit, R., Aubry, A., Anthony, R., Niemann, S., Mathys, V., Cirillo, D. M., Indra, A., Mathys, V., Atanasova, Y., Obrovac, M., Žmak, L., Pieridou, D., Dvořákov, V., Troels Lillebæk, Kummik, T., Klaos, K., Soini, H., Haanperä-Heikkinen, M., Mentula, S., Jérôme, R., Cambau, E., Niemann, S., Panayotis, I., Papaventsis, D., Bakos, Á., Szél, V., Lőrinczi, L. K., Fitzgibbon, M., Boyle, B., Cirillo, D. M., Giannoni, F., Pole, I., Norvaiša, I., Vasiliauskaite, L., Perrin, M., Deguara, C., Anthony, R., Mengshoel, A. T., Augustynowicz-Kopeć, E., Macedo, R., Coriu, R. M., Porvaznik, I., Klemen, Š., Herrera-León, L., Groenheit, R. and Werngren, J. (2024). Re: “Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe” by Lange et al. Clinical Microbiology and Infection S1198743X24002775, http://doi.org/10.1016/j.cmi.2024.06.001.
Maitre, T., Baulard, A., Aubry, A. and Veziris, N. (2024). Optimizing the use of current antituberculosis drugs to overcome drug resistance in Mycobacterium tuberculosis. Infectious Diseases Now 54, 104807, http://doi.org/10.1016/j.idnow.2023.104807.
Maitre, T., Guglielmetti, L., Robert, J., Aubry, A. and Veziris, N. (2024). Avancées dans l’antibiothérapie de la tuberculose. Rev Prat 74, 239–244.
Campbell, J. R., Brode, S. K., Barry, P., Bastos, M. L., Bonnet, M., Guglielmetti, L., Kempker, R., Klimuk, D., Laborín, R. L., Milanov, V., Singla, R., Skrahina, A., Trajman, A., Van Der Werf, T. S., Viiklepp, P. and Menzies, D. (2023). Association of indicators of extensive disease and rifampin-resistant tuberculosis treatment outcomes: an individual participant data meta-analysis. Thorax thorax-2023-220249, http://doi.org/10.1136/thorax-2023-220249.
Du Cros, P., Greig, J., Alffenaar, J.-W. C., Cross, G. B., Cousins, C., Berry, C., Khan, U., Phillips, P. P. J., Velásquez, G. E., Furin, J., Spigelman, M., Denholm, J. T., Thi, S. S., Tiberi, S., Huang, G. K. L., Marks, G. B., Turkova, A., Guglielmetti, L., Chew, K. L., Nguyen, H. T., Ong, C. W. M., Brigden, G., Singh, K. P., Motta, I., Lange, C., Seddon, J. A., Nyang’wa, B.-T., Maug, A. K. J., Gler, M. T., Dooley, K. E., Quelapio, M., Tsogt, B., Menzies, D., Cox, V., Upton, C. M., Skrahina, A., McKenna, L., Horsburgh, C. R., Dheda, K. and Marais, B. J. (2023). Standards for clinical trials for treating TB. int j tuberc lung dis 27, 885–898, http://doi.org/10.5588/ijtld.23.0341.
Patil, S. B., Tamirat, M., Khazhidinov, K., Ardizzoni, E., Atger, M., Austin, A., Baudin, E., Bekhit, M., Bektasov, S., Berikova, E., Bonnet, M., Caboclo, R., Chaudhry, M., Chavan, V., Cloez, S., Coit, J., Coutisson, S., Dakenova, Z., De Jong, B. C., Delifer, C., Demaisons, S., Do, J. M., Dos Santos Tozzi, D., Ducher, V., Ferlazzo, G., Gouillou, M., Khan, U., Kunda, M., Lachenal, N., LaHood, A. N., Lecca, L., Mazmanian, M., McIlleron, H., Moreau, M., Moschioni, M., Nahid, P., Osso, E., Oyewusi, L., Panda, S., Pâquet, A., Thuong Huu, P., Pichon, L., Rich, M. L., Rupasinghe, P., Salahuddin, N., Sanchez Garavito, E., Seung, K. J., Velásquez, G. E., Vallet, M., Varaine, F., Yuya-Septoh, F. J., Mitnick, C. D. and Guglielmetti, L. (2023). Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial. Trials 24, 773, http://doi.org/10.1186/s13063-023-07701-6.
Sahal, M. R., Senelle, G., La, K., Panda, T. W., Taura, D. W., Guyeux, C., Cambau, E. and Sola, C. (2023). Mycobacterium tuberculosis complex drug-resistance, phylogenetics, and evolution in Nigeria: Comparison with Ghana and Cameroon Ed. Rayner, S. PLoS Negl Trop Dis 17, e0011619, http://doi.org/10.1371/journal.pntd.0011619.
Günther, G., Guglielmetti, L., Leu, C., van Leth, F. and Lange, C. (2023). Relative cost of multidrug-resistant TB medicines in Europe. The International Journal of Tuberculosis and Lung Disease 27, 341–344, http://doi.org/10.5588/ijtld.23.0026.
Campbell, J. R., Chan, E. D., Anderson, L. F., Bonnet, M., Brode, S. K., Cegielski, J. P., Guglielmetti, L., Singla, R., Fox, G. J., Skrahina, A., Rodrigues, D., Kuksa, L., Viiklepp, P. and Menzies, D. (2023). Association of smoking and alcohol use with rifampin-resistant TB treatment outcomes. The International Journal of Tuberculosis and Lung Disease 27, 338–340, http://doi.org/10.5588/ijtld.22.0678.
Guthmann, J.-P., Fraisse, P., Bonnet, I. and Robert, J. (2023). Active tuberculosis screening among the displaced population fleeing Ukraine, France, February to October 2022. Eurosurveillance 28, http://doi.org/10.2807/1560-7917.ES.2023.28.12.2300155.
Aubry, A. and Veziris, N. (2023). La tuberculose, l’une des plus anciennes maladies infectieuses : quelles avancées récentes majeures ? Med Sci (Paris) 39, 203–204, http://doi.org/10.1051/medsci/2023054.
Masini, T., Furin, J., Udwadia, Z. and Guglielmetti, L. (2023). Optimal management of drug-resistant tuberculosis: Can India lead the way? Indian Journal of Medical Research 157, 220, http://doi.org/10.4103/ijmr.ijmr_300_23.
Domínguez, José, Boeree, M. J., Cambau, E., Chesov, D., Conradie, F., Cox, V., Dheda, K., Dudnyk, A., Farhat, M. R., Gagneux, S., Grobusch, M. P., Gröschel, M. I., Guglielmetti, L., Kontsevaya, I., Lange, B., van Leth, F., Lienhardt, C., Mandalakas, Anna M, Maurer, F. P., Merker, M., Miotto, P., Molina-Moya, B., Morel, F., Niemann, S., Veziris, N., Whitelaw, A., Horsburgh, Charles R, Lange, C., Domínguez, Jose, Boeree, M. J., Cambau, E., Chesov, D., Conradie, F., Cox, V., Dheda, K., Dudnyk, A., Farhat, M. R., Gagneux, S., Grobusch, M. P., Gröschel, M. I., Guglielmetti, L., Kontsevaya, I., Lange, B., van Leth, F., Lienhardt, C., Mandalakas, Anna Maria, Maurer, F., Merker, M., Miotto, P., Molina-Moya, B., Morel, F., Niemann, S., Veziris, N., Whitelaw, A., Horsburgh, Charles Robert and Lange, C. (2023). Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement. The Lancet Infectious Diseases, http://doi.org/10.1016/S1473-3099(22)00875-1.
Barbier, E., Fouchet, T., Hartmann, A., Cambau, E., Mougari, F., Dubois, C., Lubetzki, M. and Rochelet, M. (2023). Rapid electrochemical detection of Mycobacterium tuberculosis in sputum by measuring Ag85 activity with disposable carbon sensors. Talanta 253, 123927, http://doi.org/10.1016/j.talanta.2022.123927.
Khan, U. and Guglielmetti, L. (2023). Tailored TPT for drug-resistant TB - promoting equity and access to optimal care. Int J Tuberc Lung Dis 27, 89b–890, http://doi.org/10.5588/ijtld.22.0538.
Günther, G., Guglielmetti, L., Leu, C., Lange, C., van Leth, F., Hasan Hafizi, Khachatryan, N., Aroyan, H., Kabasakalyan, E., Knappik, M., Skrahina, A., Klimuk, D., Nikolenka, A., Muylle, I., Milanov, V., Velkovska, D., Tarinska, N., Bachiyska, E., Jankovic, M., Pieridou, D., Adamide, T., Nicolaou, N., Vasakova, M., Sukholytka, M., Kopeckà, E., Folkvardsen, D. B., Svensson, E., Danilovits, M., Kummik, T., Vasankari, T., Fréchet-Jachym, M., Nahmiash, A., Togonidze, T., Avaliani, Z., Kinkladze, I., Aspindzelashvili, R., Bichashvili, T., Losaberidze, G., Merabishvili, T., Kalsdorf, B., Manika, K., Tsiakitzis, K., Bakos, A., Ægisdóttir, T. R., Michelsen, G. S., Karlsdóttir, K., McLaughlin, A.-M., Fitzgibbon, M., Chemtob, D., Codecasa, L. R., Ferrarese, M., Torri, S., Gjocaj, M., Kuksa, L., Davidaviciene, E., Wirtz, G., Perrin, M., Asciak, A. P., Chesov, D., de Lange, W., Akkerman, O., Poposka, B. I., Mack, U., Jensenius, M., Kvalvik, L., Mengshoel, A. T., Kruczak, K., Duarte, R., Ribeiro, N., Ibraim, E., Kaluzhenina, A., Barkanova, O., Pesut, D., Solovic, I., Svetina, P., Souza-Galvão, M.-L. de, Millet, J.-P., Casas, X., Vives, M., Bruchfeld, J., Dalemo, P., Jonsson, J., Aeschbacher, K., Keller, P., Özkara, S., Tiberi, S., Chen, C., Terleeva, Y. and Dudnyk, A. (2023). Availability and costs of medicines for the treatment of tuberculosis in Europe. Clinical Microbiology and Infection 29, 77–84, http://doi.org/10.1016/j.cmi.2022.07.026.
Senelle, G., Sahal, M. R., La, K., Billard-Pomares, T., Marin, J., Mougari, F., Bridier-Nahmias, A., Carbonnelle, E., Cambau, E., Refrégier, G., Guyeux, C. and Sola, C. (2023). Towards the reconstruction of a global TB history using a new pipeline “TB-Annotator". Tuberculosis 143, 102376, http://doi.org/10.1016/j.tube.2023.102376.
Motta, I., Boeree, M., Chesov, D., Dheda, K., Günther, G., Horsburgh, C. R., Kherabi, Y., Lange, C., Lienhardt, C., McIlleron, H. M., Paton, N. I., Stagg, H. R., Thwaites, G., Udwadia, Z., Van Crevel, R., Velásquez, G. E., Wilkinson, R. J., Guglielmetti, L., Motta, I., Kherabi, Y., Van Crevel, R. and Guglielmetti, L. (2023). Recent advances in the treatment of tuberculosis. Clinical Microbiology and Infection S1198743X23003397, http://doi.org/10.1016/j.cmi.2023.07.013.
Holmgaard, F. B., Guglielmetti, L., Lillebaek, T., Andersen, Å. B., Wejse, C. and Dahl, V. N. (2022). Efficacy and tolerability of concomitant use of bedaquiline and delamanid for multidrug- and extensively drug-resistant tuberculosis: a systematic review and meta-analysis. Clin Infect Dis ciac876, http://doi.org/10.1093/cid/ciac876.
Wetzstein, N., Drummer, A.-P., Bockey, A., Herrmann, E., Küpper-Tetzel, C. P., Graf, C., Koch, B., Goetsch, U., Vehreschild, M. J. G. T., Guglielmetti, L., Lange, B., Wichelhaus, T. A. and Stephan, C. (2022). Occurrence of extrapulmonary tuberculosis is associated with geographical origin: spatial characteristics of the Frankfurt TB cohort 2013–2018. Infection, http://doi.org/10.1007/s15010-022-01921-9.
Kherabi, Y., Tunesi, S., Kay, A. and Guglielmetti, L. (2022). Preventive Therapy for Contacts of Drug-Resistant Tuberculosis. Pathogens 11, 1189, http://doi.org/10.3390/pathogens11101189.
Khan, U. and Guglielmetti, L. (2022). Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB. The International Journal of Tuberculosis and Lung Disease 26, 900–901, http://doi.org/10.5588/ijtld.22.0328.
Kherabi, Y., Fréchet-Jachym, M., Rioux, C., Yazdanpanah, Y., Méchaï, F., Pourcher, V., Robert, J. and Guglielmetti, L. (2022). Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019. Emerg Infect Dis 28, 1796–1804, http://doi.org/10.3201/eid2809.220458.
De Castro, N., Mechaï, F., Bachelet, D., Canestri, A., Joly, V., Vandenhende, M., Boutoille, D., Kerjouan, M., Veziris, N., Molina, J. M., Grall, N., Tattevin, P., Laouénan, C., Yazdanpanah, Y. and for the FAST TB Study Group (2022). Treatment With a Three-Drug Regimen for Pulmonary Tuberculosis Based on Rapid Molecular Detection of Isoniazid Resistance: A Noninferiority Randomized Trial (FAST-TB). Open Forum Infectious Diseases 9, ofac353, http://doi.org/10.1093/ofid/ofac353.